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ABSTRACT 
 
Newcastle disease (ND) is a highly pathogenic disease of poultry and is caused by virulent 
strains of Newcastle disease virus (NDV).  From 1998-2002 there were outbreaks of ND in 
Australia which resulted in significant disruptions to the poultry industry.  In some of these 
outbreaks however, the clinical signs observed in the infected birds did not appear to 
correlate with the World Organisation for Animal Health’s definition of a virulent virus, 
which is based on the molecular sequence at the fusion protein cleavage site.  In one 
particular outbreak at Meredith, Victoria, in 2002, a virulent virus was isolated, despite only 
a minimal increase in mortalities on the property.   Therefore, this thesis has attempted to 
determine whether, in addition to the fusion protein cleavage site, there are other 
molecular determinants of pathogenicity for NDV. 
 
The pathogenicity of the Meredith/02 virus was first characterised by experimental 
infection of specific pathogen free (SPF) chickens.  The Meredith/02 virus was compared 
with an avirulent virus (Peats Ridge/98) and two other virulent viruses (Herts 33/56 and 
Texas GB) using clinical evaluation, histopathology, immunohistochemistry and molecular 
techniques.  The Meredith/02 virus showed minimal clinical signs in a small number of 
birds and no mortalities.  The birds infected with Herts 33/56 and Texas GB were all 
euthanased at day 2 post inoculation and day 5 post inoculation respectively.  The minimal 
pathogenicity of the Meredith/02 virus was associated with decreased virus replication and 
antigen distribution in a number of tissues when compared with the Herts 33/56 and Texas 
GB viruses. 
 
Further characterisation of the Meredith/02 virus showed that it contained a virulent fusion 
protein cleavage site motif of 112RRQRRF117, which is exactly the same as the cleavage 
site of Herts 33/56.  The mean death time in eggs classified the virus as a mesogenic 
NDV.  Sequence analysis showed a number of amino acid differences throughout the 
genomes of the four viruses studied, however none of these differences were in key areas 
such as glycosylation sites.  The Meredith/02 virus was also shown to replicate well in 
embryonated eggs, throughout the chorioallantoic membrane and internal organs of the 
embryo, including the lung, liver and kidneys.  This is consistent with other virulent NDVs.   
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The V protein of the Meredith/02 virus was investigated for its role in potential attenuation 
of the virus via modulation of the host innate immune response.  However there was no 
difference found in the ability of the Meredith/02 V protein to antagonise type I interferon 
in-vitro when compared with the Herts 33/56 virus.   
 
In an attempt to analyse the viral replication complex, to identify a specific protein that may 
be involved with the minimal pathogenicity of the Meredith/02 virus, the transcription 
gradient of the virus was characterized.  It was found that the Meredith/02 virus has an 
increased transcription gradient when compared with the Herts 33/56 virus.  The gradient 
of the Meredith/02 virus was particularly steep at the N-P junction, with particularly low 
levels of the P gene transcribed at 24 hours.  However, gene start and end sequences at 
this location did not vary between the two viruses, thereby indicating that the N and P 
proteins are less likely to be associated with the steepened gradient.  Instead, this 
suggests a possible role for the large polymerase protein in decreasing transcription.  
 
Whilst this research has not yet identified specific molecular sequences responsible for the 
minimal pathogenicity of the Meredith/02 virus despite its virulent fusion protein cleavage 
site, it has focused the investigation on components of the viral replication complex.  
Therefore directions for further research include investigating the role of the replication 
complex, in particular, the large polymerase (L) gene in the pathogenicity of Australian 
NDVs.  This could also incorporate further work on the individual proteins via the use of 
minigenome assays, or by utilising reverse genetics and full-length virus clones.  
Additional transcriptional profiles of other mesogenic viruses could also be analysed.  It 
would also be interesting to compare the pathogenicity of the Meredith/02 virus with other 
viruses from the 1998-2002 Australian outbreaks in an experimental setting.   
 
The outcomes from this work have provided greater insight into an Australian NDV which 
until now has not been well characterised.  This research is also relevant to the broader 
group of mesogenic NDVs which are not easily classified according to their fusion protein 
cleavage sites. 
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CHAPTER 1  
INTRODUCTION 
 
Viruses were first discovered as a cause of disease during the late 1800s with the 
discovery of the tobacco mosaic virus.1  Ever since this time, researchers have 
investigated the properties of viruses that make them pathogenic in a particular host.  The 
pathogenicity of a virus can be described in numerous ways, including the ability to 
replicate, transmit or to cause disease.  In understanding the factors that enable these 
viruses to exert their damaging effects, it is hoped that diagnostic techniques, therapeutics 
and preventative measures such as vaccines may be developed to counteract the viral 
machinery.  Molecular analysis of the viral genome has provided immense insights into the 
molecular basis for pathogenicity for a number of viruses such as avian influenza virus and 
Newcastle disease virus (NDV) .2, 3  The use of cloning techniques has allowed for specific 
sequences and proteins to be examined in isolation and manipulated in an experimental 
setting.  This has also led to the development of diagnostic tests to target specific 
pathogenic sequences which are then able to inform risk assessments and control 
measures for the pathogen in question.   
 
This thesis investigates the molecular basis for pathogenicity of NDV in poultry.  NDV is a 
paramyxovirus which is able to infect a wide range of avian species and can be particularly 
pathogenic in chickens.  Similar to avian influenza virus, it has a range of pathogenicity 
which varies with the virus strain and the host species.  Newcastle disease (ND) has 
significant impacts throughout the much of the world in areas of Central and South 
America, Asia, the Middle East and Africa, where it is endemic.4  It is also a significant 
biosecurity risk in ND free countries where sporadic outbreaks can have great impacts on 
trade.  Australia is currently free of virulent ND, however outbreaks have occurred in the 
past, with the most recent outbreaks occurring between1998-2002.   
 
The significance of ND is reflected in its status as a notifiable disease by the World Animal 
Health organization.5  Only virulent strains of NDV are able to cause ND and are therefore 
notifiable.  As such, the definition of a virulent NDV strain is particularly important and is 
currently based upon a known determinant of pathogenicity, the fusion protein cleavage 
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site.6  In particular, the molecular sequence of multiple basic amino acids at the cleavage 
site, along with a phenylalanine at position 117, has been correlated with pathogenicity.7, 8   
 
In order to further investigate the molecular basis for NDV pathogenicity, this work has 
focused on an outbreak of ND in Australia in 2002.  During this outbreak a virus was 
isolated from a layer property in Meredith, Victoria.  Molecular sequencing of the fusion 
protein of this virus showed that it had a cleavage site motif that was classified as virulent, 
however the clinical signs observed in the field did not appear to correlate well with this 
classification.  The clinical signs were mild and mortalities were lower than expected.  
Therefore, it was hypothesized that there may be other molecular determinants of 
pathogenicity, other than this cleavage site motif.  The overall aim of this research is to 
identify these other determinants of pathogenicity. 
 
Chapter 2 of this thesis reviews the current literature surrounding ND in Australia, including 
a summary of research into molecular pathogenicity determinants for NDV.  The 
methodology used throughout this work is presented in detail in Chapter 3, however 
methods specific to certain sections will also be included in the relevant chapter.   
 
The clinical signs that were observed in the poultry involved with the outbreak at Meredith 
were fairly mild, with the most significant observations being a drop in egg production and 
only a minimal increase in mortalities over the outbreak period.9  In order to further 
investigate the phenotype associated with the virus, it was necessary to determine 
whether these observed clinical features were reproducible.  As such, chickens were 
inoculated with the Meredith/02 virus experimentally and various measures of 
pathogenicity were assessed.  This work is presented in Chapter 4.   
 
After investigating the pathogenic features of the Meredith/02 virus, it was further 
characterized by standard virological techniques in Chapter 5.  These studies were 
conducted in order to develop baseline parameters that would allow for comparisons to be 
made with other ND viruses. These measures included virus isolation, mean death time in 
eggs, histopathology of infected chicken embryos and whole genome sequencing.   
 
Based on results from previous studies that identified the NDV V protein as an antagonist 
of the chicken innate immune system, Chapter 6 investigated the V protein of the 
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Meredith/02 and its role in pathogenicity.10, 11  The Meredith virus was compared with the 
velogenic Herts 33/56 virus for its ability to induce interferon expression and to antagonize 
interferon-α, interferon-β and Mx in-vitro. 
 
In Chapter seven, the transcriptional profile of the Meredith/02 virus was compared with 
the Herts 33/56 virus.  This work was undertaken to attempt to identify particular NDV 
genes which may be associated with the attenuated phenotype of the Meredith/02 virus 
and to follow up on work that has suggested that the viral replication complex may be 
associated with pathogenicity.12, 13   
 
Chapter 8 concludes this thesis with a discussion of the research undertaken and 
recommendations for further investigations. 
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CHAPTER 2  
LITERATURE REVIEW 
2.1 Introduction 
Newcastle disease (ND) is an extremely important viral disease of poultry and wild birds 
worldwide.  It is caused by virulent strains of avian paramyxovirus type 1 (APMV-1) with 
APMV-1 being synonymous with Newcastle disease virus (NDV).   
 
The OIE defines ND as an ‘infection of poultry caused by a virus of avian paramyxovirus 
serotype 1 (APMV-1) that meets one of the following criteria for virulence: 
 
a) The virus has an intracerebral pathogenicity index (ICPI) in day-old chicks (Gallus 
gallus) of 0.7 or greater, 
or 
b) Multiple basic amino acids have been demonstrated in the virus (either directly or 
by deduction) at the C-terminus of the F2 protein and a phenylalanine at residue 
117.’6 
The disease rivals avian influenza in its impacts on trade, animal welfare and biodiversity 
and is therefore an OIE notifiable disease.5  In the developing world, poultry production is 
a significant contributor to poverty alleviation and therefore ND outbreaks can also have 
vast socioeconomic consequences.14   
2.2 History 
2.2.1 Worldwide occurrence  
ND is so named because it was first recognised as a cause of disease in poultry in 
Newcastle upon Tyne in England by Doyle in 1926.15  Doyle was the first person to 
investigate the aetiological agent of the disease via laboratory experiments and noted that 
it was a filterable virus that was unrelated to avian influenza virus.  However, the first 
known reports of the disease were from outbreaks in Jakarta, Indonesia in the previous 
year, in which very high mortalities were seen in affected poultry.16, 17  The exact origin of 
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the virus is still unknown, however given that the clinical signs of avian influenza and ND 
are similar, it is possible that the virus had been circulating in poultry over an extended 
period of time without the recognition that it was a distinct entity.  In fact, there were 
reports of disease in Europe and Scotland that resemble ND before 1926.18, 19 
 
The spread of ND throughout the world during the 20th century occurred via a number of 
panzootics, although the waves of disease were not always distinct and the epidemiology 
of the disease varied significantly between affected countries.  The history of ND 
throughout the world has been extensively reviewed in a number of publications by 
Alexander but in particular, in his publication of 2001.20 
 
The first panzootic occurred during the 1920s and 1930s with viruses detected throughout 
the world that were very similar to the strain isolated by Doyle.  However, whilst these 
viruses were almost identical to the original NDV, the range of clinical signs that they 
produced in poultry were quite variable.21 The highly pathogenic forms of ND initially 
spread throughout Indonesia, England and India.  In India the disease was termed 
‘Ranikhet disease’ after the town in which it was first seen in 1927, a name which is still in 
use today.22, 23  It has also previously been known as ‘Fowl Pest’, although confusingly this 
term is also used to refer to avian influenza virus infection.24  It is debatable as to how long 
this wave of disease continued, although researchers believe that it took more than two 
decades to establish in most countries.19  During this time, two reference strains of ND 
were isolated; Texas GB and Herts 33.25  These viruses are now used as challenge strains 
in vaccine production. 
 
Whilst the original reports of NDV were typically associated with the highly pathogenic, 
viscerotropic form of the disease, a slightly milder strain of the virus was later detected and 
studied, after isolation in California from chickens with neurological and respiratory signs.26  
The disease was termed pneumoencephalitis and it was shown by Beach that the virus 
could increase in virulence for chickens with repeated passage in chickens and eggs.  This 
form is consistent with neurotropic velogenic NDV.21 
 
The second panzootic of NDV is thought to have started during the 1960s and took a 
considerably shorter time to spread throughout the world compared with the previous wave 
of disease.  It is estimated that it only took four years for the disease to be detected in 
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most countries.20 The greater speed of spread is most likely associated with increased 
commercialisation of poultry and poultry feed, along with faster transportation speeds.19  In 
particular, the movement of caged birds is known to have been key in the introduction of 
disease into the USA, in which psittacine and mynah birds were linked to outbreaks of 
disease.27  In 1970, high mortalities of birds in a pet shop in New York City were reported 
and ongoing outbreaks of disease in captive birds were also seen over the next few years 
from 1970-1972.  Disease outbreaks in poultry were also investigated during this time and 
were often associated with the importation of game birds or other poultry, in some cases 
from Mexico or Puerto Rico.27  After this, more stringent quarantine restrictions were 
enforced on the importation of birds to the USA. 
 
During the 1970s there were a small number of reports of another virulent NDV spreading 
throughout the world, however the next true third panzootic occurred during the 1980s and 
was associated with pigeons.19  A virus isolate obtained from a pigeon in Iraq in 1978 was 
identified as an avian paramyxovirus-1 with similar characteristics to NDV.28  The virus is 
now known as pigeon paramyxovirus (PPMV-1).  The viruses found in the Middle East 
then spread to Europe in the early 1980s.29  After this, there were detections of the pigeon 
virus in poultry, often as a result of contaminated feed, as seen in Great Britain in 1984.30 
 
The fourth panzootic is ongoing and started in the mid-1980s in Southeast Asia.  The 
viruses responsible for this panzootic are from genotype VII.4, 31  Currently a potential fifth 
panzootic has been described with the circulation of viruses from sub-genotypes VIIh and 
VIIi, likely originating from Indonesia in 2009.32, 33 
 
Whilst ND is still prevalent worldwide, virulent forms are controlled in most developed 
countries by the use of strict biosecurity protocols and vaccination.  However, even with 
access to vaccination, outbreaks still occur.34, 35  In addition, APMV-1 strains continually 
circulate in wild birds, at times causing mass mortalities particularly in double-crested 
cormorants and posing ongoing risks to commercial poultry.21 
 
2.2.2 Newcastle disease in Australia  
ND has been seen in Australia on only a few occasions since it was first reported in the 
1920s. However, avirulent NDV is known to circulate in all parts of Australia with ongoing 
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detections in wild birds and poultry. 
 
1930s: Virulent NDV in Victoria 
ND was first detected in Australia in 1930 in Inverloch, Victoria.  The disease subsequently 
spread throughout Melbourne before it was brought under control.  A second outbreak 
occurred in 1932, also in Victoria and was eradicated in 1932.36, 37  The virus isolated from 
the 1932 outbreak is the oldest isolate of NDV from Australia and is known as the Albiston-
Gorrie strain. 
1960s:  Avirulent endemic NDV strains 
In 1963, chickens exported from Australia to Malaysia were reported to be infected with 
ND, however serosurveys conducted in response to this claim did not find any evidence of 
the virus in the Australian poultry flock 37, 38.   The next detection of ND in Australia was not 
made until 1966, when a lentogenic strain termed ‘V4’ was found in broilers in Queensland 
as part of a mixed infection with other viral and parasitic agents 39. Experimentally, the 
virus was shown to have an intracerebral pathogenicity index (ICPI) of 0.1, consistent with 
an avirulent virus and inoculation of embryonated eggs did not produce embyro deaths.40  
However subsequent testing of the V4 strain showed higher ICPIs of 0.91 and 1.02.41  The 
V4 virus was then found to be widespread throughout Australia, although it was never 
shown to cause clinical disease on its own.42, 43  As a result of this lack of pathogenicity, no 
attempt was made to eradicate the virus and it was then investigated for use as a vaccine 
due to its protective effects against challenge with the virulent Albiston-Gorrie NDV 
strain.44, 45  Further avirulent viruses were also isolated during the 1960s and 1970s.46, 47  
Genetically, these Australian viruses were distinct from exotic ND viruses and it is not 
known where they originated from, although spillover from wild birds was suggested when 
serological surveys in wild waterfowl demonstrated the presence of NDV antibodies.48  
However, testing of wild birds thought likely to introduce NDV into Australia in far north 
Queensland did not detect any ND virus or antibodies.  This testing involved both serology 
and virus isolation from 130 species, including pittas, pigeons, herons, gulls and terns.49 
 
In comparison with other virulent NDV strains, these Australian lentogenic strains were 
found to have extended open reading frames of the haemagglutinin-neuraminidase (HN) 
gene of 45 amino acids.50  It was thought that this HN extension may be associated with 
the low pathogenicity of the V4 strain.41 
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1978:  Avirulent NDV in an imported cockatoo 
The next isolation of a genetically distinct ND virus in Australia was in 1978, when an 
illegally imported cockatoo from Indonesia was found to be infected.51  This virus was a 
lentogenic strain and did not cause severe disease, unlike the strains that caused 
outbreaks in psittacines in the United States in the 1970s.  It is now commonly referred to 
as the Eaves-Grimes strain. 
1980s-1990s:  Evolution of avirulent ND viruses 
Throughout the 1980s and 1990s, detections of NDV from chickens continued and were all 
determined to be avirulent viruses.  Some of these viruses had been isolated from birds 
with respiratory signs, however infectious bronchitis virus was usually deemed to the be 
the aetiological agent of disease in these cases.50 
1998-2002:  Virulent NDV outbreaks in New South Wales and Victoria 
During August 1998, an isolate of NDV was detected in a flock of poultry from Peat’s 
Ridge in NSW.  This virus was isolated from birds that were showing signs of a syndrome 
termed ‘late respiratory disease’, which was thought to be caused by a combination of 
agents such as infectious bronchitis virus, Mycoplasma sp., Escherichia coli and possibly 
NDV.52  This virus was considered avirulent and had an F protein cleavage site motif of 
RRQGRL, consistent with avirulent strains.  It also had an HN extension of 9 amino acids, 
indicating a significant evolutionary change from previous Australian isolates.53   
 
It was not long after the investigation of ‘late respiratory disease’ at Peat’s Ridge, that the 
first outbreak of virulent NDV since 1932 was confirmed in Australia in September 1998.54-
56  Sequencing of the F gene cleavage site of this virus showed a virulent motif of 
RRQRRF which was only two nucleotides different from the avirulent sequence from Peats 
Ridge.53  The cleavage site of ancestor ND viruses is typically well conserved and the 
fusion protein as a whole is under negative selection pressure, indicating that unusual 
circumstances may have been involved in the generation of this virulent virus.57 
 
As a result of the detection of this virus, an eradication campaign was instigated.  
Outbreaks then occurred throughout 1998 until 2002, in New South Wales and Victoria 
and caused great disruption to the Australian poultry industry along with the 
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implementation of a mass vaccination program.  A summary of these outbreaks during this 
period is shown in Table 2.1 with a map of the location of outbreaks in Figure 2.1. 
 
 
Figure 2.1  Map of Australian ND outbreak locations (1998-2002) 
 
The initial outbreaks in 1998 occurred in western Sydney at Dean Park and Glenorie and 
again Rylstone, all in New South Wales.55, 56  Whilst the viruses involved were designated 
as virulent with ICPIs between 1.64 and 1.9, it was noted that they had reduced 
transmissibility compared with other known NDV isolates.55  However, in most cases the 
clinical signs seen during these outbreaks were consistent with velogenic neurotropic 
NDV, including torticollis and flaccid paralysis.58  The outbreaks were controlled by 
stamping out and the implementation of restricted movement zones as per government 
protocol.  In addition, sentinel chickens were placed on farms to detect the presence of 
residual virus.56 
 
However, in April 1999 NDV was once again detected in the Mangrove Mountain region of 
NSW, an area with a high density of poultry production.  This detection was the start of the 
greatest outbreak of NDV in Australia to date.56  Control of the Mangrove Mountain 
outbreak involved the culling of approximately two million birds at a cost of roughly $26 
million AUD.59, 60  Vaccination was then instituted in December 1999 using the live V4 
vaccine.60 Subsequent Australia-wide surveillance for NDV in 2000 showed that there was 
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a prevalence of 39.8% seropositive farms, although no virulent viruses were detected at 
this time.61, 62 
 
Two years after the disease events in NSW, Victoria also experienced an isolated 
outbreak.  In May 2002, a layer farm at Meredith was found to be infected with virulent 
NDV.  This outbreak differed from the previous outbreaks in that the clinical signs were not 
as severe as previously seen.  The major sign involved in this case was a drop in egg 
production of approximately 40% with only a very slight increase in mortality in one shed; 
from 0.4 to 0.8% per month.9  However, the Meredith isolate as per the other 1998-2002 
Australian isolates contained a virulent F protein cleavage site (RRQRRF) and hence was 
reportable to the OIE.  As a result, the Meredith flock was culled to eliminate the disease.9   
 
Finally, the last outbreaks of virulent NDV in Australia were detected in October and 
November 2002 in Horsley Park near Sydney.  After depopulation of these properties, 
widespread surveillance was undertaken to ensure that there were no other virulent 
viruses present within the Australian poultry flock. Then in June 2003, Australia was 
officially recognised by the OIE as being free from virulent ND and no further outbreaks 
have occurred since that date.63 
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Date Location Species Clinical signs Reference 
September 
1998 
Blacktown = 
Dean Park 
(WS) 
 
Mixed poultry: caged 
layers, free-range 
layers, broilers, pullets, 
ostriches, geese, one 
duck and feral pigeons 
30% case 
mortality rate 
56, 58 
September 
1998 
Glenorie 
(WS) 
Caged and free-range 
layers 
Increased 
mortalities and 
neurological 
disease 
58 
(unpublished data) 
September 
1998 
Rylstone Free-range broilers N/A 58 
April 1999 Mangrove 
Mountain 
(near 
Gosford) 
15 layer and broiler 
farms 
Increased 
mortalities and 
neurological 
disease 
56 
August 1999 Schofields 
(WS) 
N/A N/A 56 
December 
1999 – 
February 
2000 
Orchard Hills 
(WS) 
Layer Minimal disease, 
mild ataxia 
56, 64 (unpublished data) 
 Llandilo (WS) Layer Minimal disease, 
poor shells 
56, 64 (unpublished data) 
 Marsden 
Park (WS) 
N/A Mild increase in 
mortalities and 
neurological 
signs 
(unpublished data) 
 Rossmore 
(WS) 
N/A Occasional birds 
with neurological 
signs 
(unpublished data) 
February 
2000 
Moonbi 
(Tamworth) 
Layer Increase 
mortality with 
nervous signs  
56 
(unpublished data) 
May 2002 Meredith 
(Victoria) 
Layer Egg drop 65 
October –
November 
2002 
Horsley Park 
(WS) 
Layer N/A 66, 67 
Table 2.1  Outbreaks of ND in Australian from 1998-2002 (WS: Western Sydney; N/A: not available) 
During these outbreaks significant questions were raised regarding the origin of the 
viruses.  It was therefore necessary to determine whether the initial outbreak had occurred 
due to an exotic isolate or due to a mutation of the endemic avirulent strains.  Molecular 
sequencing of these strains was undertaken in the first few days of the outbreak and 
showed that they were unique to Australia and had most likely arisen from the 1998 Peat’s 
Ridge isolate, now termed the ‘progenitor’ virus.53   In fact, the progenitor strain was 
detected on the vast majority of affected farms in conjunction with a virulent virus.  
Sequencing of the HN gene of the progenitor virus and the virulent outbreak strains 
showed that they all had a 9 amino acid extension that was similar to two of the previous 
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avirulent Australia viruses (NSW 12/86 and Qld 1/87).53  This extension had not been seen 
elsewhere in the world and as such it was presumed that the virulent viruses had arisen 
from endemic Australian strains.   
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2.3 Aetiology 
NDV is a member of the family Paramxyoviridae, subfamily Paramyxovirinae and genus 
Avulavirus.  It is a single-strand, negative sense RNA virus, as per the other members of 
the family.  Along with NDV (APMV-1) and PPMV-1 (APMV-1, genotype VI), the genus 
Avulavirus contains the avian paramyxoviruses serotypes 2-12 and a putative APMV-13 
serotype.68, 69  ND is defined by the OIE as infection of poultry with virulent forms of APMV-
1.6   
2.3.1 Structure 
The genome of NDV is approximately 15 kb long with most current isolates having a 
genome length of 15,192 nt or 15,198 nt.  ND viruses isolated prior to 1960 predominantly 
had genomes of 15,186 nucleotides.70  The Australian ND viruses isolated from the 1998-
2002 outbreaks also have genome lengths of 15,186 nt.71  The viral genome contains six 
genes, from 3’ to 5’; nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), 
haemagluttinin-neuraminidase (HN) and the large RNA polymerase (L).  The six genes 
encode seven proteins with transcriptional editing of the P gene producing the V protein 
(Figure 2.2).  
 
As per the other members of the paramyxovirus family, NDV is an enveloped virus and 
contains both fusion (F) and haemagglutinin-neuraminadase (HN) glycoproteins proteins 
on its surface.  The virions are spherical in shape and the envelope is produced by 
budding from the host cell.72  Within the virions, the proteins associated with the helical 
nucleocapsid are the N, P and L proteins.  The M protein is a structural protein, which is 
found on the inner surface of the lipid envelope. 
 
 
 
 
Figure 2.2  NDV RNA genome showing the V protein which is produced via RNA editing of the P gene 
2.3.2 Virus entry 
The envelope proteins are responsible for viral entry into a target cell.  The HN protein 
mediates cell attachment, whereas the F protein is necessary for cell fusion.  The HN 
protein requires sialic acid residues on the surface of the host cell in order to bind.  It then 
14 
 
also plays a role in viral release from the cell via its neuraminidase activity which removes 
sialic acid receptors.73  The fusion protein is a key component of the pathogenesis and 
virulence of the virus, as the ability of the virus to enter a cell is dependent upon the 
cleavage of the inactive F0 protein by cellular proteases.  This is discussed further in the 
section on pathogenicity determinants (Chapter 2.8.3).  After fusion of the virus envelope 
with the host cell membrane, the viral nucleocapsid is released into the cytoplasm. 
2.3.3 Replication 
After entry into the cell, transcription of the negative sense viral genome occurs in the 
cytoplasm.  The RNA-dependent RNA polymerase (RdRP) transcribes the leader RNA 
and each of the viral genes into individual 5’ capped and 3’ polyadenylated mRNAs, along 
a transcription gradient.74  This leads to larger numbers of mRNA transcripts being 
produced from genes closest to the promoter region when compared with genes closer to 
the 5’ end.  The individual mRNAs are then translated into viral proteins.   
 
After sufficient numbers of viral proteins are produced, transcription stops and replication 
begins.  Replication produces a full-length antigenome of the negative sense RNA, in 
association with the N protein.75  Each of the N subunits is associated with 6 nucleotides of 
genomic RNA and hence adheres to the ‘rule-of-six’ of most paramyxoviruses.76  This 
feature explains why the genome sizes of all NDVs are always a multiple of six.   
2.3.4 Assembly and Release 
Nucleocapsids assemble in the cytoplasm of the host cell with initial attachment of the N 
protein to the RNA to form a helix followed by integration of the P and L proteins.  The 
nucleocapsids are then transported to the plasma membrane and are connected to the F 
and HN surface glycoproteins via the M protein.  The viral envelope is formed during the 
process of budding from the host cell.75 
2.4 Classification 
Whilst NDVs are of a single serotype, they can be classified genetically in a number of 
ways.  They have traditionally been classified on the basis of the full length F gene 
sequence and have been described either in terms of lineages and sub-lineages, or 
classes and genotypes.77-80  The use of multiple classification systems has led to 
15 
 
confusion and so efforts have been made to determine the most appropriate universal 
system.  Such a system has been developed based on F gene phylogeny and evolutionary 
distances.81  The fusion gene is usually chosen for comparative analysis because it is 
more likely to show genetic variation than other internal nucleocapsid genes.77  For the 
purposes of this thesis, the genotype classification system will be used as it is currently the 
most widely utilized.   
 
Using this classification system, two clades of NDV are recognised; class I and class II.  
Class I viruses have a genome of 15,198 nt, whereas class II viruses have a genomes of 
15,186 nt (“historic” isolates) and 15,192 nt (isolated after 1960).78  The majority of the 
class I viruses have been isolated from wild birds (predominantly waterfowl and 
shorebirds) and are avirulent, whereas the class II viruses contain isolates from both wild 
birds and poultry and contain both virulent  and avirulent strains.70  These two classes can 
then be further classified into genotypes.  Class I viruses contain a single genotype, 
whereas Class II viruses contain 18 genotypes.82 
2.5 Epidemiology 
2.5.1 Hosts 
NDV has the ability to infect a wide variety of avian species, however the pathogenicity of 
the virus amongst species is variable.  Poultry are most susceptible to ND, with high 
mortalities seen in layer and broiler farms.  Other commercial species such as turkeys and 
ducks are also known to be susceptible to ND but clinical signs are typically less severe 
than those seen in chickens.83  In addition, viruses with virulent fusion protein cleavage 
sites have been detected in commercial ducks with no apparent clinical signs seen in the 
infected birds, thus posing a potential risk to other poultry species.84   
 
Whilst waterfowl are thought to be reservoirs of avirulent ND viruses, the epidemiology of 
these viruses in wild birds is unclear.85  However, the potential for these viruses to become 
virulent was seen experimentally when a lentogenic NDV isolated from a migratory goose 
was passaged in chickens, resulting in a virulent fusion protein cleavage site but only mild 
clinical signs in poultry.86 
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Disease associated with NDV infection has also been seen in significant outbreaks in wild 
birds such as cormorants, pigeons, pelicans, gulls and peacocks.87-90  In 1990, an 
epizootic of ND occurred in double-crested cormorants (Phalacrocorax auritus), white 
pelicans (Pelecanus erthrorhynchos) and gulls (Larus spp.) in Canada.91  Similar 
outbreaks in cormorants were also seen in North America.  Subsequently, viruses very 
similar to these wild bird isolates were found in turkeys in North Dakota and it is postulated 
that the turkeys were infected by the wild birds.92  Migratory birds have also been 
implicated in the infection of chickens and turkeys in Great Britain in 1997.93  In addition, 
wild pigeons and feed contaminated with pigeon faeces were thought to be responsible for 
ND outbreaks in poultry the UK.94   
 
NDV is also recognised as a zoonotic agent.  The predominant clinical sign shown by 
those infected is conjunctivitis, however there have also been occasional reports of ND 
causing flu-like symptoms.21, 95   The majority of people reported to be infected with NDV 
are those with close contact with poultry (e.g. abattoir workers) or laboratory staff.  As yet 
there have been no reports of human to human spread. 
2.5.2 Transmission 
The majority of ND outbreaks occur as a result of disease spread from infected poultry.83  
Introduction of disease can occur from a number of sources including trade in poultry and 
poultry products and via the smuggling of live birds or eggs.  Once the disease has been 
established in a flock, spread of the virus is typically by movement of birds, via fomites 
(feed, equipment) and potentially by windborne dispersal.96 
 
During an outbreak, bird to bird transmission is usually via the respiratory route with 
inhalation of droplets, or via the faecal-oral route.96 
 
2.6 Clinical Signs 
The clinical signs of ND may vary with the pathotype of the virus.  Four main pathotypes 
were described in the 1970s and the terminology is still in use today.  The pathotypes 
include velogenic (highly virulent), mesogenic (moderately virulent), lentogenic (low 
virulence) and avirulent forms which have been derived from the mean death time (MDT) 
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in eggs.  The velogenic viruses can then also be further divided into velogenic 
viscerotropic and velogenic neurotropic forms based on pathological features.25  In 
general, velogenic viruses are associated with high mortalities with viscerotropic viruses 
causing severe depression and diarrhoea.   Neurotropic viruses also cause neurological 
signs such as ataxia, head tremors and paresis, along with respiratory distress.  
Mesogenic viruses usually present with respiratory disease and may also cause mortalities 
in young birds.  Lentogenic viruses induce minimal clinical signs, however when present 
they are usually respiratory in nature.6  Avirulent viruses typically do not induce clinical 
signs at all.  There is however overlap between the pathotypes and the age, immune 
status and the presence of concurrent diseases should be taken into consideration when 
interpreting the clinical signs. 
2.7 Pathology 
 
The gross and histological features of ND vary with the pathotype of virus.  Velogenic 
viruses have a strong tropism for lymphoid tissue and the central nervous system.97  
Infection with viscerotropic, velogenic pathotypes typically produces haemorrhagic lesions 
within the intestinal tract which can be attributed to necrosis of lymphoid tissue within 
these regions.   In particular, fibrinonecrotic lesions are commonly seen in the caecal 
tonsils and the small intestine.98  Spleens are often enlarged and mottled and the 
proventriculus may contain haemorrhagic foci, again usually centred on lymphoid 
aggregates.  These gross findings correspond histologically to necrosis of lymphoid tissue 
with replacement haemorrhage and fibrin.  Immunohistochemical staining and in situ 
hybridization has shown that the lymphoid tropism observed is usually associated with 
replication of virus in macrophages.98, 99  Initially, replication occurs within lymphocytes and 
macrophages in the eyelid conjunctiva.100  This progresses to the detection of positive 
staining in mononuclear cells throughout multiple organs, along with positive staining in 
epithelial cells of the respiratory and gastrointestinal tracts. 
 
Infection with neurotropic velogenic strains show minimal lesions grossly, however 
respiratory disease with haemorrhagic tracheitis and increased exudate within the 
bronchioles and trachea may be present.  Histologically, lesions are consistently seen 
throughout the central nervous system.  They consist of non-suppurative inflammation 
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predominantly perivascularly, along with gliosis and neuronal degeneration.  The 
distribution of lesions is important for sample collection, as lesions are most frequently 
seen throughout the caudal CNS (spinal cord, medulla, brain stem), with minimal lesions 
present in the cerebrum.21  The ability of the various pathotypes of NDV to cause lesions in 
the brain may be associated with differences in peripheral replication and the ability to 
invade neural tissue.101, 102  Whilst both mesogenic and velogenic viruses have the ability 
to invade neural tissue, the rate of replication of mesogenic viruses is comparatively 
slower.  Lentogenic viruses do not appear to have the ability to replicate in neural cells at 
all.  In some cases, viscerotropic pathotypes may cause death of birds before neurological 
lesions have time to develop.102   
 
Experimentally, mesogenic viruses show limited gross pathological changes apart from 
splenic enlargement and increased air sac opacity.98  This corresponds to lymphoid 
hyperplasia within the spleen and lymphoid follicle formation within the air sacs.  In 
addition, mononuclear myocardial inflammation may also be present. 
 
Minimal gross findings are seen with lentogenic strains, although histologically, there may 
be airsaculitis or tracheitis.   
 
Whilst ND is typically non-pathogenic in wild birds, in outbreaks of disease in double-
crested cormorants in the United States and Canada, lesions were typically of a 
neurotropic pathotype.  Minimal gross lesions were seen, however histologically, there was 
evidence of mononuclear perivascular cuffing in the brain and spinal cord, along with 
gliosis and white matter vacuolation.91 
 
In Australia, investigations into ‘late respiratory syndrome’ of broilers, identified the 
presence of lentogenic NDV in cases where tracheitis had been diagnosed histologically in 
conjunction with E. coli infection.52  Further experimental work using Australian lentogenic 
isolates of NDV showed that they were able to cause conjunctivitis with varying degrees of 
tracheitis.  This inflammation was represented histologically by lymphocyte infiltration and 
antigen was found present within the lesions.103   
 
The pathological features of disease seen during the 1998-2002 outbreaks of ND in 
Australia are poorly described in the literature.  The AUSVETPLAN manual notes that 
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there were few gross pathological changes seen during these outbreaks, however 
perivascular lymphocytic cuffing in the brainstem was seen microscopically.83  One of the 
Australian strains isolated during 1998 from Glenorie has been used in two experimental 
trials in the United States and the virus was described as velogenic viscerotropic.101, 104  All 
birds infected with this virus showed slight depression with mild neurological signs, along 
with one very sick bird but all recovered by the end of the trial.  Grossly, they had mild 
eyelid petechiation and splenic enlargement, along with proventricular haemorrhage in 2 
birds.101  Histologically, mild inflammation and necrosis was seen in the eyelid, along with 
lymphoid necrosis in a number of tissues.  The brains showed non-suppurative 
perivascular cuffing.  It was found that lesions were equally distributed between the 
cerebrum and the medulla oblongata with no immunohistochemical staining detected in 
any tissues (presumably because virus had been cleared before the birds were 
euthanased at day 10).101   
 
2.8 The molecular basis for pathogenicity 
2.8.1 Defining pathogenicity 
Whilst the terms virulence and pathogenicity are sometimes used interchangeably, it is 
helpful to define them when attempting to determine their basis.   Pathogenicity can be 
thought of as the ability of the organism to cause damage or disease in a host.105, 106  
Pathogenicity is therefore determined by a combination of factors, such as those attributed 
to the pathogen, the host and the environment.  As a result, the pathogenicity of an 
organism may vary depending on the host species, or the immune status of the host.  
Virulence on the other hand, has been defined as a measure of the degree of 
pathogenicity and as such is a more quantitative factor when measured in a known host in 
a laboratory setting.  In the context of laboratory research, virulence can be measured in a 
number of ways such as the median lethal dose (LD50), or by survivability indexes.107  It is 
often described as a physical characteristic of the pathogen in question, attributed to 
certain virulence factors such as the toxin produced by a bacteria or a viral surface 
protein.106  In addition, virulence can be used in an epidemiological context to ascribe 
increased case fatality rates at the population level due to a particular, more virulent 
pathogen.105  Certain characteristics of a virulent pathogen may exert an effect in some 
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hosts whilst causing little pathology in others.  For example, a virulent virus as defined by 
an experimental model may be pathogenic in poultry but not in waterfowl.  
 
Therefore, both virulence and pathogenicity must be examined in the context of the host 
with factors such as host immune status being particularly important.  Obviously, there will 
be significant overlap between factors that cause increased pathogenicity and virulence 
with certain virulence factors contributing to increased pathogenicity in a particular 
species.  Whilst the focus of this research will be the pathogenicity of NDV, standard 
nomenclature around ND uses the terms ‘virulent’ and ‘avirulent’ to classify virus strains.  
As such, ‘virulent’ and ‘avirulent’ will be used when referring to the OIE classification. 
2.8.2 Assessing pathogenicity 
A number of techniques have been used to define and quantify the pathologenicity of ND 
viruses in vivo, such as the intracerebral pathogenicity index (ICPI), the intravenous 
pathogenicity index (IVPI) and the mean death time in eggs (MDT).   
 
The IVPI scores clinical signs in intravenously inoculated 6 week old chickens, whereas 
the ICPI uses a 0-2 scoring system of intracerebral inoculation of 1 day old chicks.  The 
MDT measures the average time of embryonated eggs to die after allantoic inoculation 
with virus.21  The ICPI was previously the most commonly used and well validated of the 
pathogenicity tests, however it has a number of drawbacks in that it represents an artificial 
route of inoculation and also has significant welfare concerns.  The World Organisation for 
Animal Heath (OIE) has acknowledged this and recommends that there must be strong 
justification for the use of the ICPI over in-vitro methods.6  As a consequence, sequencing 
of the fusion protein cleavage site has replaced the ICPI in the majority of laboratories for 
determining the pathogenicity of a virus.  However, as with all diagnostic tests, 
pathogenicity tests are not perfect and in some cases these tests have not accurately 
reflected the virulence seen in the field cases.  For example, a number of studies have 
shown that viruses with similar ICPIs have had variable pathogenicity experimentally, 
when using a natural route of infection.108, 109   
 
Additionally, sequencing of the fusion protein cleavage site of some NDV isolates has also 
not always correlated with pathogenicity.86, 104, 108, 110  In some cases, mesogenic viruses, 
which contain virulent, multibasic cleavage sites, when inoculated into poultry in an 
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experimental setting, may only produce mild clinical signs.97  This is also the case with 
some instances of pigeon paramyxovirus infection of poultry, where virulent cleavage sites 
have not been reflected in increased pathogenicity indexes or clinical signs in field 
infections.111  
 
Finally, NDVs with avirulent F gene cleavage sites have been shown to have ICPI and 
IVPI indices characteristic of virulent NDV strains.112  Table 2.2 contains previously 
published pathogenicity indices from some NDVs and shows that some of various indices 
do not always correlate with the cleavage site motif, as indicated by the PPMV-1 and 
SQZ/04 viruses. 
 
Virus Fusion 
protein 
cleavage 
site 
Virulence* MDT ICPI IVPI Reference 
La Sota GRQGRL Avirulent 103 <0.5 0.0 97 
Roakin RRQKRF Virulent 68 1.45 0.0 97 
SQZ/04 GRQGRL Avirulent  2.00 2.68 112 
PPMV-1 
340/91 
RRQKRF Virulent  0.66 0.22 111 
Texas GB RRQKRF Virulent 55 1.75 2.7 97 
Herts 33 RRQRRF Virulent 49 1.9 2.7 97 
Table 2.2  A comparison of pathogenicity indices for a range of NDVs  
(MDT: velogenic <60 hours, mesogenic 60-90 hours, lentogenic >90 hrs; ICPI: velogenic >1.5, mesogenic 0.7-1.5, 
lentogenic <0.7; IVPI: range 0 – 3 with virulent viruses approaching 3; *virulence as determined by the fusion protein 
cleavage site motif) 
 
2.8.3 Viral determinants of pathogenicity 
The pathogenicity of NDV in poultry varies widely between strains of the virus.  This 
variation was recognised very early in the history of NDV with some strains causing high 
mortalities in chickens compared with others that caused only mild respiratory disease.  
Determining the molecular basis for pathogenicity and virulence is an important step in 
both diagnostics and research and helps to identify strains that are likely to cause severe 
disease so that control measures can be instituted.   
 
Over the last couple of decades, the molecular basis for the virulence and pathogenicity of 
NDV has been studied in detail, predominantly due to advances in molecular technology 
and the use of reverse genetics.  Throughout the literature, molecular studies have 
primarily focused on the fusion (F) and haemagglutinin-neuraminidase (HN) genes due to 
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their key roles in virus entry into cells.  However, in a comprehensive review by Dortmans 
et al., other virulence factors for ND were discussed.3  It was noted that whilst the F protein 
cleavage site is a key determinant of virulence, additional factors such as the viral 
replication complex play important roles in the pathogenicity of the virus.  The roles of 
each of the NDV proteins in pathogenicity are reviewed below. 
Fusion protein 
The fusion protein has long been recognised as the primary determinant of virulence for 
NDV.  The ability of host proteases to cleave the precursor F0 glycoprotein into its active 
form is particularly important.  Activation of the F0 protein into the F1 and F2 polypeptides 
allows cell fusion to occur and viral entry into the host cell.113  The ability of proteases to 
cleave the glycoprotein is dependent upon the pathotype of the virus.  Cleavage of the 
precursor protein in lentogenic ND viruses can only be achieved by certain trypsin-like 
enzymes, which restricts the activity of the virus in the host to particular cells and organ 
systems, primarily epithelial cells of the respiratory and gastrointestinal tracts.114  However, 
cleavage of the precursor protein in velogenic viruses can be achieved by multiple cellular 
enzymes, allowing viral entry into numerous tissues and the potential for widespread 
pathology in multiple organ systems.  These enzymes include furin and PC6 and their 
functionality is dependent on the amino acid sequence of the viral cleavage site.115  
Molecular analysis has shown that for furin-like proteases to cleave the protein, there is a 
requirement for multiple basic amino acids at the F0 cleavage site, along with a 
phenylalanine at residue 117 (the N terminus of the F1 protein).116, 117  The OIE’s definition 
of a virulent NDV reflects these findings.6   
 
The significance of this F protein cleavage site has also been substantiated using reverse 
genetics techniques.8, 118, 119 120  In a number of studies, when mutating the cleavage site 
of a lentogenic strain to a virulent motif, the ICPI was shown to dramatically increase albeit 
not to the same level of a virulent strain with the same cleavage site.119, 121  In one 
pathogenesis study, inserting a virulent cleavage motif into the lentogenic backbone only 
very marginally increased antigen distribution in 4 week old chickens with no mortalities 
seen.110  A similar study by the same investigator showed an increase in clinical disease 
due to the presence of a virulent F gene.108 
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However, there have also been reports of ND viruses isolated from clinically healthy 
poultry, which have subsequently been found to contain virulent F protein sequences.122, 
123   In addition, in flocks with mild disease and minimal mortalities attributed to infectious 
bronchitis virus, velogenic ND viruses have also been isolated.124  In the context of some 
African viruses with multibasic cleavage sites and minimal pathogenicity, a Q114R 
mutation was found to attenuate replication.125 
 
The pigeon paramyxovirus is also a clear example of where the fusion protein cleavage 
site does not always reflect pathogenicity for poultry.126, 127  In one case it was found that 
two PPMV-1 viruses with different intracerebral pathogenicity indexes (0.025 and 1.3) had 
only four amino acid differences in their genome.128  Of these, only a substitution at 
position 453 from S to P in the F protein was found to effect pathogenicity and changed 
the ICPI from 1.6 to 1.3 in a Herts backbone.   
 
In 2011, PPMV-1 was detected for the first time in Australia.  When this virus was 
experimentally inoculated into chickens, despite containing a cleavage site of RRQKRF, 
no clinical disease was observed (Bergfeld, J., unpublished).   
This means that whilst the F gene is very important in pathogenicity, it is not the sole 
determinant.  In total there are 20 papers that have investigated the role of the fusion 
protein in NDV virulence, either alone, or in combination with other proteins, using reverse 
genetics.  Nine of these papers showed a significant association between a virulent F 
protein cleavage site and pathogenicity.  However, three papers showed equivocal 
associations.  
Haemagglutinin-Neuraminidase protein 
The HN protein has also been studied to determine its contribution to the pathogenicity 
and virulence of NDV.  There is a strong correlation between HN gene length and 
pathogenicity in chickens.  The HN length varies between 571 and 616 amino acids 
depending on the NDV strain and longer HN genes are often referred to as having 
extended open reading frames of between 6 to 45 aa.  Viruses with an HN length of 571 
aa are solely velogenic, whereas longer HN precursor lengths of 616 aa (45 aa extension) 
are only found in avirulent viruses.  However HN lengths of 577 aa can be found in 
multiple NDV pathotypes, see Table 2.3.121   
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Virus HN length (aa) HN extension (aa) Pathotype Reference 
Herts 33 571 0 Velogenic 129 
 
Anhinga 571 0 Velogenic 130 
Texas GB 577 6 Velogenic 131 
Beaudette C 577 6 Mesogenic 132 
 
La Sota 
 
577 6 Lentogenic 
 
130 
 
B1 577 6 Lentogenic 
 
130 
 
Meredith (AUS) 580 9 Velogenic 133 
Jilin/01/2008 582 11 Velogenic 134 
Ulster 
 
616 45 Avirulent 
 
135 
 
V4 616 45 Avirulent 
 
130 
Table 2.3  HN lengths of selected ND viruses and their respective pathotypes 
 
The association of virulence with the length of the HN gene may be due to the requirement 
for cleavage of the HN0 precursor in avirulent viruses.   Viruses with 616 aa HN proteins 
require cleavage by proteases to become biologically active, as in the case of the Ulster 
strain.136  It has been found that without cleavage, the extended C-terminus blocks the 
sialic acid binding site of the NA domain of the HN protein.137  This cleavage is not 
required by velogenic strains such as Texas GB and Herts 33. 
 
Römer-Oberdorfer et al. investigated the role of the HN and F proteins using reverse 
genetics and found that the F protein cleavage site is the predominant pathogenicity 
determinant regardless of the HN protein length.121  However they did note that when an F 
protein cleavage site of a lentogenic virus was mutated to a velogenic cleavage site, the 
corresponding virulence of the virus only increased to a mesogenic (not velogenic) level, 
indicating a potential role in virulence for the HN and/or other proteins.  Changing the 
length of the HN extension in the presence of the virulent F gene did not alter the ICPI 
significantly, see Table 2.4.   
 
Other studies using similar techniques of interchanging HN genes within a known NDV 
backbone have produced variable results.  In one study the insertion of the HN gene from 
a mesogenic virus into a lentogenic backbone increased the pathogenicity of the 
recombinant virus as expected, inducing wider antigen distribution in embryonic tissues 
and an increased ICPI from 0.00 to 0.75.138  However, the insertion of a lentogenic HN into 
a mesogenic backbone did not produce a lentogenic virus; the ICPI decreased from 1.58 
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to 1.02 with a corresponding increase in the MDT from 62 hrs to 84 hrs.  However, a very 
similar experiment using the same cloned viruses could not repeat these findings 
though.108 
 
Another study used the LaSota backbone with the F cleavage site mutated to a virulent 
motif to investigate the impact of interchanging segments of the genome with those from 
the virulent Herts virus.129  Inserting the entire Herts HN gene into the LaSota mutant 
increased the ICPI slightly from 1.28 to 1.40.  This study also investigated the roles of the 
head and stem regions of the HN protein in pathogenicity by creating mutants containing 
the stem of La Sota and the globular head of Herts and vice versa.  The resultant ICPIs did 
not vary significantly, indicating that both the stem and head are involved in virulence.   
 
It had been identified that there was a need for a cysteine residue at position 123 in the 
HN protein for the formation of disulfide-linked HN dimers.139  Mutant clones with and 
without this amino acid showed that the cysteine residue in the HN increased the ICPI of 
the recombinant virus from 1.28 to 1.49.140   
 
Wakamatsu et al. showed that a lentogenic HN could decrease pathogenicity in a 
Beaudette C backbone, however a virulent HN could not increase the severity of clinical 
disease in 4 week old chickens.108 Estevez however, was not able to show any effect of 
the HN gene on pathogenicity via inoculation of day old chicks intranasally and 
intraocularly.141 
 
Studies on the length of the HN extension have showed that longer extensions leading to 
an HN length of 616 aa are associated with mild attenuation, although an effect on tissue 
tropism was not detected.142  Another investigation of the effect of the HN extension length 
on pathogenicity showed moderate attenuation with a 45 aa extension, particularly with an 
R596C mutation.143  Zhao et al. also found a similar decrease in pathogenicity when a 45 
aa extension was added to a mesogenic Anhinga backbone, producing extended MDTs 
and lower ICPIs compared with the parental strain.130   
 
Site-directed mutagenesis has also been used to further understand the role of HN 
glycosylation sites.  As expected, the mutations of glycosylation sites of the HN protein 
attenuated the associated viruses.144  Mutations of the HN at position 526 from Y to Q also 
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attenuated the recovered virus.132  However, there was a minimal effect on virulence by 
deleting amino acids associated with the cytoplasmic tail of the HN.145   
 
In addition, a study was conducted to observe the effect of mutating the untranslated 
regions of the NDV HN gene.  Results suggested that the 3’ end did not have observed 
effects on virulence, however deletion of the 5’ end attenuated the virus in-vivo.146   
 
Molecular techniques have not yet been used to analyse the effect of the 9 aa extension of 
Australian ND viruses.  However, based on the literature, it is possible that this extension 
may have an attenuating effect on virulence, albeit not to the same extent as a 45 aa 
extension. 
 
In summary, 19 papers have investigated the HN protein’s role in pathogenicity including 
some that focus on the length of the HN gene, particular the C-terminal extension.  
Overall, 5 papers showed a mild to moderate association of the HN protein with 
pathogenicity, however 3 cases showed no HN effect, remaining papers showed 
indeterminate results.   
Viral replication complex 
The viral replication complex comprises the nucleocapsid protein (NP), phosphoprotein (P) 
and large polymerase protein (L). It has been hypothesized that increased viral replication 
may increase viral virulence, therefore these proteins alone or in combination may play 
key roles in the pathogenicity of NDV.147  There are 2 main studies which have 
investigated the viral replication complex in detail using reverse genetics.12, 13  In the study 
by Rout et al., the proteins were examined individually and it was found that the N and P 
gene play a minimal role in pathogenicity, however the L gene significantly increased 
replication.  However, interestingly, in this study it was the insertion of a lentogenic L gene 
that caused greater replication. 
 
The study by Dortmans et al. used the PPMV-1 strain AV324 and the virulent Herts 33 
virus to investigate the role of the viral replication complex and the M protein.12  This work 
showed the most significant changes in virulence when multiple genes were interchanged 
simultaneously as measured by the ICPI.  Insertion of the NP, P and L genes from the 
virulent Herts virus into the AV324 backbone increased ICPI from 0.10 to 1.30.  This is the 
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largest change in ICPI that has been produced experimentally with genes other than the F 
gene.  In this study, the matrix protein did not appear to alter pathogenicity significantly. 
 
Another study which implicates the P and L genes in pathogenicity involved the serial 
passage of an avirulent PPMV-1 virus in chicken brains with an increase of ICPI from 0.44 
to 0.9 by passage 5.  This was associated with 3 amino acid mutations, 2 in the L protein 
and 1 in the P.148 
 
A further study examining all 6 NDV genes showed that whilst the F gene is the main 
determinant of pathogenicity, the polymerase L gene is the second most important 
contributor.120 
V protein 
The V protein is produced by P gene mRNA editing.  The V protein may also contribute to 
the virulence of NDV, by modulating the innate immune response of the host and acting as 
an alpha interferon antagonist.10, 149, 150  In one study, mutations introduced into the V 
protein of recombinant ND viruses were found to attenuate the virus and decrease the 
virulence of the viruses in embryonated eggs.151  A further study supported this theory and 
found that viruses with mutations in the V protein were attenuated in-vivo.149 
Intergenic and untranslated regions 
Two papers have investigated the role of the untranslated regions of the NDV genome.  
The role of the untranslated regions of the HN gene were found to play important roles in 
pathogenicity, as seen when their deletion at the 5’ and 3’ ends attenuated the virus.146  
However, mutations of the 3’ end did not have any observed effects. 
 
Insertion of a green fluorescent protein gene between the P and M genes did not affect 
pathogenicity, however insertion of the fluorescent protein gene between the HN and L 
genes decreased pathogenicity.152 
 
Large additions and deletions of the intergenic regions between the F and HN genes and 
the HN and L genes all attenuated pathogenicity.153 
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2.8.4 Summary 
Approximately 42 papers and 9 theses have investigated the molecular basis for 
pathogenicity of NDV with particular reference to the use of cloning techniques and 
reverse genetics.  Of these papers, 20 focus on the F gene, 19 on the HN gene, 1 on the 
M gene, 4 on the viral replication complex (NP, P and L), 3 on the V gene and 3 on the 
intergenic or untranslated regions with a number of papers examining multiple genes at 
the one time.  Some of these mutant viruses can be seen in Table 2.4. 
 
The majority of these reverse genetics studies used the mesogenic Beaudette C as a 
plasmid backbone so that both increases and decreases in pathogenicity could be 
detected.  Assessment of pathogenicity after mutating a viral clone was commonly 
achieved using the ICPI, MDT and to a lesser extent IVPI.  There were only a small 
number of studies (4) that used grown chickens to assess tissue tropism and clinical signs 
with an additional two studies using day old chickens infected by a natural route. 
 
Notably, the majority of papers that have used reverse genetics to assess virulence or 
pathogenicity have used ICPI and MDT to quantify the effects of their mutations.  There is 
limited work assessing pathogenicity via tissue tropism, survival curves or clinical signs in 
older birds.  The effect of gene mutations on tissue tropism has been evaluated in 3 
papers using embryos and one day old chicks inoculated by natural routes of infection.138, 
141, 142  There are only 4 papers that have used birds older than one day.110 108 109, 146  
Three of the papers used 4-week-old birds and assessed clinical signs, however the paper 
by Yan et al used 2-week-old birds only to assess virus distribution in tissues.  Therefore, 
this lack of experimentation using older birds limits the ability apply the research findings, 
particularly given that the ICPI and MDT do not always correlate with pathogenicity in a 
field situation. 
 
In summary, mutation of lentogenic fusion protein cleavage sites to virulent cleavage sites 
markedly increased ICPIs, which suggests that the F gene is a key pathogenicity 
determinant in most cases. However a number of studies have also shown that virulence 
of NDV is a result of multiple genes and not solely due to the cleavability of the F gene or 
the HN gene.109, 110, 119, 121, 138  The overall consensus therefore is that whilst the amino 
acid sequence at the fusion protein cleavage site is a major predictor of the ability of an 
NDV to cause disease, pathogenicity of NDV is a multigenic trait.
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Plasmid Virus  MDT ICPI IVPI Clinical signs Reference 
NDFL LaSota (lentogen) - 0 - - 8 
NDFLtag LaSota with a virulent F gene - 1.28 - - 
rNDV Clone 30 (lentogen with 6aa HN extension) - 0.0 - - 121 
rNDVF1 Clone 30 with virulent F cleavage site mutation - 1.28 - - 
rNDVHN1 Clone 30 with avirulent F cleavage site and 1aa HN extension - 0.04 - - 
rNDVH2U Clone 30 with avirulent F cleavage site and 45aa extension - 0.19 - - 
rNDVF1H1 Clone 30 with virulent F cleavage site and 1aa HN extension - 1.3 - - 
rNDVF1N2U Clone 30 with virulent F cleavage site and 45aa extension - 1.21 - - 
rBC  Beaudette C (mesogen)  - 1.58 1.45 - 119 
rLaSota LaSota (lentogen) - 0.00 0.00 - 
rLaSota V.F LaSota with same cleavage site as BC - 1.12 0.00 -  
FL-Herts Full length velogenic Herts 56 1.54 - - 126 
 rgAV324 PPMV1 110 0.10 - -  
FL-Herts (F)AV324 Herts with PPMV1 F gene 52 1.56 - -  
rgAV324(F)Herts PPMV1 with Herts F gene -  - -  
rLaSota LaSota 96 0.00 - - 138 
rLaSo BC HN LaSota with Beaudette C HN 84 0.75 - -  
rBC Beaudette C 62 1.58 - -  
rBC LaSo HN Beaudette C with LaSota HN 72 1.02 - -  
LaSota E13-1 Wild type LaSota 125 0.01 0.01 0 sick 110 
NDFL Recombinant LaSota 123 0.08 0.00 0 sick 
NDFLtag LaSota with a virulent cleavage site 77 1.60 1.71 nasal discharge 
(1/10) 
rLaSo LaSota >90 0.19 0.00 - 108 
rBC Beaudette C 48 1.66 2.06 - 
rLaSoVF LaSota with virulent cleavage site 59 1.69 2.39 8/10 sick 
rLaSo BCHN La Sota with Beaudette C HN >90 0.00 0.00 0 sick 
rBCLaSoHN Beaudette C with LaSota HN gene 60 1.58 1.27 0 sick  
rAnh Anhinga (mesogen) - 0.89 - - 109 
rAnhTkHN Anhinga with HN from Turkey North Dakota (neurotropic velogen) - 1.00 - -  
rAnhTkFHN Anhinga with F&HN from Turkey ND - 1.16 - Head twitch (1/6)  
rAnhCAHN Anhinga with Calfornia HN (viscerotropic velogen) - 0.86 - Depressed (3/6)  
rAnhCAFHN Anhinga with California F&HN - 1.14 -   
FL-Herts Herts 33 - 1.54 - - 12 
FL-Herts (NP-P-
L)AV324 
Herts 33 with PPMV NP, P and L genes - 0.55 - - 
rgAV324 PPMV1 - 0.10 - - 
rgAV324(NP-P-
L)Herts 
PPMV1 with Herts NP, P and L genes - 1.03 - - 
Table 2.4  A summary of recombinant viruses and their pathogenicity indices.  (- , not described)
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CHAPTER 3  
GENERAL MATERIALS AND METHODS 
3.1 Laboratory animal use 
Experiments requiring the use of animals were undertaken in accordance with the 
Australian National Health and Medical Research Council’s Australian code of practice for 
the care and use of animals for scientific purposes.154  The design of such experiments 
was examined and approved by the CSIRO Australian Animal Health Laboratory’s Animal 
Ethics Committee.   
3.2 Cell culture 
DF-1 cells, a continuous chicken fibroblast cell line from the American Tissue Culture 
Collection (ATCC, CRL-12203), were grown in DMEM Dulbecco’s modified Eagle Medium 
(Life Technologies) with 10% foetal calf serum (FCS; Serana, Bunbury), 2 mM glutamine, 
amphotericin B (1.25 µg/ml), penicillin (100 IU/ml) and streptomycin (100 µg/ml).  Cells 
were incubated at 37oC with 5% CO2. 
3.3 Virus titration in eggs 
Prior to use, viruses were titrated in specific pathogen free (SPF) embryonated eggs 
(Charles River Laboratories, Australia) and the infectivity titre determined.  Viruses were 
diluted using tenfold dilutions to create a dilution series from 10-1 to 10-10.  Eggs were 
inoculated into the allantoic sac with 100 µl of diluted virus per egg, using 4 eggs per 
dilution.  The eggs were then incubated at 37oC for 5 days and the allantoic fluid harvested 
to test for the presence of virus by haemagglutination. 
Haemagglutination activity was determined by adding 50 µl of PBS to each well of a 96-
well round bottomed plate.  Next, 50 µl of the test allantoic fluid was added to the first 
column of the plate and diluted across the plate using doubling dilutions for 4 wells.  
Finally, 50 µl of 0.5% washed chicken red blood cells collected in Alsevers solution was 
added to each well, including one row each of negative and positive controls.  The plates 
were then left at room temperature for approximately 45 minutes before reading.  
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Complete haemagglutination was indicated by the absence of a red button at the bottom of 
the well and samples were described as either positive or negative. 
 
To determine the infective titre of the virus, the Reed and Muench formula was applied and 
expressed as the 50 percent embryo infectious dose (EID50) per ml.155 
3.4 Histopathology and immunohistochemistry 
Histopathology was performed according to the CSIRO AAHL Standard Operating 
Procedures (SOP) for the histopathology laboratory (SOP: 13-04-068).  All samples were 
first fixed in 10% in neutral buffered formalin for between 24-48 hours.  The samples were 
trimmed, processed into paraffin wax and sectioned at 4 µm.  For histopathology, slides 
were then stained with haematoxylin and eosin and mounted. 
 
Immunohistochemistry was undertaken using the CSIRO AAHL Immunohistochemistry 
SOP (SOP: 13-04-096).  In all cases, the mouse monoclonal antibody Q91-1 (AAHL) 
against the NDV nucleoprotein was used as the primary antibody.  The DAKO PT LINK 
(Dako) was used for antigen retrieval by heating the slides to 97oC for 30 minutes then 
cooling to 70oC in the Envision FLEX Target high pH retrieval solution and washing for 5 
minutes in TRIS buffer.  After this, endogenous peroxidases were quenched by the 
addition of a 3 per cent H2O2 solution.  The tissues were then incubated with a mouse 
monoclonal antibody (Q91-6, produced at AAHL) against the NDV nucleoprotein at a 
1/800 dilution.  The EnVision™ FLEX+ Mouse Linker (Dako) was used to amplify the 
antibody signal prior to the addition of the secondary anti-mouse antibody using the 
Envision Flex/HRP conjugate and aminoethylcarbazone (AEC) chromogen (Dako).  Slides 
were then counterstained with Lillie-Mayer haematoxylin using 0.5% haematoxylin 
Certistain (Australian Biostain, Traralgon, Australia) and Scott’s tap water before 
coverslipping with an aqueous mountant. 
3.5 Serology  
The only serological test used throughout this study was the haemagglutination inhibition 
(HI) test.  The test was performed following OIE procedures with some modifications.6  
The variations from the OIE test method were the use of 8 haemagglutinating units (HAU) 
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of inactivated homologous antigen instead of 4 HAU and the addition of 0.5% chicken red 
blood cells instead of 1% red blood cells.  Phosphate buffered saline (PBS) and test serum 
were added in 25 µl volumes, prior to the addition of 25 µl of 8 haemagglutinating units 
(HAU) of virus antigen.  Chicken red blood cells were then added at 0.5% (v/v) in 50 µl.  
Haemagglutination inhibition was detected after 30-45 minutes of incubation at room 
temperature via the presence of a red button at the bottom of the well.  Samples showing 
inhibition at a dilution of 1/8 or greater were deemed positive. 
 
Antigen was produced for all four viruses by propagation of each virus in the allantoic 
cavity of 10-day old embryonated eggs for four days, clarification of allantoic fluid by 
centrifugation and inactivation by gamma-irradiation at 5 Mrads (50 kGray). 
3.6 Virus isolation 
Isolation of live virus from tissue samples was undertaken in 9-11 day old SPF eggs.  
Unless otherwise specified, tissue samples of approximately 0.5 cm3 were collected into 
viral transport media containing PBS, penicillin, streptomycin, gentamicin and 1% bovine 
serum albumin with 2 mm aluminium silicate beads (Biospec Products Inc, Bartlesville OK, 
USA).  The samples were immediately stored at -80oC until required.  Tissue samples 
were first homogenized for 30 seconds using a bead beater (FastPrep-24, M.P. 
Biomedicals, Irvine, California, USA).  The samples were then centrifuged for 60 seconds 
at 13,000 rpm with a benchtop microcentrifuge and the supernatant aliquoted.  The 
supernatant was inoculated into the allantoic cavity of the embryonated eggs using 200 µl 
per egg.  If the tissue had already been tested positive via PCR for NDV genome, only 2 
eggs were inoculated per sample.  If the NDV status of the sample was unknown, 3 eggs 
were inoculated per sample.  The eggs were then incubated at 37oC for 7 days and were 
checked daily for any deaths.  Before processing, eggs were chilled at 4oC overnight.  The 
allantoic fluid was harvested and tested for the presence of virus via haemagglutination as 
described in Chapter 3.3.   
3.7 Mean death time in eggs 
The mean death time (MDT) of the viruses was determined via inoculation of SPF eggs.  
Each virus was diluted tenfold to provide four dilutions:  10-6, 10-7, 10-8 and 10-9.  Each 
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dilution was used to inoculate the allantoic cavity of 5, 10-day-old embryonated eggs using 
100 µl per egg.  The eggs were then incubated at 37oC.  After 8 hours, another 5 eggs 
were inoculated with the same virus dilutions and also incubated at 37oC.  The eggs were 
then examined for deaths twice a day for 7 days.  The minimum lethal dose was 
determined as the highest dilution to kill all 10 embryos inoculated with that dilution.  
Finally, the mean death time could be calculated by taking the average time for the 
embryos to die when inoculated by the minimum lethal dose.   
 
Classification of the mean death time is represented in Table 3.1. 
 
Pathotype Mean Death Time 
Lentogenic > 90 hours 
Mesogenic 60 – 90 hours 
Velogenic < 60 hours 
Table 3.1  Mean death time indices 
3.8 Nucleic acid isolation 
Total RNA was extracted from a number of sources, either tissue samples, allantoic fluid, 
or cell culture material.   Tissue samples were homogenized as described in Chapter 3.6 
before inactivation in extraction buffer.  Allantoic fluid was first clarified by centrifugation at 
10,000 rpm using a Heraeus Multifuge 3SR Plus centrifuge (Thermo Scientific).  Cell 
culture material was inactivated by removing the cell culture media then adding extraction 
buffer directly to the cells in the tissue culture plate.  
 
Either the MagMAXTM-96 Viral RNA Isolation kit (Ambion, Life Technologies, Mulgrave, 
Australia) or the QIAamp Viral RNA Mini Kit (Qiagen) was used to extract the RNA, in both 
cases by following the manufacturers’ directions and using the extraction buffers provided 
in the kits.   
 
The MagMAXTM kit was used in conjunction with 96 well deep well plates (Thermo 
Scientific) and the Kingfisher Flex extraction machine (Thermo Scientific) so that large 
volumes of samples could be extracted concurrently.  Samples were inactivated in 
MagMAXTM Lysis/Binding solution using 50 µl sample per 130 µl of lysis solution.  Wash 
solution 1 was added to two deep well plates using 150 µl per well.  Wash solution 2 was 
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added to an additional 2 plates, also using 150 µl per well.  The elution buffer was added 
to a standard 96 well plate using 60 µl per well.  The samples were also added to a deep 
well plate along with 20 µl of premixed RNA binding beads (10 µl) and lysis binding 
enhancer (10 µl).  The plates were then loaded onto the Kingfisher machine and the 
appropriate protocol selected to run.  
 
The QIAamp Viral Mini kit was used when there were less than 20 samples for RNA 
extraction.  The following procedure was used: 560 µl of AVL buffer containing carrier RNA 
was placed in a 1.5 ml microcentrifuge tube.  Then 140 µl of the sample was added to the 
buffer and vortexed.  The samples were incubated at room temperature for 10 minutes and 
560 µl of ethanol added to the tube.  A QIAamp mini column was then used to collect the 
virus/buffer mixture in 560 µl aliquots, between which the column was centrifuged at 6000 
x g for 1 minute and the flowthrough discarded.  Subsequently, 500 µl of buffer AW1 was 
added and centrifuged at 6000 x g for 1 minute, followed by 500 µl of buffer AW2 with 
centrifugation at 20,000 x g for 3 minutes.  The RNA was then eluted in 60 µl of AVE buffer 
by centrifugation at 6000 x g for 1 minute.  The RNA was either used immediately or 
stored frozen at -80oC. 
3.8.1 Nucleic acid quantification 
RNA and DNA samples were quantified using either the NanoDrop spectrophotometer 
(ND-1000 NanoDrop Technologies, Inc.) or the Qubit fluorometer (Qubit 2.0, Invitrogen). 
 
When using the NanoDrop instrument, the machine was first initialized using 2 µl of 
nuclease-free water.  Following this a blank sample was analyzed using 2 µl of the elution 
solution that the RNA or DNA was contained in (Qiagen AVE buffer or nuclease-free 
water).  Finally, 2 µl of the sample was added and the sample analysed after selecting the 
appropriate input (DNA or RNA) on the associated software program. 
 
The Qubit 2.0 was calibrated before use using the supplied Standards #1 and #2 as per 
the manufacturer instructions, adding 10 µl of standard to 190 µl of working solution.  The 
sample solution was made by adding 1-20 µl of sample to 180-199 µl of working solution 
such that the total volume was 200 µl.  Thin walled, 0.5 ml PCR tubes were used in the 
instrument. 
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3.9 Quantitative Polymerase chain reaction (qPCR) 
3.9.1 TaqMan RT-PCR 
Prior to performing real-time PCR, viral RNA was extracted from samples and quantified 
according to Chapter 3.8.  The reverse transcription and PCR reactions were then 
performed in one step using the AgPath-IDTM One-Step RT-PCR kit (Applied Biosystems, 
Victoria, Australia), an ABI 7500 real-time PCR machine (Applied Biosystems) and 
MicroAmp® Fast Optical 96-well Reaction plates (Applied Biosystems).  In most cases, the 
qPCR reaction was a multiplex of the NDV M gene and the 18S rRNA housekeeping gene 
with primer sequences shown in Appendix 1, Table A1. 
 
The reactions were run using 20 µl volumes containing NDV M gene forward and reverse 
primers (200 nM of each) and probe (100 nM), along with 18S forward and reverse primers 
(50 nM of each) and probe (200 nM).  Additional reagents included nuclease-free water 
(5.9 µl), template RNA (2 µl), 2X RT-PCR Buffer (10 µl) and 25X RT-PCR Enzyme Mix 
(0.8 µl). 
 
Cycling conditions were as follows: 
Reverse transcription:  45oC for 10 min  
Reverse transcriptase inactivation and denaturation:  95oC for 10 min 
Amplification:  45 cycles of 95oC for 15 sec and 60oC for 45 sec 
 
Positive samples were those with a cycle threshold (CT) less than 40.  This threshold has 
been established as the standard for NDV across the Laboratories for Emergency Animal 
Disease Diagnosis and Response (LEADDR) Network.  Thresholds were set at 0.05 for 
the NDV M gene and 0.02 for the 18S rRNA gene to allow comparisons to be made across 
different PCR plates.  Reactions were carried out in triplicate with positive, negative and no 
template control samples used on each plate.  If required, copy numbers of the gene of 
interest were normalized to the 18S rRNA house-keeping gene using standard curves 
according to Chapter 3.10. 
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3.9.2 SYBR Green RT-PCR 
SYBR Green RT-PCR was used for cytokine expression analysis and viral gene mRNA 
transcript quantification.  The Power SYBR® Green RNA-to-CT™ 1-Step Kit, ABI 7500 
PCR-machine (Applied Biosystems) and MicroAmp® Fast Optical 96-well Reaction plates 
(Applied Biosystems) were used unless otherwise specified.  Reactions were conducted in 
10 µl volumes using Power SYBR® Green RT-PCR Mix 2X (5.0 µl), forward and reverse 
primers (200 nM final concentration of each), RT Enzyme Mix 125X (0.08 µl), template 
RNA (1 µl) and nuclease-free water (3.52 µl).  No more than 100 ng of template RNA was 
used in the reaction.  The sequences of the primers used can be found in Appendix 1, 
Tables A4 and A5. 
 
Cycling conditions were as follows (unless otherwise specified): 
Reverse transcription:  48oC for 30 min  
Activation of DNA polymerase:  95oC for 10 min 
Amplification:  45 cycles of 95oC for 15 sec and 60oC for 1 min 
Melt curve:  95oC for 15 sec, 60oC for 15 sec, 95oC for 15 sec 
 
A melt curve was performed after each reaction to determine whether there was any non-
specific amplification.  Samples were analysed in triplicate with negative and no template 
control samples used on each plate. 
 
The data was analysed using the ΔΔCT method and expressed as fold changes (relative 
quantity) compared with the control with 95% confidence intervals calculated using AB 
7500 software v2.0.6 (Life Technologies).  The efficiencies of the PCR reactions were first 
determined by standard curve to ensure that the reactions were comparable. 
3.10 RNA copy number quantification 
Quantification of viral RNA in tissue samples was achieved by generating standard curves 
to normalise copy numbers of the NDV M gene to copy numbers of 18S rRNA.  This allows 
for comparisons of NDV RNA loads to be made between tissue samples without weighing 
individual samples. 
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3.10.1 RNA isolation 
18S RNA was extracted from an uninfected control chicken brain sample using the 
MagMAXTM-96 Viral RNA Isolation kit (Ambion) as per Chapter 3.8.  Similarly, NDV-M 
RNA was isolated from allantoic fluid inoculated with the Meredith/02 ND virus. 
3.10.2 Conventional Polymerase Chain Reaction 
cDNA was generated from the NDV-M gene and 18S fragments and then amplified using 
the Superscript III One-step RT-PCR kit with Platinum® Taq DNA polymerase (Applied 
Biosystems).   The following reagent volumes were used for both gene RNA segments:  
template RNA (1 µl), buffer 2X (25 µl), forward primer (10 µM, 1.5 µl), reverse primer (10 
µM, 1.5 µl), enzyme (1 µl) water (20 µl), for a total reaction volume of 50 µl.   
The reactions were run using the following cycling conditions: 
cDNA synthesis:  45oC for 30 minutes x 1 cycle 
Denaturation:  94oC for 2 minutes x 1 cycle 
Amplification:  94oC for 15 seconds, 55oC for 30 seconds, 68oC for 60 seconds x 40 cycles 
Final extension:  68oC for 5 minutes x 1 cycle 
4oC ∞ 
3.10.3 Agarose gel electrophoresis 
The PCR products generated from both reactions were then run on a 1% agarose gel for 
45 minutes at 100V as per Chapter 3.13.2.   
3.10.4 Gel purification 
Bands of the appropriate size corresponding to 121 bp for the NDV M gene and 187 bp for 
18S were extracted from the gel and the DNA purified using the Wizard® SV Gel and PCR 
Clean-Up System (Promega) as described in in Chapter 3.13.3.   
3.10.5 Ligation 
The NDV M gene and 18S cDNA fragments were ligated into the pGEM®-T easy vector 
(Promega, Madison, USA).  The ligation reactions were performed in 10 µl volumes using 
the following reagents:  rapid ligation buffer 2X (5 µl), pGEM®-T easy vector (0.5 µl), T4 
DNA ligase (1 µl) and cDNA (3.5 µl).  The samples were incubated for 1 hour at room 
temperature.  Both a positive control and background control were used.   
38 
 
3.10.6 Transformation 
The vectors were then transformed in E. coli cells as per Chapter 3.13.5.  The transformed 
cells were plated out onto LB agar plates containing ampicillin (100 mg/ml) and incubated 
at 37oC overnight.  Colonies were inoculated into centrifuge tubes containing 2 ml LB with 
ampicillin (0.1 mg/ml) and incubated once again at 37oC for 12-16 hours.   
3.10.7 Colony PCR 
The colonies selected for broth inoculation above were also screened via PCR according 
to Chapter 3.13.6 using the GoTaq® Hot Start Green Master Mix.  M13 universal forward 
and reverse primers were used (10 µM, 1 µl), the primer sequences of which can be found 
in Appendix 1, Table A2.   
The resulting PCR products were then run on a 1% agarose gel at 100V for 45 minutes to 
check for bands of the appropriate size.   
3.10.8 Plasmid purification 
If the colony PCR showed that the vector with the correct insert had been obtained, the 
corresponding broth that had previously been incubated overnight was used to purify the 
plasmid DNA using the Wizard® Plus SV Minipreps DNA Purification System (Promega).   
The method is described in Chapter 3.13.7.  The plasmid DNA was eluted into 100 µl of 
nuclease-free water and quantified as previously in Chapter 3.8.1, using the NanoDrop.  
The DNA was stored frozen at -20oC until required for sequencing.  Sanger sequencing 
was used to ensure that no sequence mutations had been introduced into the insert DNA 
(NDV-M gene or 18S) as per Chapter 3.11 using M13 primers (Appendix 1, Table A2).   
3.10.10 Maxiprep 
After ensuring that the NDV-M and 18S rRNA plasmids contained the correct DNA 
sequences, the plasmids were grown to a high concentration using the PureYield™ 
Plasmid Maxiprep System according to Chapter 3.13.7, using 200 µl ampicillin to grow the 
plasmids in the LB broth.   
3.10.11 Digestion 
The circular plasmid DNA was linearised by restriction enzyme digestion.  The reactions 
were carried out in 50 µl volumes using 20 µl of the NDV-M or 18S rRNA plasmid DNA, 
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buffer B 10X (5 µl, Promega), SpeI restriction enzyme (2 µl, Promega), bovine serum 
albumin (5 µl, BSA) and nuclease-free water (18 µl).  The digestion mixture was incubated 
for 37oC for 90 minutes. 
The digested products were run on a 1% agarose gel as above to remove any undigested 
products.  Bands of the expected size, 3,136 bp for NDV-M and 3,200 for 18S were 
excised from the gel and purified using the Wizard® SV Gel and PCR Clean-Up System 
(Promega) as described previously (Chapter 3.13.7).   
 
The resulting linearised DNA was quantified using the NanoDrop to determine the DNA 
concentration in the elution.   
3.10.12  Copy number determination 
In order to create a standard curve for each of the gene targets, it was necessary to 
calculate the number of DNA molecules per µl.  It had been previously shown in our 
laboratory using Hendra and Nipah viruses (also single strand RNA viruses), that 
calculating standard curves using DNA was equivalent to the curves created using RNA, 
therefore reverse transcription of the DNA into RNA was not undertaken (Glenn Marsh, 
pers. comm.).  The weight of DNA per µl was used in the calculation, thereby calculating 
the copy number per µl. 
 
The calculation was as follows:  
Number of molecules (copy number) =  
[weight (ng) * 6.0221 x 1023*]/[(plasmid length + insert (bp)) * 660 Da * 1 x 109] 
*Avogadro’s number 
3.10.13  Standard curves 
Standard curves were created using the plasmid cDNA  that had previously been isolated 
from the control chicken brain sample (18S rRNA) or the Meredith/02 virus infected 
allantoic fluid (NDV-M).  Both RNA samples were diluted ten-fold in nuclease free water to 
create a dilution series from neat to 10-7.  A qPCR reaction was then performed using the 
reagents and conditions specified in Chapter 3.9.1.  The CT values were plotted against 
the dilutions which had been converted into copy numbers and the line of best fit 
calculated (Microsoft Excel).   
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The line of best fit equation was as follows: 
y = a*ln(x) + b, 
where y = CT, x = copy number, a = slope of the curve, b = the y intercept 
 
Therefore, copy numbers could then be calculated from CT values using the line of best fit 
as below: 
Copy number (x) = e^((Ct – b)/a) 
3.10.14 Normalisation of qPCR data 
The NDV M gene copy numbers were then normalised to a defined number of 18S rRNA 
copies.  This was undertaken so that comparisons between different tissue samples could 
be made and to take into account the fact that different sized samples with different tissue 
densities were used in the RNA isolation step.  Initially, the average copy number of the 
sample run in triplicate was taken and then NDV M gene copy numbers were normalised 
to 108 copies of 18S rRNA.   
 
In most cases, the data were then also log transformed to allow for a better visual 
representation of the spread of the results. 
3.11 Sanger sequencing 
Sequencing of plasmids and short fragments of viral genome was undertaken using the 
Sanger sequencing method.  The sequencing PCR reaction was performed using M13 
primers (pGEM-T easy vector) or pCAGGS primers (pCAGGS vector) and the BigDye® 
Terminator v3.1 cycle sequencing kit (Applied Biosystems).  A list of primers can be found 
in Appendix 1 (Tables A2 and A3). 
 
Reactions were undertaken in 20 µl using template DNA (1 µl), BigDye® 5X sequencing 
buffer (3 µl), BigDye® ready reaction mix (1 µl), forward primer and nuclease-free water.   
 
The cycling conditions were as follows: 
Denaturation: 96oC for 1 minutes x 1 cycle 
PCR amplification: 96oC for 10 seconds (denaturation), 50oC for 5 seconds (annealing), 
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60oC for 4 minutes (extension) x 25 cycles 
4oC ∞ 
 
Sequencing was then performed using an ABI 3130xl (or 3500xl) Genetic Analyzer 
(Applied Biosystems).  When the 3130xl machine was used, 1 ng/100 bp of template was 
used compared with 2 ng/100 bp of template for the 3500xl machine. 
3.12 Whole Genome Sequencing 
Whole genome sequencing was performed using the MiSeq (Illumina) platform based on a 
previously published method.156   
3.12.1 Virus purification 
Initially, viruses were grown in the allantoic cavity of 10-day-old SPF eggs.  The harvested 
allantoic fluid was initially clarified by centrifugation at 10,000 rpm to remove gross debris 
material using a Heraeus Multifuge 3SR Plus centrifuge (Thermo Scientific).  A 
discontinuous sucrose gradient was then prepared using 50% (w/v) sucrose in 2 ml at the 
bottom of an ultracentrifuge tube (Beckman Coulter SW41) and 20% sucrose in 4 ml at the 
top of the tube.  The sucrose solutions were prepared by adding the appropriate amount of 
sucrose powder (Sigma) to Tris-NaCl-EDTA (TNE) buffer (i.e. 10 g sucrose in 40 ml of 
TNE for a 20% solution).  The 50% solution was first added to the centrifuge tube.  
Secondarily, the 20% solution was added by slowly pouring down the side of the tube, 
making sure that the interface was not disrupted.  The interface between the two solutions 
was then marked for easy identification after centrifugation.  Finally, 5 ml of the clarified 
allantoic fluid was slowly added to the tubes.  The tubes were centrifuged for 3 hours at 
36,000 rpm for 90 minutes at 4oC in a JS-24 centrifuge (Beckman Coulter) with a slow 
acceleration and deceleration applied so that the gradient was not disturbed.  After 
centrifugation, the cloudy band containing purified virus that had formed at the interface 
between the sucrose solutions was removed and 1 ml was stored at -80oC until required. 
3.12.2 RNA isolation 
RNA extraction was performed using the QIAamp Viral RNA Mini Kit (Qiagen) as per 
Chapter 3.8, however vacuum was used rather than centrifugation.  Initially, 1 ml of 
purified allantoic fluid was added to 4 ml of AVL buffer (without carrier RNA) and vortexed 
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for 15 seconds.  The samples were then incubated at room temperature for 10 minutes.  A 
vacuum connector was then connected to the Eluator™ Vacuum Elution Device 
(Promega) and a QIAamp Mini spin column added.  A vacuum was applied and the 
allantoic fluid/buffer solution was added to the spin column in 630 µl aliquots.  The column 
was then washed using 750 µl of AW1 buffer followed by 750 µl of AW2 buffer.  Next, the 
column was placed in a wash tube and centrifuged at 14,000 rpm for 1 minute using a 
benchtop centrifuge and the filtrate discarded.  Following this, the column was positioned 
in a 1.5 ml Eppendorf tube and the RNA incubated with 60 µl of AVE buffer for 1 minute.  
Finally, the RNA was eluted by centrifugation at 8,000 rpm for 1 minute and stored frozen 
and -80oC.   
3.12.3 Reverse transcription 
Viral RNA from the previous step was reverse transcribed using the Superscript III 
transcriptase kit (Invitrogen).  Initially, 1 µl of 454 cDNA primer containing random 
octamers was added to 1 µl of dNTP Mix (10 mM, Invitrogen) with 11 µl of template RNA 
(details of the cDNA primer can be found in Appendix 1, Table A2).  The mix was heated 
at 65oC for 5 minutes and placed on ice for 1 minute.  Next, 4 µl of 5X first-strand buffer 
was added, along with 1 µl 0.1 M DTT, 1 µl RNaseOUT (Invitrogen) and 1 µl Superscript 
III.  The tubes were then flicked to mix the reagents and incubated at 50oC for 1 hour and 
then at 100oC for 2 minutes.  Samples were left to cool on ice. 
3.12.4 Double strand synthesis 
Double strand synthesis was performed by adding 20 µl of the sample to 2.5 µl 10X DNA 
polymerase buffer (Promega M195A), 1 µl dN8 454 cDNA primer and 1.5 µl Klenow 
(Promega M220A).  The samples were mixed and incubated at 37oC for 30 minutes, then 
inactivated at 70oC for 15 minutes. 
3.12.5 Random PCR 
The cDNA was amplified via random PCR using the Expand High Fidelity kit (Roche).  
Reactions were undertaken in 50 µl volumes using 5 µl 10X Expand Buffer with MgCl2, 1 
µl dNTP (10mM), 4 µl 454 amplification primer (20 µM), 37 µl nuclease free water, 1 µl 
Expand High Fidelity enzyme and 2 µl template cDNA.   
All samples were amplified in duplicate using the reaction conditions: 
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Denaturation: 95oC for 5 minutes x 1 cycle 
PCR amplification: 94oC for 1 minute (denaturation), 50oC for 1 minute (annealing), 72oC 
for 1 minute (extension) x 25 cycles 
Final extension:  72oC for 7 minutes x 1 cycle 
4oC ∞ 
 
The sequence of the 454 amplification primer can be found in Appendix 1, Table A2.   
3.12.6 Check gel 
In order to determine whether the PCR products contained amplicons of the expected size, 
they were run on a 1% agarose gel as per Chapter 3.13.2.  The products were expected to 
form a streak on the gel between 300 – 800 bp.  The samples used for sequencing were 
all greater than 300 bp. 
3.12.7 PCR product purification 
The PCR products containing amplicons of the correct size were purified using the 
Wizard® SV Gel and PCR Clean-Up System (Promega).  The procedure was performed 
according to the method described in Chapter 3.13.3, however the original PCR products 
were used as opposed to excising the gel.  Therefore the initial procedure involved adding 
an equal amount of membrane binding solution to the PCR product before adding the 
mixture to the SV column assembly. 
3.12.8 Removal from the AAHL secure laboratories 
In order to access the Illumina MiSeq, the PCR products were removed from the AAHL 
secure laboratories.  This required the products to be decontaminated by adding ethanol 
such that 70% of the total volume was 100% ethanol. 
After removal, the DNA was quantified using the Qubit DS high sensitivity DNA assay (Life 
Technologies).   
3.12.9 Sequencing  
Sequencing of the DNA was performed using the MiSeq platform (Illumina) according to 
the manufacturer’s instructions.  The genome of each of the four viruses was assembled 
using read mapping and de novo assembly using the CLC Genomics Workbench (CLC 
Genomics Workbench v.6.0.5).  Read mapping was performed for the Meredith/02, PR/98 
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and Texas GB viruses using previously published sequences AY935490, AY935497 and 
GU978777.  Whereas the alignment for the Herts 33/56 virus consisted of 2 independent 
read mappings and 2 denovo assemblies.  For the purposes of this research the ends of 
the sequences were not required and therefore not determined. 
3.13 Cloning (P and V genes) 
3.13.1 Conventional PCR 
The Superscript III One-step RT-PCR kit with Platinum® Taq DNA polymerase (Applied 
Biosystems) or the Q5® High-Fidelity 2X Master Mix (New England BioLabs) was used to 
amplify cDNA.  Reagents were used according to the kit manufacturer’s instructions unless 
otherwise specified.  The PCR reactions were performed using a Multigene Gradient 
thermal cycler (Labnet).  Annealing temperatures were adjusted according to the NEB 
online Tm calculator (http://tmcalculator.neb.com/#!/).  
3.13.2 Agarose gel electrophoresis 
In most cases, unless otherwise stated, a 1% agarose gel was used to separate DNA 
fragments.  The 1% gel was prepared using agarose powder (Sigma) in tris-acetate-edta 
(TAE) buffer with the addition of 0.01% SYBR® Safe (Invitrogen).  Samples were loaded 
onto the gel with 6X gel loading buffer (Thermo Scientific) and a 1 Kb Plus DNA ladder 
(Invitrogen) and were electrophoresed for 45 minutes at 100V.   Images of the resulting 
bands were taken using a DC120 camera (Kodak). 
3.13.3 Gel purification 
The Wizard® SV Gel and PCR Clean-Up System (Promega) was used to purify DNA 
bands after agarose gel electrophoresis.  Bands were cut from the gel, weighed and 
placed into 1.5 ml microcentrifuge tubes.  Membrane binding solution was added at 10 µl 
per 10 g of gel and the tube then incubated at 60oC and vortexed until the gel had 
dissolved.  The dissolved gel was then transferred to an SV minicolumn combined with a 
collection tube.  The tubes were centrifuged at 13,000 rpm for 1 minute and the 
flowthrough discarded resulting in the DNA binding to the SV minicolumn.  The column 
was washed twice with membrane wash solution and centrifuged at 13,000 rpm for 1 
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minute after the first wash then for 5 minutes after the second wash.  The DNA was eluted 
in 50 µl of nuclease-free water after centrifugation.  
3.13.4 Ligation 
Ligation reactions were incubated at room temperature for one hour or at 4oC overnight. 
3.13.5 Transformation 
All vectors were transformed using Top 10 F Escherichia coli (E. coli) cells using 2 µl of the 
ligated plasmid and 50 µl of the E. coli cells which had previously been thawed on ice.  
The mixture was transferred to a cuvette and the cells electroporated at 1.8 Volts using a 
Gene Pulser (Bio-rad).  Into the cuvette, 500 µl of Luria-Bertani broth (LB) was added and 
mixed.  The mixture was then transferred to a 15 ml tube and incubated for 1 hour at 37oC 
on a platform shaker at 250 rpm.  An aliquot, of the transformed mixture, 50 µl, was then 
plated out using beads onto LB agar plates containing an antibiotic appropriate to the 
plasmid.  The plates were incubated at 37oC overnight.  Colonies were then picked from 
the plates using toothpicks and added to 15 ml centrifuge tubes containing 2 ml LB with 
the appropriate antibiotic (0.1 mg/ml) and incubated overnight at 37oC on a platform 
shaker at 250 rpm.  The same colonies were simultaneously used in a screening colony 
PCR to ensure that the vector contained the correct target insert.   
3.13.6 Colony PCR 
Colony PCRs were conducted with the GoTaq® Hot Start Green Master Mix by placing the 
colonies collected via toothpicks directly into the mastermixes.  The reactions were 
undertaken in 10 µl volumes containing GoTaq Master Mix 2X (5 µl), forward primer (10 
µM), reverse primer (10 µM) and nuclease-free water to make a total reaction volume of 
10 µl.   
Cycling conditions were: 
Denaturation: 95oC for 2 minutes x 1 cycle 
PCR amplification: 95oC for 30 seconds (denaturation), 50oC for 30 seconds (annealing), 
72oC for 60 seconds (extension) x 30 cycles 
Final extension:  72oC for 7 minutes x 1 cycle 
4oC ∞ 
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3.13.7 Plasmid purification 
Plasmids were purified using the Wizard® Plus SV Minipreps DNA Purification System 
(Promega) or the PureYield™ Plasmid System (Promega). 
An aliquot (1 ml) of the LB broth was transferred into a 1.5 ml microcentrifuge tube and 
centrifuged at 13,000 rpm for 5 minutes to form a cell pellet.  The supernatant was 
removed and the pellet resuspended in cell resuspension solution (250 µl).  Alkaline 
protease (10 µl) was added to the mix and incubated for 5 minutes at room temperature.  
Neutralization solution (350 µl) was added next and the mixture centrifuged at 13,000 rpm 
for 10 minutes.  The solution was then poured into a spin column which had been inserted 
into a collection tube in order to bind the DNA to the column.  The tubes were centrifuged 
at 13,000 rpm for 1 minute and the flowthrough discarded.  Wash solution containing 
ethanol (750 µl) was added to the column and centrifuged once again.  The wash was 
repeated with 250 µl of wash solution.  Finally, the DNA was eluted into 100 µl of 
nuclease-free water.   
 
For greater yields of plasmid DNA, the PureYield™ Plasmid Maxiprep System (Promega) 
was used.  The 2ml plasmid broths obtained during the transformation step above 
(Chapter 3.13.5)  were used to grow the subsequent culture by adding 1 ml aliquots into 
200 ml LB with appropriate antibiotics in 1 litre conical flasks.  The flasks were incubated 
overnight at 37oC on a platform shaker at 250 rpm.  The cultures were centrifuged at 5,000 
x g for 10 minutes and the supernatant discarded.  The pelleted cells were suspended in 
12 ml cell resuspension solution.  Next, 12 ml of cell lysis solution was added and the 
solution incubated for 3 minutes at room temperature.  After adding 12 ml of neutralization 
solution, the lysed cells were centrifuged at 14,000 x g for 20 minutes.  The lysate was 
then poured through the PureYield™ clearing columns into the PureYield™ Maxi binding 
columns using the Eluator™ Vacuum Elution Device (Promega).  The binding columns 
were washed using 5 ml of endotoxin removal wash and 20 ml of column wash, in both 
cases by applying a vacuum to the columns.  The plasmid DNA was eluted by vacuum into 
1 ml of nuclease-free water.   
 
The resultant DNA concentration was analysed using the NanoDrop (Chapter 3.8.1) and 
the DNA sequenced using Sanger sequencing (Chapter 3.11). 
47 
 
3.14 Transfection 
3.14.1 Transfection with plasmid DNA 
Transfection of DF-1 cells with plasmid DNA was performed using Lipofectamine® LTX 
with Plus™ Reagent (Invitrogen).  Cells were seeded at a density of 5 x 104 cells per well 
in 24-well tissue culture plates and grown until 80% confluency using growth media with 
5% foetal calf serum.  Cells were then transfected using a DNA:Lipofectamine ratio of 1:3 
after previously optimising the ratio to achieve maximum transfection efficiency. Initially, 
growth media was removed and the cells washed once with PBSA.  Subsequently, 500 µl 
of Opti-MEM (ThermoFisher Scientific) was added to all wells.  Next (in per well volumes), 
in separate tubes, Lipofectamine LTX (1.5 µl) was diluted in Opti-MEM (25 µl) and plasmid 
DNA (0.5 µg) was diluted in Opti-MEM (25 µl) with PLUS reagent (0.5 µl).  The diluted 
reagents were incubated for 5 minutes and then the diluted DNA was added to the diluted 
Lipofectamine LTX and incubated for 5 minutes.  The lipid complex (50 µl) was then added 
to the cells in a dropwise manner and the cells incubated at 37oC with 5% CO2.  After 10 
hours, the lipid complex was removed from the cells and growth media with 5% foetal calf 
serum added.    
 
The transfection optimisation process was conducted using four different ratios of DNA to 
Lipofectamine (1:2, 1:3, 1:4 and 1:5) in Opti-MEM, using the pCAGGS-GFP plasmid in DF-
1 cells.  Each of these dilutions were added to cells in duplicate.  One of the duplicates 
was allowed to incubate overnight in Opti-MEM and the other had the media removed after 
6 hours and replaced with growth media.  The transfection efficiency was assessed at 24 
and 56 hours by counting the number of fluorescent cells per four 10X fields.  The 
optimum transfection conditions were found to occur when the transfection media was 
removed after 6 hours and with a 1:3 DNA to Lipofectamine ratio. 
 
3.14.2 Transfection with polyionsinic:polycytidylic acid (Poly I:C) 
 
Poly I:C was also used to transfect cells in order to mimic infection with viral dsRNA.  
Growth media was removed from cells and washed with PBSA.  Then the same volumes 
of Lipofectamine LTX, Opti-MEM complex were used as in Chapter 3.14.1 with 0.5 µg of 
Poly I:C added instead of plasmid DNA. 
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3.15 Primers and probe design 
In-house primers and probes were designed using Geneious (Geneious R8, v. 8.0.5) 
software and were manufactured by Geneworks at their PCR/Sequencing purity level. 
Lyophilized primers and probes were made up into 100 µM stock solutions using nuclease-
free water.  Aliquots of 20 µl were then diluted to 10 µM working stocks and stored frozen 
at -20oC.  These aliquots were only thawed a maximum of 3 times or until degradation was 
evident. 
A complete list of primer and probe sequences can be found in Appendix 1. 
3.16 Sequence Analysis 
The two software programs used to analyse both Sanger sequence and whole genome 
sequence data, were the CLC Genomics Workbench (CLC Genomics Workbench v.6.0.5) 
and Geneious (Genious R8, v. 8.0.5).  
3.17 Statistical analysis 
Statistical analyses were undertaken using either GraphPad Prism 5.02 for Windows 
(GraphPad Software) or MS Excel 2013 (Microsoft). 
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CHAPTER 4  
 
AN AUSTRALIAN NEWCASTLE DISEASE VIRUS WITH A VIRULENT 
FUSION PROTEIN CLEAVAGE SITE PRODUCES MINIMAL 
PATHOGENICITY IN CHICKENS 
 
4.1 Introduction 
Newcastle disease (ND) is a viral disease of birds, which is endemic in many countries 
and can have severe impacts on domestic poultry and in some cases wild birds.  It is 
caused by virulent strains of Newcastle disease virus (NDV), which is classified within the 
genus Avulavirus in the family Paramyxoviridae and is synonymous with avian 
paramyxovirus serotype 1 (APMV-1).21  NDV is a negative sense RNA virus, containing 6 
genes (3’-NP-P-M-F-HN-L-5’) that encode 7 proteins: the nucleocapsid protein (NP), the 
phosphoprotein (P), the matrix protein (M), the fusion protein (F), the haemagglutinin-
neuraminidase protein (HN), the large polymerase protein (L), and the V protein which is 
produced by RNA editing of the P gene.157  There is wide variability in pathogenicity 
between isolates of NDV which has led to grouping of the various viruses into five 
pathotypes (from most pathogenic to least pathogenic):  viscerotropic velogenic, 
neurotropic velogenic, mesogenic, lentogenic and asymptomatic.21,6  Viscerotropic 
velogenic viruses are highly pathogenic with lesions associated with the gastrointestinal 
tract.  Neurotropic velogenic viruses are also highly pathogenic, however respiratory and 
neurological signs predominate.  Mesogenic viruses vary in their pathogenicity but often 
present with respiratory signs in younger birds and low morbidity and mortality.  
Lentogenic viruses are associated with mild respiratory disease, and birds infected with 
asymptomatic viruses show little to no clinical signs at all.6  The intracerebral pathogenicity 
index (ICPI) is commonly used to classify these viruses and is conducted by intracerebral 
inoculation of 1 day old chicks.  In addition, sequencing of the F protein cleavage site has 
also been found to correlate with pathogenicity.129  According to the OIE guidelines, 
virulent, notifiable strains are those which contain multiple basic amino acids (lysine or 
arginine) at the F protein cleavage site with a phenylalanine at residue 117, or have an 
intra-cerebral pathogenicity index (ICPI) of 0.7 or greater.6  Therefore, both mesogenic and 
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velogenic viruses are all classified as virulent despite some mesogenic viruses causing 
minimal disease.3, 126 
 
From 1998, Australia experienced multiple outbreaks of ND in commercial poultry 
including broiler and layer chickens and quail, before it was subsequently eradicated in 
2002.56,63  Whilst outbreaks of ND have not occurred in Australia since 2002, NDVs 
continue to circulate in wild birds and outbreaks of pigeon paramyxovirus (APMV-1 
genotype VIb) have occurred in pigeons and wild birds from 2011, with the potential to 
cause disease in poultry.158  Currently circulating avirulent viruses in wild birds in Australia 
are from both Class I and Class II genotype I and whilst it was speculated that the 1998-
2002 outbreak viruses may have originated in wild birds, testing of wild birds at the time of 
the outbreak was not able to definitively prove this.53, 159, 160 
 
The ND outbreaks in 1998 were predominantly located within the Mangrove Mountain 
region of New South Wales (NSW) and were immediately preceded by the isolation of a 
NDV in chickens from Peats Ridge, NSW (PR/98).  PR/98 was detected in association with 
respiratory disease in broiler chickens and was shown to have an avirulent F protein 
cleavage site.53  It was found that the sequence of the PR/98 virus cleavage site varied by 
only two nucleotides from the sequence found in virulent viruses.  These two nucleotide 
changes induced two amino acid changes from 112RRQGRL117 (PR/98) to 112RRQRRF117 
(virulent).53  The PR/98 virus was thought to be the precursor to the virulent viruses 
detected during this time, as it was isolated on the majority of properties that went on to 
have outbreaks of ND.    
 
Whilst most of the ND viruses isolated from the 1998-2002 disease outbreaks were 
classified as virulent on account of their F protein cleavage site motifs, it was noted that 
the disease syndrome often differed from what was expected of a velogenic virus.9, 56  
There was slower spread throughout the flock, less severe clinical signs and a lower case 
fatality rate than would be observed with typical velogenic ND viruses.  Of particular note 
was an outbreak in 2002 on a layer farm in Meredith, Victoria, in which egg production had 
decreased by 40%, production of soft-shelled eggs had increased and there was a very 
slight rise in mortalities per month from 0.4% to 0.8%.9  Despite not having the clinical 
appearance of a velogenic virus, the ICPI of the isolated NDV was determined to be 1.61 
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and the F protein cleavage site motif was 112RRQRRF117.71  As a result, a stamping out 
policy was instituted and the birds were culled. 
 
Given the significant trade and economic implications of ND outbreaks, it is important to 
determine whether the current OIE definition of virulent, notifiable strains of NDV based on 
the F protein cleavage site motif is justified.  A number of studies have shown that whilst 
the F protein is critical in predicting the behaviour of an ND virus, pathogenicity is 
multifactorial and proteins other than the F protein may play key roles.12, 109, 120 
 
There have been limited in vivo experimental studies using Australian ND virus isolates.  
Previous experimental studies using an Australian virus with a virulent F protein cleavage 
site of 112RRQRRF117, isolated from Glenorie, NSW (9809-19-1107) found that affected 
birds showed mild to severe depression, respiratory disease and neurological signs with 
no mortalities and recovery after 10 days.101, 104 
 
Although the field data indicate that some Australian viruses isolated from 1998-2002 with 
virulent cleavage sites are not highly pathogenic, it is not understood why there is this 
apparent contradiction.  Given the paucity of information on the disease from these 
outbreaks, one of our objectives was to confirm the field observations that chickens 
infected with these viruses develop only mild clinical disease.  A second objective was to 
determine the pathogenesis of the viral infections in chickens evaluated experimentally. 
 
In this study we characterised the infection caused by a virulent Australian NDV 
(Meredith/02) and compare it with an avirulent Australian virus (PR/98).  Two highly 
virulent reference viruses, the viscerotropic Herts 33/56 and neurotropic Texas GB were 
included for comparison.  The results of this work will be important in understanding the 
risk framework associated with  Australian NDVs, the appropriate outbreak response to 
their detection in poultry flocks and whether the current OIE definition of ND is applicable 
in the Australian situation. 
4.2 Materials and Methods 
All of the animal experiments included in this paper were conducted in accordance with the 
Australian National Health and Medical Research Council’s Australian Code of Practice for 
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the Care and Use of Animals for Scientific purposes.154  The design of the experiments 
and care of the animals were approved by the CSIRO Australian Animal Health 
Laboratory’s Animal Ethics Committee. 
 
All experimental work involving the use of live virus was conducted at biosafety level 3 
(BSL-3). 
4.2.1 Animals and handling 
Fifty, 8-week-old specific-pathogen-free (SPF), White Leghorn chickens were used in the 
study.  The birds were randomly assigned to one of five groups of ten birds (including one 
control group).  Each group of chickens was housed in a separate room at BSL-3 
comprising bare floor and a retreat area with artificial perches and sawdust.  The male to 
female ratios of the birds in each group varied from 1:1 to 2:3.  The birds were allowed four 
days to acclimatise to the rooms before challenge and had free access to feed and water 
at all times.  Animals were monitored twice daily when clinically healthy and up to every 
two hours during the day when clinical signs were evident.  Prior to euthanasia, birds were 
anaesthetised with a combination of xylazine at 5 mg/kg (Xylazil-20; Ilium, Smithfield, 
Australia) and ketamine at 53 mg/kg (Metamil; Ilium, Smithfield, Australia) delivered via the 
intramuscular route. 
4.2.2 Virus isolates 
Four ND virus isolates were used in this study; two Australian viruses and two virulent 
viruses exotic to Australia (Table 4.1).  The Meredith/02 virus was originally isolated from a 
cloacal swab collected during an outbreak of ND at Meredith, Victoria in 2002 and was 
classified as virulent because it contained a polybasic F protein cleavage site and an ICPI 
of 1.61.71  The PR/98 virus was isolated at Peats Ridge, NSW in 1998 and is known as the 
avirulent precursor virus to the subsequent virulent ND outbreaks.  The PR/98 virus has an 
ICPI of 0.6.71  Both of these Australian viruses had undergone one passage in eggs prior 
to their use in this study.  The two exotic viruses were Herts 33/56, which is a viscerotropic 
velogenic virus (Class II, genotype IV) and Texas GB (Class II, genotype II), which is a 
neurotropic velogenic virus with ICPIs of 1.9 and 1.75 respectively.97  Both viruses were 
imported from Central Veterinary Laboratory, Weybridge, England in 1992 with an 
unknown passage history.   
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Prior to use, each virus isolate was grown in 9-11 day old embryonated SPF chicken eggs 
(Charles River Laboratories, Australia) via inoculation of 0.2 ml into the allantoic cavity and 
incubation at 37oC for 4 days. 
 
Virus name Reference 
number 
Location Date of 
isolation 
Fusion 
protein 
cleavage site 
motifa 
Meredith/02 02-1334/ 
0205-10-
0004  
Meredith, 
Victoria, 
Australia 
8/05/2002 112RRQRRF117 
PR/98 98-1154/ 
9809-04-
1555 
Peats Ridge, 
New South 
Wales, 
Australia 
 
14/09/1998 112RRQGRL117 
Herts 33/56 9303-11-
1630 
Hertsfordshire, 
UK 
1933 112RRQRRF117 
Texas GB 9302-26-
1330 
Texas, USA 1948 112RRQKRF117 
Table 4.1  Virus isolates used in the study.  aBasic amino acids are indicated in bold 
 
4.2.3 Experimental design 
Each group of ten birds was challenged with one of the four virus isolates using allantoic 
fluid diluted in PBS to give a titre of 105 50% embryo infectious doses (EID50) in 200 µl per 
bird.  The inoculum was equally divided between the ocular, nasal and oral routes and 
administered into the conjunctival sac, both nares and caudal pharynx respectively.  The 
control birds were inoculated similarly with 200 µl of phosphate buffered saline.  At days 2 
and 4 post challenge (dpc), two birds from each group were euthanized to assess viral 
replication in tissues.  The remaining six birds were then observed over 14 days.  Birds 
were euthanized at the point at which they developed moderate clinical signs or at the end 
of the trial period on day 14.  Moderate clinical signs were defined as inactivity, infrequent 
eating, huddling and not reverting to normal behaviour on stimulation. 
 
Prior to challenge and at 7 days post challenge, 1-2 ml of blood was collected from the 
ulnar vein and placed into serum separator tubes.  At euthanasia, blood was collected via 
cardiac puncture after anaesthesia.  The blood was then allowed to clot at room 
temperature for 30 mins before being centrifuged at 1300 g for 10 mins.  The serum was 
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removed and stored frozen at -20oC until testing.  Immediately prior to testing, sera were 
heat inactivated at 56oC for 30 minutes.   
 
At euthanasia a range of tissue samples were collected from all birds.  Samples for 
histology and immunohistochemistry were fixed in 10% neutral buffered formalin for 24-48 
hours before processing.  Tissues for histology included trachea, lung, air sac, heart, 
spleen, eyelid, thymus, caecal tonsils, bursa, pancreas, proventriculus, gizzard, 
duodenum, skin, skeletal muscle and brain.  For molecular analysis and virus isolation, 
approximately 0.5 cm3 samples of fresh brain, spleen, lung, kidney and small intestine, 
were collected into tubes containing 970 µl viral transport media (PBS, penicillin, 
streptomycin and gentamicin and 1% bovine serum albumin) with 2 mm aluminium silicate 
beads (Biospec Products Inc, Bartlesville OK, USA).  These samples were stored frozen at 
-80oC until required.  Tissues from control birds were only tested by histopathology and 
immunohistochemistry. 
4.2.4 Serology 
The titre of antibodies was measured by haemagglutination inhibition (HI) assay using 
standard methods, as described in Chapter 3.5.6   
 
4.2.5 Histopathology and Immunohistochemistry 
Histopathology and immunohistochemistry were performed according to Chapter 3.4, 
using a mouse monoclonal antibody (Q91-1) for immunohistochemistry. 
 
4.2.6 RNA isolation and quantitative reverse transcriptase polymerase chain 
reaction (qRT-PCR) 
RNA isolation and qRT-PCR was conducted as described in Chapters 3.6, 3.8 and 3.9.  
RNA was extracted using the MagMAXTM-96 Viral RNA Isolation kit (Ambion) with 100 µl 
of the tissue supernatant combined with 260 µl MagMAXTM Lysis/Binding solution.  After 
isolation, RNA was quantified via NanoDrop, as per Chapter 3.8.1 and used immediately 
with the remainder stored at -80oC.   
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qRT-PCR in triplicate was conducted using the AgPath-IDTM One-Step RT-PCR kit 
(Applied Biosystems, Victoria, Australia).  The NDV M gene primers and probe were 
multiplexed with eukaryotic 18S primers and probe, the sequences of which can be found 
in Appendix 1, Table A1.  Previously published NDV M gene primers and probe were 
multiplexed with eukaryotic 18S primers and probe to allow for quantitation of NDV RNA 
copy numbers (Table 2).161   
 
Relative quantification was conducted via standard curves generated according to Chapter 
3.10.   NDV M gene copy numbers were then expressed relative to 108 copies of 18S 
RNA. 
 
4.2.7 Virus Isolation 
Virus isolation was only conducted on PCR-positive tissue samples.  An aliquot (200 µl) of 
the tissue homogenate supernatant was inoculated into the allantoic sac of 10 day old SPF 
embryonated chicken eggs in duplicate, which were then incubated at 37oC for 7 days.  
Allantoic fluid was then tested for haemagglutination activity (HA).   
 
4.2.8 Sequencing 
The whole genome of each of the virus isolates was sequenced via the MiSeq (Illumina) 
platform using a variation of a published method which can be found in Chapter 3.12 156.   
 
At the conclusion of the trial, partial re-sequencing of the virus isolates was performed on 
RNA extracted from tissue samples to ensure that the F protein cleavage site and the HN 
extension had not mutated during in vivo replication.  The sequencing was performed by 
Sanger sequencing  using published primers7, 71, the Big Dye Terminator Reaction Kit v. 
3.1 (Applied Biosystems) and an ABI 3130xl Genetic Analyzer (Applied Biosystems) 
according to Chapter 3.11.  
 
4.2.9 Statistical Analysis 
Kaplan-Meier survival curves were generated using GraphPad Prism 5.02 for Windows 
(GraphPad Software, San Diego, USA).  Survival curves were analysed using the Mantel-
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Cox log-rank test with pairs of survival curves compared at a time.  GraphPad Prism was 
also used to analyse serology and PCR data using the Student’s t-tests and the Mann-
Whitney U test respectively.  Statistical significance was set at p<0.05 for all analyses. 
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4.3 Results 
4.3.1 Clinical signs 
All birds challenged with the Meredith/02 virus survived until the end of the trial (apart from 
the clinically healthy birds euthanized at 2 and 4 dpc according to the study design).  
However at 3 dpc, the five birds were seen to be slightly less active in the morning with 
two birds displaying very mild laboured respiration.  These clinical signs had resolved 
within 6 hours. 
No clinical signs were observed in any of the birds inoculated with the PR/98 virus. 
All birds inoculated with the exotic Herts 33/56 and Texas GB viruses showed moderate 
clinical signs as defined by a decreased response to stimulation, decreased feed intake 
and huddling before the end of the trial period and were euthanized at that point.  Eight 
birds in the Herts 33/56 group showed clinical signs at 2 dpc, including moderate 
depression, head tucking and an unwillingness to move away when approached.  All birds 
in this group were then euthanized at 2 dpc, including 2 healthy birds as per the study 
design.  Two birds inoculated with the Texas GB isolate showed moderate depression, 
head tucking and mild ataxia at 4 dpc and were euthanized at that time.  At 5 dpc, the 
remainder of these birds (n=4), displayed ataxia, with three birds showing an obvious head 
twitch. These birds were then euthanized at 5 dpc. 
No abnormalities were detected clinically in any of the control birds. 
A survival curve comparing the euthanasia time points for birds infected with each of the 
different viruses is given in Figure 4.  The survival times for the birds infected with the 
Australian viruses were significantly different from those infected with the Herts 33/56 
(p=0.0009) and Texas GB viruses (p=0.0012). 
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Figure 4.1  Kaplan-Meier survival curve of the birds infected with the four viruses over 14 days. The plot does not include 
the 4 birds in each group that were euthanased on 2 and 4 dpc challenge according to the study design.  Error bars 
indicate 95% confidence intervals. 
 
4.3.2 Serology 
All birds were negative for serum antibodies prior to challenge.  All birds in the Meredith/02 
and PR/98 groups had seroconverted by 7 dpc with significantly different (p=0.01) 
geometric mean titres of 28.2 and 26.3 respectively.  By 14 dpc, mean titres had reached 
210.2 in the Meredith/02 group and 27.2 in the PR/98 group, again showing significant 
differences (p=0.0004) between the virus strains.   None of the birds inoculated with the 
Herts 33/56 virus had seroconverted due to the early euthanasia time point at 2 dpc. Low 
levels of antibodies (22 and 24) were detected at 5 dpc in two birds inoculated with the 
Texas GB virus with the rest of the birds being euthanized without detectable antibodies. 
 
4.3.3 Gross Pathology 
Gross pathological findings were restricted to the birds infected with the exotic isolates of 
NDV.  In birds infected with the Herts 33/56 isolate, the most consistent findings were 
haemorrhagic caecal tonsils (10/10), haemorrhage at the junction of the proventriculus and 
oesophagus (4/10) and mild splenic enlargement with pale mottling (4/10).  Birds 
inoculated with the Texas GB isolate displayed moderate cloudiness of the air sacs (2 
birds on 4 dpc and 2 birds on 5 dpc), along with one bird with mild splenomegaly on 5 dpc.  
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There were no gross lesions detected in birds inoculated with the Australian ND viruses or 
in control birds. 
4.3.4 Histopathology 
The histological lesions noted in birds infected with the Meredith/02 and PR/98 isolates of 
NDV were minimal.  The lesions involved mild infiltrates of heterophils in the epithelium 
and submucosa around sites of inoculation, i.e. the nasal turbinates (Fig. 4.2), trachea and 
conjunctiva. These features were observed in the Meredith/02 group within all birds 
euthanized on 2 and 4 dpc and in 2 birds euthanized on 14 dpc.  Only the two birds 
euthanized on 2 dpc in the PR/98 groups showed mild heterophilic infiltrates in the nasal 
turbinates and conjunctiva. 
 
In birds infected with the Herts 33/56 virus, histological lesions were predominantly seen in 
sites of lymphoid tissue accumulation such as the thymus (10/10), conjunctiva (10/10), 
spleen (9/9), proventriculus (at the oesophageal and gizzard junctions, 10/10), caecal 
tonsils (10/10), bursa (9/10) and nasal turbinates (8/10).  In these regions, there was 
moderate to marked necrosis and apoptosis of lymphocytes and macrophages, with 
oedema, fibrin deposition and heterophil infiltration (Fig. 4.3). 
 
In birds inoculated with the Texas GB virus, there was moderate loss of cilia throughout 
the tracheas, with occasional necrosis of epithelial cells and moderate numbers of 
inflammatory cells, predominantly heterophils (8/10).  The other significant lesions were 
seen within the central nervous system and comprised perivascular lymphocyte cuffing 
and glial nodule formation throughout the cerebrum, cerebellum and brainstem (8/10).  
Occasional neuronal necrosis was also seen, most commonly in the cerebellum or 
brainstem.  These lesions were seen in all birds except those euthanized on 2 dpc. 
 
There were no histological lesions detected in any of the control birds. 
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Figure 4.2  Meredith/02, nasal turbinates, mild heterophil and lymphocyte infiltrates  
in the epithelium and submucosa with loss of cilia.  Haematoxylin and eosin. 
 
 
 
Figure 4.3  Herts 33/56, caecal tonsils, necrosis of lymphoid follicles with a  
marked heterophil infiltrate.  Haematoxylin and eosin.  
 
50 µm 
50 µm 
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4.3.5 Immunohistochemistry 
Antigen was detected in birds infected with all four viruses, however the distribution and 
quantity of the staining varied between the different virus groups (Table 4.2).  Antigen 
staining appeared as fine to moderate-sized granules in both the cytoplasm and the 
nucleus of cells.  At euthanasia of the Herts 33/56 birds, antigen was detected in the brain 
(9/10), nasal turbinates (10/10), eyelids (10/10), larynx/trachea (4/8), lung (10/10), heart 
10/10, spleen (9/9), kidney (7/10) and caecal tonsils (10/10).  In the Texas GB birds, 
antigen was also detected in the brain (8/10), nasal turbinates (10/10), eyelids (8/9), 
larynx/trachea (9/10), lung (8/10), heart (8/10), spleen (10/10), kidney (8/10) and caecal 
tonsils (8/10).  The quantity of antigen was scored on a 3 point scale (Table 4.2).  In 
contrast, birds inoculated with the Meredith/02 virus showed antigen predominantly 
restricted to sites of inoculation, with staining seen in the nasal turbinates (7/10), eyelid 
(4/10), larynx/trachea (Fig. 4.5 3/8), spleen (4/4) and caecal tonsils (3/9).  Birds inoculated 
with the PR/98 virus also showed antigen staining in the nasal turbinates (4/10), eyelid 
(2/10), larynx/trachea (Fig. 4.6, 2/10) only on 2 and 4 dpc.  There was also antigen staining 
in the spleen of one bird euthanized a 14 dpc.  The antigen detected in the spleen and 
caecal tonsils at 2 and 4 dpc in the Meredith/02 birds indicates a greater degree of 
systemic replication than with the PR/98 virus. No immunohistochemical staining was 
detected in any tissues from control birds.   
 
Comparisons of the staining intensity between birds infected with the different viruses can 
be seen in Figure 4.4.
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Animal 
identification 
Day of 
euthanasia 
Brain Brainstem Nasal 
Turbinates 
Eyelid Larynx/ 
Trachea 
Lung Heart Spleen Kidney Caecal 
tonsils 
Meredith/02            
6 2 - - + ++ n/d - - + - + 
7 2 - - + ++ n/d - - + - - 
1 4 - - +++ + +++ - - + - + 
4 4 - - + + + - - ++ - + 
2 14 - - + - + - - - - - 
3 14 - - + - - - - - - - 
5 14 - - + - - - - - - - 
8 14 - - - - - - - - - - 
9 14 - - - - - - - - - - 
10 14 - - - - - - - - - n/d 
PR/98            
13 2 - - + + + - - - - - 
19 2 - - ++ - - - - - - - 
12 4 - - ++ + + - - - - - 
16 4 - - ++ - - - - - - - 
11 14 - - - - - - - - - - 
14 14 - - - - - - - + - - 
15 14 - - - - - - - - - - 
17 14 - - - - - - - - - - 
18 14 - - - - - - - - - - 
20 14 - - - - - - - - - - 
Herts 33/56            
21 2 ++ + + +++ + ++ ++ +++ + +++ 
22 2 ++ + + +++ - + + +++ + +++ 
23 2 + - ++ +++ + + + +++ - +++ 
24 2 + - + +++ ++ ++ + +++ + +++ 
25 2 ++ ++ +++ +++ n/d ++ ++ n/d + +++ 
26 2 + ++ +++ +++ - ++ ++ +++ ++ +++ 
27 2 ++ - +++ +++ ++ + ++ ++ - +++ 
28 2 + - ++ +++ n/d + + +++ ++ +++ 
29 2 - - + +++ - ++ ++ +++ - +++ 
30 2 + - + +++ - + ++ ++ + ++ 
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Texas GB            
12 2 - - + ++ - - - + - - 
20 2 - - + + ++ - - + - + 
11 4 + + ++ - +++ ++ ++ + ++ + 
16 4 ++ ++ + + + ++ ++ + ++ + 
18 4 ++ + ++ + +++ ++ ++ ++ ++ ++ 
19 4 + + ++ n/d +++ + + ++ + + 
13 5 ++ ++ ++ + ++ + + + ++ + 
14 5 ++ + ++ + ++ ++ ++ + + + 
15 5 +++ +++ + ++ ++ + + + + - 
17 5 +++ +++ + + +++ ++ + ++ ++ + 
Table 4.2  Tissue staining by immunohistochemistry  (n/d:  not done, +++ widespread staining, ++ clusters of positive cells, + small number of  
individual positive staining cells, - no staining)
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The cellular tropism also varied between viruses, with birds infected with the Herts 33/56 
viruses showing a stronger lymphoid tissue tropism than both the Australian viruses and 
the Texas GB virus.  The birds infected with the Herts 33/56 virus showed a predominance 
of staining in lymphoid tissue within mononuclear cells in both lymphocytes and 
macrophages (Fig. 4.7).  The positive staining lymphoid tissue was found throughout the 
upper respiratory tract and gastrointestinal tract.  Antigen was also detected in the brain in 
both neurones and glial cells.  The most notable difference between the Texas GB virus 
and the other viruses was the large amount of staining in the central nervous system, in 
which cell bodies and processes of large neurons were stained, particularly Purkinje cells 
in the cerebellum (Fig. 4.8) and brainstem nuclei.  These birds also displayed greater 
staining of respiratory epithelial cells in the upper respiratory tract when compared with the 
Herts 33/56 infected birds (Table 4.3).   
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Figure 4.4  Immunohistochemical staining of nasal turbinates, conjunctiva, trachea, caecal tonsils and cerebellum.  
Immunohistochemistry for NDV nucleoprotein (red). 
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Figure 4.5  Meredith/02, larynx, staining of epithelial cells.   
Immunohistochemistry for NDV nucleoprotein (red).   
 
 
Figure 4.6  Peats Ridge/98, larynx, staining of epithelial cells.   
Immunohistochemistry for NDV nucleoprotein (red). 
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Figure 4.7  Herts 33/56, nasal turbinates, staining of lymphocytes and macrophages.  Immunohistochemistry for NDV 
nucleoprotein (red). 
 
 
Figure 4.8  Texas GB, cerebellum, staining of Purkinje cells and dendrites.   
Immunohistochemistry for NDV nucleoprotein (red). 
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Animal 
identification 
Day of euthanasia Epithelial Lymphoid 
Meredith/02    
6 2 + - 
7 2 + - 
1 4 +++ - 
4 4 + - 
2 14 + - 
3 14 + - 
5 14 - + 
8 14 - - 
9 14 - - 
10 14 - - 
PR/98    
13 2 + - 
19 2 ++ - 
12 4 ++ - 
16 4 ++ - 
11 14 - - 
14 14 - - 
15 14 - - 
17 14 - - 
18 14 - - 
20 14 - - 
Herts 33/56    
21 2 + + 
22 2 - + 
23 2 + ++ 
24 2 - + 
25 2 ++ +++ 
26 2 + +++ 
27 2 + +++ 
28 2 + ++ 
29 2 - + 
30 2 - + 
Texas GB    
12 2 + + 
20 2 + + 
11 4 ++ - 
16 4 + - 
18 4 ++ - 
19 4 ++ - 
13 5 ++ - 
14 5 ++ - 
15 5 + - 
17 5 + - 
Table 4.3  Cellular tropism within the nasal turbinates by immunohistochemistry 
(+++ widespread staining, ++ clusters of positive cells, + small number of individual positive staining cells, - no staining) 
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4.3.6 Polymerase chain reaction 
Five tissue samples (brain, spleen, lung, kidney, small intestine) from each of the birds 
were tested for NDV RNA via qRT-PCR (Table 4.4).  All five tissue samples from all ten 
birds infected with the Herts 33/56 virus showed detectable levels of NDV RNA at the time 
of euthanasia (2 dpc).  The majority of tissue samples collected from birds infected with 
the Texas GB virus at 2, 4 and 5 dpc were positive for NDV RNA (42/50 samples).  Initially 
only the spleen samples from the two birds euthanized on 2 dpc were positive, however all 
tissues from the remaining birds were positive on both 4 dpc and 5 dpc.  A total of 15 
samples were NDV RNA positive from the 10 birds inoculated with the Meredith/02 virus, 
including all 10 spleen samples with one positive kidney sample (4 dpc), three positive 
lung samples (2 and 4 dpc) and one positive duodenum sample (4 dpc) .  Only 5 tissues 
were viral RNA positive from the birds infected with the PR/98 virus, consisting of two 
spleen samples from 2 and 4 dpc, two duodenum samples from 2 and 14 dpc and one 
cerebrum samples from 14 dpc.   
 
When comparing viral RNA loads between the viruses, 2 dpc was chosen as the 
comparative time point because at the point of euthanasia at 14 dpc, all of the birds 
infected with the exotic velogenic viruses had already been euthanized.  Comparisons of 
RNA loads in the spleen using the Mann-Whitney U test showed that when compared with 
each other, all four viruses had significantly different copy numbers at 2 dpc when 
normalised to 18S (p<0.05; Fig. 4.9). 
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Figure 4.9  NDV RNA copy numbers in spleen samples at 2 dpc; bars represent mean values. All comparisons between 
viruses were significantly different (p<0.05, Mann-Whitney U test). 
 
 
 
4.3.7 Virus Isolation 
Virus isolation was attempted from five different tissues (brain, kidney, lung, spleen and 
small intestine) when PCR results were positive (Table 4.4).  Virus was re-isolated from all 
but one PCR-positive tissue in one bird in both the Herts 33/56 and Texas GB virus 
groups. In both groups, the PCR-positive, virus isolation-negative sample was cerebrum.   
 
In birds exposed to the Meredith/02 ND virus, virus was only recovered from birds 
euthanased at 2 and 4 dpc and not from those euthanased at 14 dpc.  No virus was 
isolated from birds inoculated with the PR/98 virus at any time point (Table 4.4).   
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Animal 
identification 
Day of 
euthanasia 
Cerebrum Kidney Lung  Spleen Duodenum 
Meredith/02       
6 2 -/nd -/nd -/nd +/+ -/nd 
7 2 -/nd -/nd +/+ +/+ -/nd 
1 4 -/nd +/+ +/+ +/+ +/+ 
4 4 -/nd -/nd +/+ +/+ -/nd 
2 14 -/nd -/nd -/nd +/- -/nd 
3 14 -/nd -/nd -/nd +/- -/nd 
5 14 -/nd -/nd -/nd +/- -/nd 
8 14 -/nd -/nd -/nd +/- -/nd 
9 14 -/nd -/nd -/nd +/- -/nd 
10 14 -/nd -/nd -/nd +/- -/nd 
Peats Ridge/98       
13 2 -/nd -/nd -/nd -/nd -/nd 
19 2 -/nd -/nd -/nd +/- +/- 
12 4 -/nd -/nd -/nd -/nd -/nd 
16 4 -/nd -/nd -/nd +/- -/nd 
11 14 -/nd -/nd -/nd -/nd -/nd 
14 14 -/nd -/nd -/nd -/nd +/- 
15 14 -/nd -/nd -/nd -/nd -/nd 
17 14 -/nd -/nd -/nd -/nd -/nd 
18 14 +/- -/nd -/nd -/nd -/nd 
20 14 -/nd -/nd -/nd -/nd -/nd 
Herts 33/56       
21 2 +/+ +/+ +/+ +/+ +/+ 
22 2 +/+ +/+ +/+ +/+ +/+ 
23 2 +/+ +/+ +/+ +/+ +/+ 
24 2 +/+ +/+ +/+ +/+ +/+ 
25 2 +/+ +/+ +/+ +/+ +/+ 
26 2 +/+ +/+ +/+ +/+ +/+ 
27 2 +/+ +/+ +/+ +/+ +/+ 
28 2 +/+ +/+ +/+ +/+ +/+ 
29 2 +/- +/+ +/+ +/+ +/+ 
30 2 +/+ +/+ +/+ +/+ +/+ 
Texas GB       
12 2 -/nd -/nd -/nd +/+ -/nd 
20 2 -/nd -/nd -/nd +/+ -/nd 
11 4 +/+ +/+ +/+ +/+ +/+ 
16 4 +/+ +/+ +/+ +/+ +/+ 
18 4 +/+ +/+ +/+ +/+ +/+ 
19 4 +/+ +/+ +/+ +/+ +/+ 
13 5 +/+ +/+ +/+ +/+ +/+ 
14 5 +/+ +/+ +/+ +/+ +/+ 
15 5 +/- +/+ +/+ +/+ +/+ 
17 5 +/+ +/+ +/+ +/+ +/+ 
Table 4.4  PCR and virus isolation in tissues (PCR / virus isolation); nd: not done. 
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4.3.8 Sequencing 
Whole genome sequencing of the virus isolates showed that the viruses had the same 
fusion cleavage site sequences as previously reported.71, 129, 131  Sequence results are 
shown in Table 4.5. 
 
 F protein cleavage 
site motifa 
Virulence HN extension 
length 
Meredith/02 112RRQRRF117 Virulent 9 amino acids 
PR/98 112RRQGRL117 Avirulent 9 amino acids 
Herts 33/56 112RRQRRF117 Virulent 4 amino acids 
Texas GB 112RRQKRF117 Virulent 6 amino acids 
Table 4.5  Fusion protein cleavage site motifs and HN extension length (basic amino acids are highlighted in bold) 
 
Partial sequencing of the F protein and HN extension from samples collected from the 
Meredith/02, Herts 33/56 and Texas GB inoculated birds after the infection trial were 
consistent with the sequence results of the virus inoculum, indicating that these regions 
had not mutated at these sites during replication in the birds.  Due to the low virus titres in 
the birds infected with the PR/98 virus, sequencing was not successful on samples from 
these birds.  
4.4 Discussion 
This study investigated the pathogenicity of the atypical Australian NDV Meredith/02 by 
comparison with an avirulent Australian virus and two exotic velogenic viruses.  The 
atypical Australian virus (Meredith/02), possessed a virulent F protein cleavage site 
sequence according to the OIE definition but did not induce severe clinical signs, which is 
consistent with the field observations at the time of its isolation.9  This is unusual given that 
ND viruses with multiple basic amino acids at the F protein cleavage site and a 
phenylalanine at position 117 are usually associated with a virulent phenotype.129 
 
Whilst birds exposed to the Meredith/02 virus appeared very mildly depressed for a short 
period of time on 3 dpc, they all completely recovered within hours.  The PR/98 virus was 
typical for most avirulent ND viruses, in that no clinical signs were observed in inoculated 
birds.  As expected, the velogenic viruses Herts 33/56 and Texas GB viruses induced 
severe clinical signs, leading to the euthanasia of all birds by 2 and 5 dpc respectively.  
The clinical signs seen in the birds inoculated with Herts 33/56 and Texas GB viruses were 
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typical for viscerotropic and neurotropic viruses, respectively and were similar to those 
previously reported.101, 162 
 
This work has confirmed the observation made by Susta et al., that some Australian 
isolates of NDV obtained from 1998 – 2002 are less pathogenic in an experimental setting 
than other viruses with similar virulent cleavage site motifs.104  This is despite the 
Meredith/02 virus and the APMV-1/chicken/Australia/9809-19-1107/1998 viruses having 
the same virulent F protein cleavage site of 12RRQRRF117 and high ICPIs of 1.61 and 1.88 
respectively.  The Meredith/02 virus in particular appears even less pathogenic than the 
APMV-1/chicken/Australia/9809-19-1107/1998 virus.  However previously, the Australian 
NDV isolates responsible for the 1998-2002 outbreaks, including the Meredith/02 virus had 
been described as velogens, based on F protein cleavage site sequence data and ICPI 
values.56, 104  Clearly, the cleavage site sequence and ICPI data alone is not sufficient to 
classify pathotype, although currently these are the best measures available to predict the 
behaviour of an NDV. 
Phylogenetic analysis of Australian ND viruses detected during the 1998-2002 outbreaks 
placed them within class II, genotype I, of which the majority of isolates are avirulent and 
found in wild birds.81  The presence of a 9 amino acid extension to the HN protein 
identifies these viruses as uniquely Australian.50, 71   The Meredith/02 isolate was shown to 
cluster with the other 1998-2002 isolates, although it was slightly more divergent from 
others in the group.71  This slight increase in phylogenetic distance may account for the 
difference in pathogenicity between the 9809-19-1107 virus reported by Susta et al. and 
the Meredith/02 virus reported here.  Additionally, Susta et al. used slightly younger 4-
week old chickens, which may have led to increased susceptibility to disease.   
 
The presence of a virulent F protein cleavage site enables the ND virus to be cleaved by 
proteases that are widespread throughout numerous cell types.  This allows the virus to 
enter and replicate in a greater range of cells and organ systems than those with an 
avirulent cleavage site motif.113, 163  Therefore, in accordance with its cleavage site motif, it 
would be expected that the Meredith/02 virus would also have a wide antigen distribution.  
The distribution and concentration of virus as measured by immunohistochemistry, PCR 
and virus isolation indicated that whilst the virus was able to replicate systemically in the 
spleen of all birds and in the kidney, lung and duodenum of 3/10 birds, live virus was 
cleared from all tissues by 14 dpc.  Compared with the virulent exotic viruses, the virus 
load of the Meredith/02 virus was markedly reduced, corresponding with fewer and less 
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severe histopathological lesions, and minimal clinical signs in the inoculated birds.  The 
antigen was primarily restricted to the mucosa at the sites of inoculation.  In comparison, 
the viscerotropic Herts 33/56 virus preferentially targeted lymphoid tissue early in the 
course of infection.  This indicates that the presence of a virulent F protein cleavage site in 
the Meredith/02 virus whilst allowing for some systemic viral replication, was not 
associated with the high viral loads in tissues associated with typical velogenic viruses.   
 
In general, the pathogenicity of a virus is determined by a number of factors including the 
route of exposure to the virus, the immune status and immune response of the birds, and 
the ability of the virus to replicate and disseminate throughout the host tissues.21  
Increased virus replication and a greater inflammatory response within lymphoid tissues 
has been associated with increased pathogenicity of velogenic ND viruses.164  The results 
of our study indicate that the low pathogenicity of the Meredith/02 virus must be attributed 
to regions of the viral genome other than the F protein cleavage site, given that the 
cleavage site contains a virulent motif.  Studies using reverse genetics have also indicated 
that regions of the NDV genome other than the F protein cleavage site may also contribute 
significantly to pathogenicity.3, 12, 120  For example, the viral replication complex has been 
associated with the decreased pathogenicity of the pigeon paramyxovirus for chickens, 
despite its virulent cleavage site motif.12 
 
Overall, this experimental work has confirmed the field observations, that despite 
containing a virulent F protein cleavage site as defined by the OIE, the Meredith/02 isolate 
of NDV is not highly pathogenic for chickens.  Clinical signs, pathological lesions and 
antigen distribution in the experimentally infected birds were instead consistent with a 
lentogenic or mesogenic virus.   
 
The risk posed by these Australian viruses is unclear.  This evolution of an avirulent to 
virulent virus is unusual and has only been described once before in Ireland.165  Whilst the 
PR/98 virus has been shown to only require two nucleotide changes to become 
pathogenic, it is uncertain whether the Meredith/02 virus is also a significant risk to the 
poultry industry.  Whilst the Meredith/02 virus displayed minimal pathogenicity in the field 
and very limited pathogenicity in an experimental setting, there is still a possibility that this 
virus may increase in pathogenicity given appropriate circumstances.   It is possible that 
the Meredith/02 was not yet well adapted to chickens.  High pathogenicity may evolve with 
intensive production systems, such as most commercial chicken operations in Australia, 
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due to the large numbers of birds held in such facilities allowing numerous passages of the 
virus.  In addition, concurrent infection with agents such infectious bronchitis virus or 
infectious bursal disease virus may induce immunosuppression and allow for virus 
evolution.  Immune pressure induced by vaccination may also contribute to an increased 
NDV mutation rate and result in increased pathogenicity.  However, the genetic changes 
necessary for this transformation are unknown.  Conversely, this virus may be a stable 
genetic type that may not continue evolving greater pathogenicity, and therefore have a 
low risk for commercial poultry. Currently, we are not able to assess this on the genetic 
information that we have, but knowledge of the impacts of potential mutations would be 
important for risk assessment and outbreak response. At the time of its detection, a 
conservative approach was taken and the affected flocks were depopulated. However, this 
approach may not be necessary if it can be demonstrated that such viruses have little risk 
of further evolution towards higher pathogenicity. 
4.5 Conclusions 
The Australian NDV, Meredith/02, whilst containing a virulent F protein cleavage site 
(RRQRRF) consistent with a virulent virus, was only mildly pathogenic in chickens in an 
experimental setting.  Viral replication primarily occurred in sites of inoculation and there 
were no mortalities associated with the viral infection.  The decreased pathogenicity of the 
virus may therefore be associated with regions of the genome other than the F protein 
cleavage site. 
 
  
 76 
CHAPTER 5  
VIRUS CHARACTERISATION 
5.1 Introduction 
Some Australian Newcastle disease viruses (NDVs) are unusual in that whilst they are 
classified as virulent according to the molecular sequence at the fusion protein cleavage 
site, they do not induce severe disease when inoculated into chickens.  This was 
demonstrated in the previous chapter (Chapter 4:  An Australian Newcastle disease virus 
with a virulent fusion protein cleavage site produces minimal pathogenicity in chickens).  
The four NDVs used in this work were Peats Ridge/98, Meredith/02, Texas GB and Herts 
33/56.  The Peats Ridge/98 and Meredith/02 viruses are Australian viruses, with avirulent 
and virulent fusion protein cleavage sites respectively.  Despite containing a virulent 
cleavage site sequence motif, the Meredith/02 virus does not behave like a typical virulent 
NDV in either an experimental setting or in the field.  Therefore, it was hypothesized that 
there may be genetic elements other than the fusion protein cleavage site in this virus that 
could contribute to pathogenicity.   
 
NDV belongs to the family Paramyxoviridae in the genus Avulavirus.  They comprise a 
negative sense, single strand RNA genome of six genes, from 3’ to 5’: nucleoprotein (N), 
phosphoprotein (P), matrix (M), fusion (F), haemagglutinin-neuraminidase (HN) and large 
polymerase (L).  The genes encode seven (and putatively eight) proteins with the 
additional V and W proteins produced via RNA editing of the P gene.   
 
In order to examine which sections of the viral genome should be targeted for further 
investigation into their role in virulence, the four viruses were characterised by standard 
virological techniques and whole genome sequence analysis.  Replication in cells and 
embryonated eggs was compared and the amino acid sequences associated with key 
functional areas of each of the virus proteins were analysed, including cleavage and 
glycosylation sites.   
 
The overall aim of these analyses was to determine whether there were any specific 
differences in the genome of the Meredith/02 virus when compared with the Herts 33/56 
and Texas GB viruses, that may account for its lower than expected pathogenicity. 
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5.2 Materials and Methods 
5.2.1 Viruses 
As per Chapter 4, the four viruses used in this work were Peats Ridge/98 (Australia), 
Meredith/02 (Australia), Texas GB (velogenic neurotropic) and Herts 33/56 (velogenic 
viscerotropic).  Before use, these viruses were all propagated via chorioallantoic 
inoculation in 10 day old embryonated SPF chicken eggs for 5 days. 
5.2.2 Virus titration and mean death time in eggs 
Each virus was grown in both cell culture and eggs to determine end-point titres and the 
mean death time in eggs (MDT).  Virus titration in cell culture was conducted in DF-1 cells 
as per Chapter 3.2, using DMEM with incubation at 37oC with 5% CO2.  Prior to the 
addition of virus, TPCK-treated trypsin (Worthington, New Jersey) was added to the media 
to give a final concentration of 2 µg/ml. 
 
Viruses were also titrated in specific pathogen free eggs as per Chapter 3.3.  A ten-fold 
dilution series was used to inoculate 100 µl of virus per egg.  Eggs were then incubated for 
5 days and allantoic fluid tested for the presence of virus by haemagglutination.   
 
The mean death time (MDT) in eggs was determined for each virus as per Chapter 3.7.  
The MDT is the mean time for all the embryos inoculated with the most dilute virus 
inoculum to be killed.  Briefly, two groups of five, 9-11 day old embryonated SPF eggs 
were inoculated with each of 10-6, 10-7, 10-8 and 10-9 dilutions of virus, eight hours apart.  
Eggs were observed over 7 days and the time of egg deaths recorded. The mean death 
time for each virus was then calculated. 
5.2.3 Whole genome sequencing 
Whole genome sequencing was conducted using the MiSeq platform according to Chapter 
3.12.  Prior to sequencing, viruses were purified using a discontinuous sucrose gradient 
and ultracentrifugation.  RNA was then extracted using the QIAamp Viral RNA Mini Kit 
(Qiagen) and reverse transcribed using the Superscript III transcriptase kit (Invitrogen).  
Double strand cDNA was then synthesized and amplified using random PCR with the 
Expand High Fidelity kit (Roche) and the 454 amplification primer (see Appendix 1, Table 
A2 for the primer sequence).  PCR products were then purified using the Wizard® SV Gel 
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and PCR Clean-Up System (Promega) and sequenced using the MiSeq (Illumina).  The 
genomes were assembled using read mapping and de novo assembly with CLC Genomics 
Workbench (CLC Genomics Workbench v.6.0.5.). 
5.2.4 Sequence analysis 
Sequence alignments and phylogenetic analysis were undertaken using Geneious 
(Geneious R8, v. 8.0.5) with the PhyML plugin.  Sequences for comparison were primarily 
based on Dimitrov et al. and represent viruses from all NDV classes and genotypes.82  
Nucleotide alignments were conducted using Geneious with default settings of a 65% cost 
matrix, gap open penalty of 12, gap extension penalty of 3 and refinement iterations of 2.  
The most appropriate model for phylogenetic tree construction was determined using the 
jModelTest2.166  A maximum likelihood tree was then created using the general time-
reversible model with invariant sites (0.420), a gamma distribution (2.595) and 1000 
bootstrapped replicates using Geneious.  The number of replicates was chosen based on 
the number of sequences examined (n=23).167   
 
Amino acid sequences were aligned and examined for known pathogenicity determinants 
and glycosylation sites.  Alignments were conducted using Geneious global alignment 
using default settings of Blosum 62 cost matrix, gap open penalty of 9 and gap extension 
penalty of 3.  N-linked glycosylation sites were predicted using NetNGlyc 
(http://www.cbs.dtu.dk/services/NetNGlyc/).  BLAST searches were performed to compare 
amino acid sequences (https://blast.ncbi.nlm.nih.gov/Blast.cgi). 
5.2.5 Embryo histopathology and immunohistochemistry 
After the initial growth of virus stocks in 10-day-old embryonated chicken eggs, the 
embryos and chorioallantoic membranes were harvested after 5 days and fixed in 10 per 
cent neutral buffered formalin for 24-48 hrs.  The membranes and multiple sections of the 
whole embryos were then processed for histology and stained with haematoxylin and 
eosin.  The Q91-6 NDV NP monoclonal antibody was used for immunohistochemistry.  
Further histology methodology can be found in Chapter 3.4. 
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5.3 Results 
5.3.1 Virus titration 
The virus titres for each of the virus isolates in both DF-1 cells and in SPF eggs can be 
seen in Table 5.1. 
 Virus DF-1 cells Eggs (SPF) 
Meredith/02 105.75 TCID50/ml 109.3 EID50/ml 
PR/98 105.75 TCID50/ml 1010.0 EID50/ml 
Herts 33/56 107.50 TCID50/ml 109.2 EID50/ml 
Texas GB 107.75 TCID50/ml 109.5 EID50/ml 
Table 5.1  Virus titres in cell culture and SPF eggs. 
 
The cytopathic effect of each of the viruses in DF-1 cells was typical for paramyxoviruses, 
with fusion of cells and the formation of syncytia.  The cytopathic effect for the Texas GB 
virus can be seen in Figure 5.1. 
 
Figure 5.1  The cytopathic effect induced by Texas GB in DF-1 cells, consisting of syncytial cells. 
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5.3.2 Mean death time in eggs 
The MDT and corresponding classification for each of the viruses can be seen below in 
Table 5.2.  The classification of the MDT is as follows, lentogenic: >90 hours, mesogenic 
60 – 90 hours, velogenic <60 hours.   
 
Virus Mean Death Time 
(hours) 
Pathotype 
Meredith/02 68 Mesogenic 
PR/98 116 Lentogenic 
Herts 33/56 44 Velogenic 
Texas GB 60 Velogenic 
Table 5.2  Mean death time in eggs.  Lentogenic, >90 hours, mesogenic 60-90 hours, velogenic <60 hours. 
As expected, the PR/98 virus was classified as lentogenic and the Herts 33/56 and Texas 
GB viruses were velogenic.  The Meredith/02 virus was classified as mesogenic. 
5.3.3  Sequence analysis 
After translation and alignment, the sequences were compared with previously published 
NDV sequences and important functional regions of genomes analysed.  Results of these 
analyses are shown below in Figures 5.2 – 5.7.   
 
The Meredith/02 sequence showed 99.6% nucleotide agreement with the previously 
published Meredith/02 sequence in Genbank (AY935490).  Similarly, there was 99.8% 
similarity between the Peats Ridge/98 sequence obtained here and the Peats Ridge/98 
Genbank sequence (AY935491).  The Texas GB virus showed between 98.3-100% nt 
similarity with two partial Texas GB sequences in Genbank (AY935490, JN872191).  The 
Herts 33/56 virus was most similar overall to the Ulster/67 virus in Genbank with 90% nt 
similarity (AY562991.1).  However when BLASTn was used against Herts ’33 virus 
sequences from Czegledi, et al., it had 100% nt identity to partial fusion protein sequences 
from Herts 33/56 viruses (AY1701401.1, AY170138.1).168   
 
The full-length sequences of all four viruses were 15,186 nucleotides in length.  Results 
from alignments of both nucleotides and amino acids of individual genes and proteins can 
be seen in Tables 5.3 – 5.8.  Overall, the most variability was found within the 
phosphoprotein gene and the highest conservation within the polymerase gene.   
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N gene Meredith/02 PR/98 Herts 33/56 Texas GB 
Meredith/02  99.591 95.092 95.919 
PR/98 98.980  95.501 96.124 
Herts 33/56 90.646 90.918  93.670 
Texas GB 89.490 90.102 87.959  
Table 5.3  N gene distance matrix.  Distances are represented as percentage similarities.  Nucleotide similarities are 
represented with grey shading and amino acid similarities are unshaded.   
 
P gene Meredith/02 PR/98 Herts 33/56 Texas GB 
Meredith/02  98.228 86.352 88.872 
PR/98 99.074  87.618 89.632 
Herts 33/56 87.500 88.089  86.364 
Texas GB 88.763 89.184 87.205  
Table 5.4  P gene distance matrix.  Distances are represented as percentage similarities.  Nucleotide similarities are 
represented with grey shading and amino acid similarities are unshaded.   
 
M gene Meredith/02 PR/98 Herts 33/56 Texas GB 
Meredith/02  99.176 92.595 93.407 
PR/98 99.178  93.419 93.956 
Herts 33/56 88.082 88.721  91.771 
Texas GB 88.676 89.498 87.352  
Table 5.5  M gene distance matrix.  Distances are represented as percentage similarities.  Nucleotide similarities are 
represented with grey shading and amino acid similarities are unshaded.   
 
F gene Meredith/02 PR/98 Herts 33/56 Texas GB 
Meredith/02  98.915 92.948 92.043 
PR/98 98.857  92.405 92.405 
Herts 33/56 88.989 89.350  89.873 
Texas GB 89.651 89.892 87.665  
Table 5.6  F gene distance matrix.  Distances are represented as percentage similarities.  Nucleotide similarities are 
represented with grey shading and amino acid similarities are unshaded.   
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HN gene Meredith/02 PR/98 Herts 33/56 Texas GB 
Meredith/02  98.135 90.878 91.387 
PR/98 98.967  90.909 91.246 
Herts 33/56 88.290 88.754  89.617 
Texas GB 88.809 88.924 87.406  
Table 5.7  HN gene distance matrix.  Distances are represented as percentage similarities.  Nucleotide similarities are 
represented with grey shading and amino acid similarities are unshaded.   
 
L gene Meredith/02 PR/98 Herts 33/56 Texas GB 
Meredith/02  99.503 95.650 96.508 
PR/98 99.116  96.011 96.733 
Herts 33/56 90.529 90.907  94.877 
Texas GB 90.242 90.695 90.083  
Table 5.8  L gene distance matrix.  Distances are represented as percentage similarities.  Nucleotide similarities are 
represented with grey shading and amino acid similarities are unshaded.   
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5.3.3.1  N protein 
The nucleocapsid gene encodes a protein of 489 amino acids with most of the variability 
seen in the carboxyl terminus.  However, even in this region there was good sequence 
similarity between Texas GB and the Australian viruses.  The amino acid alignment of the 
N protein for all four viruses is shown in Figure 5.2. 
 
 
Figure 5.2  N protein alignment 
  
Herts 33/56 1 M S S V F D E Y E Q L L A A Q T R P N G A H G G G E K G S T L K V E V P V F T L N S D D P E D R W N F A V F C L R I A V
Texas GB  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D . . . . . . . . . . . . . . . . . . . . . . . . . .
Meredith/02  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Herts 33/56 61 S E D A N K P L R Q G A L I S L L C S H S Q V M R N H V A L A G K Q N E A T L A V L E I D G F T N G A P Q F N N R S G V
Texas GB  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . M . . . . . . . . .
Meredith/02  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S . . . . . . . . . . . . V . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V . . . . . . . . .
Herts 33/56 121 S E E R S Q R F M M I A G S L P R A C S N G T P F V T A G V E D D A P E D I T D T L E R I L S V Q A Q V W V T L A K A M
Texas GB  . . . . A . . . A . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . . . . . . I . . . . . . . V . . . .
Meredith/02  . . . . A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I . . . . . . . V . . . .
Peats Ridge/98  . . . . A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I . . . . . . . V . . . .
Herts 33/56 181 T A Y E T A D E S E T R R I N K Y M Q Q G R I Q K R Y I L H P V C R S A I Q L T I R Q S L A V R I F L V S E L K R G R N
Texas GB  . . . . . . . . . . . . . . . . . . . . . . V . . K . . . Y . . . . . T . . . . . . . . . . . . . . . . . . . . . . ? .
Meredith/02  . . . . . . . . . . . . . . . . . . . . . . V . . K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . . . V . . K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Herts 33/56 241 T A G G T S T Y Y N L V G D V D S Y I K N T G L T A F F L T L K Y G I N T K T S A L A L S S L A G D I Q K M K Q L M R L
Texas GB  . . . . . . . . . . . . . . . . . . . R . . . . . . . . . . . . . . . . . . . . . . . . . . . S . . . . . . . . . . . .
Meredith/02  . . . . . . . . . . . . . . . . . . . R . . . . . . . . . . . . . . . . . . . . . . . . . . . S . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . R . . . . . . . . . . . . . . . . . . . . . . . . . . . S . . . . . . . . . . . .
Herts 33/56 301 Y R M K G D N A P Y M T L L G D S D Q M S F A P A E Y A Q L Y S F A M G M A S V L D K G T G K Y Q F A R D F M S T S F W
Texas GB  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Meredith/02  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S . . . . . . . . . . . . . .
Herts 33/56 361 R L G V E Y A Q A Q G S S I N E D M A A E L K L T P A A R R G L A A A A Q R V S E G T S N M D M P T Q Q V G V L T G L S
Texas GB  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E . . S I . . . . . . . . . . . . . .
Meredith/02  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D . . S . . . . . . . A . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D . . S . . . . . . . A . . . . . . .
Herts 33/56 421 D G S S Q A P Q S V P N G A Q E Q P D A G N G E T Q F L D L M R A V A N S M R E A P N S A Q G T P Q P G P P P T P G P S
Texas GB  E . G . . . L . G G S . R S . G . . E . . D . . . . . . . . . . . . . . . . . . . . . . . . . . . . S . . . . . . . . .
Meredith/02  . . G . . . S . G A L . R S . G . . . T . D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Peats Ridge/98  . . G . . . . . G A L . R S . G . . . T . D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Herts 33/56 481 Q D N D I D W G Y
Texas GB  . . . . T . . . .
Meredith/02  . . . . T . . . .
Peats Ridge/98  . . . . T . . . .
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5.3.3.2  P protein 
The phosphoprotein gene encodes a 395 amino acid protein and is the most variable of all 
the proteins.  The phosphoprotein gene also contains an RNA editing site which allows for 
the production of a secondary V protein via the insertion of G nucleotide and a subsequent 
frame-shift.  The amino acid alignment of the P protein for all four viruses is shown in 
Figure 5.3.  There are a number of sequence differences at various sites, with differences 
unique to the Australian viruses present at 22 positions, predominantly in the 3’ half of the 
gene.  The significance of these changes is currently unknown. 
 
 
Figure 5.3  P protein alignment 
  
Herts 33/56 1 M A T F T D A E I D E L F E T S G T V I D S I I T A Q G K P A E T ? G R S A I P Q G K T K A P S A A R E K H G S T Q S P
Texas GB  . . . . . . . . . . . . . . . . . . . . . N . . . . . . . . . . . V . K . . . . H . . . . . L . . . W . . . . . I . P .
Meredith/02  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V . . V . . . . . . . . . . . . L . . . W . . . . . I . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V . . V . . . . . . . . . . . . L . . . W . . . . . I . . .
Herts 33/56 61 A S Q D T P D L Q D R S D K Q Q S T T E Q V I P H D S P S V T S T D Q P S V Q A T D E T G D T Q L K T G A S N S L L S M
Texas GB  . . . . . . . R . . . . . . . P . . P . . A T . . . . . P A . . A . . . P A . . . . . V V . . . . R . . . . . . . . L .
Meredith/02  V . . . . . . R . . . . . . . L . . P . . A S . N . . . P A . . . . . . P T . . A . . A . . . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . R . . . . . . . L . . P . . A S . N . . . P A . . . . . . P T . . A . . A . . . . . . . . . . . . . . . .
Herts 33/56 121 L D K L S N K S S N A K K G P W S S P Q E G H Q Q R Q T Q Q Q G N L P S R G N S Q G R P Q N Q A K A A P G N Q G T G V N
Texas GB  . . . . . . . . . . . . . . . . . . . . . . N H . . P . . . . . S Q . . . . . . . E . . . . . V . . . . . . . . . D A .
Meredith/02  . . . . . S . . . . . . . . . V . . . . K K . H . . L . . . . . S Q Q . . . . . . E . . . S . . . . I H . . . V . D . .
Peats Ridge/98  . . . . . . . . . . . . . . . G . . . . K R . H . . L . . . . . S Q Q . . . . . . E . . . S . . . . I . . . . V . D . .
Herts 33/56 181 I A Y H G Q W E E S Q R S A G V I P H A L R S E Q S Q D N T P A P V D H V Q L P V D F V Q A M M S M M E A I S Q K I S K
Texas GB  T . . . . . . . . . . L . . . A T . . . . . . R . . . . . . L V S A . . . . P . . . . . . . . . . . . . . . . . R V . .
Meredith/02  T . . . . . . . . . . L . V . A T H . . . . . . . . . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . R V . .
Peats Ridge/98  T . . . . . . . . . . L . V . A T H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R V . .
Herts 33/56 241 V D Y Q L D L V S K Q T S S I P L M R S E I Q Q L K T S V A V M E A N L G M M K I L D P G C A N I S S L S D L R A V A R
Texas GB  . . . . . . . . L . . . . . . . M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V . . . . . . . . . . .
Meredith/02  . . . . . . . . L . . . . . . . M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . L . . . . . . . M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V . . . . . . . . . . .
Herts 33/56 301 S H P V L V A G P G D P S P Y V N Q ? G E M A L N K L S Q P V Q H P S E L I K P A M A G G P D I G V E K D T V R A L I M
Texas GB  . . . . . . S . . . . . . . . . T . G . . . . . . . . . . . . P . . . D . . . . . T . C . . . . . . . . . . . . . . . .
Meredith/02  . . . . . I S . . . . . . . . . T . G . . . . . . . . . . . . . R . . . . . . . . T . S . . . V . . . . . . . . . . . .
Peats Ridge/98  . . . . . I S . . . . . . . . . T . G . . . . . . . . . . . . . R . . . . . . . . T . S . . . . . . . . . . . . . . . .
Herts 33/56 361 S R P M H P S S S A K L L S K L D A A G S I E E I R K I K R L A L N G
Texas GB  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ? . . . .
Meredith/02  . . . . . . . . . . R . . . . . . . . . . . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . R . . . . . . . . . . . . . . . . . . . . . . . .
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5.3.3.3  V protein 
As previously discussed, the V protein is produced by RNA editing of the P gene and is 
239 aa in length.  The Australian viruses ranged between 84.94% - 87.40% aa in similarity 
to the Herts 33/56 and Texas GB sequences, particularly throughout the cysteine rich 
region (highlighted in blue in Figure 5.4). 
 
 
Figure 5.4  V protein alignment.  The cysteine rich region is highlighted in blue. 
  
Herts 33/56 1 M A T F T D A E I D E L F E T S G T V I D S I I T A Q G K P A E T ? G R S A I P Q G K T K A P S A A R E K H G S T Q S P
Texas GB  . . . . . . . . . . . . . . . . . . . . . N . . . . . . . . . . . V . K . . . . H . . . . . L . . . W . . . . . I . P .
Meredith/02  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V . . V . . . . . . . . . . . . L . . . W . . . . . I . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V . . V . . . . . . . . . . . . L . . . W . . . . . I . . .
Herts 33/56 61 A S Q D T P D L Q D R S D K Q Q S T T E Q V I P H D S P S V T S T D Q P S V Q A T D E T G D T Q L K T G A S N S L L S M
Texas GB  . . . . . . . R . . . . . . . P . . P . . A T . . . . . P A . . A . . . P A . . . . . V V . . . . R . . . . . . . . L .
Meredith/02  V . . . . . . R . . . . . . . L . . P . . A S . N . . . P A . . . . . . P T . . A . . A . . . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . R . . . . . . . L . . P . . A S . N . . . P A . . . . . . P T . . A . . A . . . . . . . . . . . . . . . .
Herts 33/56 121 L D K L S N K S S N A K K G P M V E P S R R A P T T S D A T A R E S T K P W K Q S R E T A E P G Q G C P W K P G H R R E
Texas GB  . . . . . . . . . . . . . . . . . . . P . G E . P . . . S . . G K . . Q . R . . P G K . . . . S . . R . . . . . . . . .
Meredith/02  . . . . . S . . . . . . . . . S . . . . K K . S S . . . S . T G . . . . . R . . P . . . . . . . . . H . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . R . . . . K K . S S . . . S . T G . . . . . R . . P . . . . . . . . . H . . . . . . . . .
Herts 33/56 181 H S I S W T M G G V T T V S W C N P S C S P I R A E P R Q Y S C T C G S C P A T C R L C A G D D V Y D G G D I T E D K
Texas GB  . . . . . . . . . . . . I . . . . . . . . . . K . . . . . . P . I . . . . . . . . . . . . S . . . . . . . N . . . S .
Meredith/02  . . . . . . . . . . . . I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . N . . . G .
Peats Ridge/98  . . . . . . . . . . . . I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . N . . . G .
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5.3.3.4  M protein 
The matrix protein is 364 aa in length. It initially localises to the nucleus during virus 
replication and transcription, whilst in later stages it is associated with budding of the NDV 
virus from the cellular membrane.169  To enable nuclear localisation, it contains a nuclear 
localisation signal (highlighted in blue in Figure 5.5).170    The signal contains two clusters 
of basic amino acids between positions 246 and 263.  There was a non-basic amino acid 
substitution R259G in the Meredith/02 virus.  Otherwise, there was good sequence 
conservation between all four viruses. 
 
 
Figure 5.5  M protein alignment.  The nuclear localisation signal is highlighted in blue. 
  
Herts 33/56 1 M D S S R T I G L Y F D S A L P S S N L L A F P I V L Q D T G D G K K Q I V P Q Y R I Q X L D L W T D S K E D S V F I T
Texas GB  . . . . . . . . . . . . . . H S . . . . . . . . . . . . . . . . . . . . . A . . . . . . R . . S . . . . . . . . . . . .
Meredith/02  . . . . . . . R . . . . . T F . . . . . . . . . . . . . . . . . . . . . . A . . . . . R R . . S . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . R . . . . . T F . . . . . . . . . . . . . . . . . . . . . . A . . . . . . R . . S . . . . . . . . . . . .
Herts 33/56 61 T Y G F I F Q V G N E E A T V G M I N D K P K R N L L S S A M L C L G S V P N V G D L I E L A R A C L T M V I T C K K S
Texas GB  . . . . . . . . . . . . . . . . . . . . N . . . E . . . A . . . . . . . . . . T . . . V . . . . . . . . . . V . . . . .
Meredith/02  . . . . . . . . . . . . . . . . . . . . N . . . E . . . T . . . . . . . . . . . . . . V . . . . . . . . . . V . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . N . . . E . . . T . . . . . . . . . . . . . . V . . . . . . . . . . V . . . . .
Herts 33/56 121 A T D T E R M V F S I V Q A P Q V L Q S C R V V A N K Y S S V N A V K H V K A P E K I P G S G T L E Y K V N F V S L T V
Texas GB  . . N . . . . . . . V M . . . . . . . . . . . . . . . . . . . D . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Meredith/02  . . N . . . . . . . V . . . . . . . . . . K . . . . . . . . . . . . . . . R . . . . . . . . . A . . . . . . . . . . . .
Peats Ridge/98  . . N . . . . . . . V . . . . . . . . . . K . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . .
Herts 33/56 181 V P K K D V Y K I P T A A L K V S G S S L Y N L A L N V T I D V E V D S K S P L V K S L S K S D N G Y Y A N L F L H I G
Texas GB  . . . . . . . . . . . . V . . . . . . . . . . . . . . . . . N . . . . P R . . . . . . . . . . . S . . . . . . . . . . .
Meredith/02  . . R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P . . . . . . . . . . . . S . . . V . . . . . . .
Peats Ridge/98  . . R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P . . . . . . . . . . . . S . . . V . . . . . . .
Herts 33/56 241 L L S T V D K R G R K V T F D K L E R K I R R L D L S V G L S D V L G P S V L V K A R G A R T K L L A P F F S S S G T A
Texas GB  . M T . . . R . . K . . . . . . . . K . . . S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Meredith/02  . M . . . . . K . K . . . . . . . . G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Peats Ridge/98  . M . . . . . K . K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Herts 33/56 301 C Y P I A N A S P Q V A K I L W S Q T A C L R S V R V I I Q A G T Q R A V A M T A D H E V T S T K L E K G H T I A K Y N
Texas GB  . . . . . . . . . . . . . . . . . . . . . . . . . K I . . . . . . . . . . . V . . . . . . . . . . . . . . . . L . . . .
Meredith/02  . . . . . . . . . . . . . . . . . . . . . . . . . K . . . . . . . . . . . . V . . . . . . . . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . . . . . . K . . . . . . . . . . . . V . . . . . . . . . . . . . . . . . . . . .
Herts 33/56 361 P F K K
Texas GB  . . . .
Meredith/02  . . . .
Peats Ridge/98  . . . .
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5.3.3.5  F protein 
The NDV fusion protein (563 aa) contains the cleavage site, which is the main determinant 
of pathogenicity and is highlighted in red in Figure 5.6.  The Peats Ridge/98 virus 
contained the avirulent cleavage site motif of 112RRQGRL117, whilst the other three viruses 
had virulent cleavage sites with the Meredith/02 and Herts 33/56 cleavage sites being 
identical, 112RRQRRF117.  The fusion protein contains 6 potential N-linked glycosylation 
sites (highlighted in blue).  All of these sites were identical throughout the fours viruses 
except for the first site, in which the Herts 33/56 virus contained a K.  Other important 
structural components, the two heptad repeat domains are boxed.171 
 
 
Figure 5.6  F protein alignment.  The cleavage site is indicated in red, glycosylation sites in blue, cysteine residues in 
green, the fusion peptide in a green box and heptad repeats in black boxes. 
  
Herts 33/56 1 M S S K S S T R I P V P L T L I V W I A L A L S C V R L A S S L D G R P L A A A G I V V T G D K A V N I Y T S S Q T G S
Texas GB  . G P R P . . K N S A . M M . T . R V . . V . . . I C P . N . I . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Meredith/02  . G F R . . . . . S . . . M . T . R F M . . . . . . C P T . A . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Peats Ridge/98  . G F R F . . . . S . . . M . T . R V M . . . . . . C P T . A . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Herts 33/56 61 I I V K L L P N M P K D K E A C A K A P L E A Y N K T L T T L L T P L G D S I R R I Q E S V T T S G G R R Q R R F I G A
Texas GB  . . . . . . . . L . . . . . . . . . . . . D . . . R . . . . . . . . . . . . . . . . . . . . . . . . . . . . K . . . . .
Meredith/02  . . I . . . . . . . . . . . . . . . . . . . . . . R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Peats Ridge/98  . . I . . . . . . . . . . . . . . . . . . . . . . R . . . . . . . . . . . . . . . . . . . . . . . . . . . . G . L . . .
Herts 33/56 121 V I G G V A L G V A T A A Q I T A A S A L I Q A T Q N A A N I L R L K E S I A A T N E A V H E V T D G L S Q L A V A V G
Texas GB  I . . . . . . . . . . . . . . . . . A . . . . . K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Meredith/02  I . . . . . . . . . . . . . . . . . . . . . . . N . . . . . . . . . . . . . . . . . . . . . . . . N . . . . . . . . . .
Peats Ridge/98  I . . . . . . . . . . . . . . . . . . . . . . . N . . . . . . . . . . . . . . . . . . . . . . . . N . . . . . . . . . .
Herts 33/56 181 K M Q Q F V N D Q F N K T A Q E L D C I K I T Q Q V G V E L N L Y L T E L T T V F G P Q I T S P A L T Q L T I Q A L Y N
Texas GB  . . . . . . . . . . . . . . . . . G . . R . A . . . . . . . . . . . . . . . . . . . . . . . . . . . N K . . . . . . . .
Meredith/02  . . . . . . . N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Herts 33/56 241 L A G G N M D H L L T K L S A G N N Q L S S L I G S G L I T G S P I L Y D S Q T Q L L G I Q V T L P S V G N L N N M R A
Texas GB  . . . . . . . Y . . . . . G V . . . . . . . . . S . . . . . . N . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Meredith/02  . . . . . . . Y . . . . . G V . . R . . . . . . S . . . . . . N . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . Y . . . . . G V . . R . . . . . . S . . . . . . N . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Herts 33/56 301 T Y L E T L S V S T I K G F A S A L V P K V V T Q V G S V I E E L D T S Y C I E T D L D L Y C T R I V T F P M S P G I Y
Texas GB  . . . G . . . . . . T R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Meredith/02  . . . . . . . . . . T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Herts 33/56 361 S C L S G N T S A C M Y S K T E G A L T T P Y M T L K G S V I A N C K M T T C R C V D P P S V I S Q N Y G E A V S L I D
Texas GB  . . . . . . . . . . . . . . . . . . . . . . . . . I . . . . . . . . . . . . . . . . N . . G I . . . . . . . . . . . . .
Meredith/02  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . G I . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . G I . . . . . . . . . . . . .
Herts 33/56 421 K Q S C N V L S L D G I T L R L S G E F D A T Y Q K N I S I R D S Q V I V T G N L D I S T E L G N V N N S I S N A L D K
Texas GB  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Q . . . . . T . . . . . . . . . . . . . . . . . . . . . N .
Meredith/02  R . . . . I . . . . . . . . . . . . . . . . . . . . . . . . Q . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Peats Ridge/98  R . . . . I . . . . . . . . . . . . . . . . . . . . . . . . Q . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Herts 33/56 481 L D E S N S K L N K V D V K L T S T S A L I T Y I I L T I I S L V C G I L S L V L A C Y L M S K Q K A Q Q K T L L W L G
Texas GB  . E . . . . . . D . . N . . . . . . . . . . . . . V . . . T . . . F . . . . . A . . . . . . Y . . . . . . . . . . . . .
Meredith/02  . E . . . . . . . . . N . . . A . . . . . . . . . V . . V . . . . . . . . . . . . . . . . . Y . . . . . . . . . . . . .
Peats Ridge/98  . E . . . . . . D . . N . . . A . . . . . . . . . V . . V . . . . . . . . . . . . . . . . . Y . . . . . . . . . . . . .
Herts 33/56 541 N N T L D Q M R A T T K I
Texas GB  . . . . . . . . . A . . M
Meredith/02  . . . . . . . . . . . . M
Peats Ridge/98  . . . . . . . . . . . . M
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5.3.3.6  HN protein 
The HN protein, like the F protein also has 6 potential N-linked glycosylation sites, 
however only four of these are functional and are highlighted in blue in Figure 5.7.  172.  
The Australian viruses contained a different motif (NSSG) at the first HN glycosylation site 
compared with the exotic viruses.  Heptad repeats (HR1 and HR2) were conserved in all 
viruses and are seen between residues 73-88 for HR1 and 96-116 for HR2.173  The HN 
length varies between the viruses as a result of extensions of 3, 6, 9 and 9 aa for the Herts 
33/56, Texas GB, Meredith/02 and PR/98 viruses respectively. 
 
Figure 5.7  HN protein alignment.  Glycosylation sites are indicated in blue, cysteine residues in green, the 
transmembrane peptide in a green box, heptad repeats in black boxes and the HN extension in a blue box. 
Herts 33/56 1 M D R A V R Q V A L E N D E R E A K N T W R L V F R I A I L I L I V V T L A I S A A A L A D S M E A S T P H D L V V V S
Texas GB  . . . . . S . . V . . . . . . . . . . . . . . I . . . . . . L . T A M . . . T . V . S . V Y . . G . . . . S . . . G I P
Meredith/02  . . . . . S . . . . . . . . . . . . . . . . . . . . . . . . L S T . . . . . . . . . . . . Y . . . . . . . S . . . G I P
Peats Ridge/98  . . . . . S . . . . . . . . . . . . . . . . . . . . . . . . L S T . . . . . . . . . . . . Y . . . . . . . S . . . G I P
Herts 33/56 61 T A I S K A E E K I T A T L G F N Q D V V D R I Y K Q V A L E S P L A L L N T E S T I M N A I T S L S Y Q I N G A A N N
Texas GB  . R . . R . . . . . . S A . . S . . . . . . . . . . . . . . . . . . . . . . . . T . . . . . . . . . . . . . . . . . . .
Meredith/02  . . . . R . . . . . . S A . S S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S . . . . S
Peats Ridge/98  . . . . R . . . . . . S A . . S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S . . . . S
Herts 33/56 121 S G C G A P I H D P D Y I G G I G K E L I V D D A S D V T S F Y P S A F Q E H L N F I P A P T T G S G C T R I P S F D M
Texas GB  . . W . . . . . . . . F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Meredith/02  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Herts 33/56 181 S A T H Y C Y T H N V I L S G C R D H S H S H Q Y L A L G V L R T S A T G R V F F S T L R S I N L D D T Q N R K S C S V
Texas GB  . . . . . . . . . . I . . . . . . . . . . . . . . . . . . . . . . T . . . . I . . . . . . . . . . . . . . . . . . . . .
Meredith/02  . . . . . . . . . . . . . . . . K . . . . . . . . . . . . . . . . . . . . K . . . . . . . . . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . ? . . . . K . ? ? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Herts 33/56 241 S A T P L G C D M L C S K V T E T E E E D Y N S A A P T S M A H G R L G F D G Q Y H E K D L E V T T L F R D W V A N Y P
Texas GB  . . . . . . . . . . . . . . . . . . . . . . . . . V . . L . V . . . . . . . . . . . . . . . D . . . . . E . . . . . . .
Meredith/02  . . . . . . . . . . . . . I . . . . . . . . . . . I . . . . V . . . . . . . . . . . . . . . D . . . . . E . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . I . . . . . . . . . . . T . . . . V . . . ? . . . . . . . . . . . D . . . . . E . . . . . . .
Herts 33/56 301 G V G G G A F I D N R V W F S V Y G G L K P N S P S D A A Q D G K Y V I Y K R Y N D T C P D G Q D Y Q I R M A K S S Y K
Texas GB  . . . . . S . . . S . . . . . . . . . . . . . . . . . T V . E E . . . . . . . . . . . . . . E . . . . . . . . . . . . .
Meredith/02  . . . . . S . . . . . . . . P . . . . . . . . . . . . T . . E . . . . . . Q . . . . . . . . E . . . . . Q . . . . . . .
Peats Ridge/98  . . . . . S . . . . . . . . P . . . . . . . . . . . . T . . E . . . . . . Q . . . . . . . . E . . . . . Q . . . . . . .
Herts 33/56 361 P G R F G G K R V Q Q A I L S I K V S T S L G E D P V L T L P P N T V T L M G A E G R V L T V G T S H F L Y Q R G S S Y
Texas GB  . . . . . . . . I . . . . . . . . . . . . . . . . . . . . V . . . . . . . . . . . . . I . . . . . . . . . . . . . . . .
Meredith/02  . . . . R . . . I . . . . . . . . . . . . . . . . . . . . V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Herts 33/56 421 F S P A L L Y P M T V S N K T A T L Q S P Y T F N A F T R P G ? I P C Q A S A R C P N L C V T G V Y T D P Y P L V F H R
Texas GB  . . . . . . . . . . . . . . . . . . H . . . . . . . . . . . . S . . . . . . . . . . . S . . . . . . . . . . . . I . Y .
Meredith/02  . . . . . . . . . I . . . . . . . . H . . . . . . . . . . . . N . . . . . . . . . . . P . . . . . . . . . . . . . . Y .
Peats Ridge/98  . . . . . . . . . I . . . . . . . . H . . . . . . . . . . . . N . . . . . . . . . . . S . . . . . . . . . . . . . . Y .
Herts 33/56 481 N H T L R G V F G T M L D D ? Q A R L N P V S A V F D S I S R S R I T R V S S S S T K A A Y T T S T C F K V V K T N K T
Texas GB  . . . . . . . . . . . . . S ? . . . . . . A . . . . . . T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Meredith/02  . . . . . . . . . . . . . . N . . . . . . . . . . . . . . . . . . . . . . . . . . V . . . . . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . N . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . . . . . . .
Herts 33/56 541 Y C L S I A E I S N T I F G E F R I V P L L V E I L K E D E T R K A - - - - - -
Texas GB  . . . . . . . . . . . L . . . . . . . . . . . . . . . N . G A . E . R S G - - -
Meredith/02  . . . . . . . . . . . L . . . Y . . . . . . . . . . . D . G V . E . R S S R L S
Peats Ridge/98  . . . . . . . . . . . L . . . Y . . . . . . . . . . . D . G V . E . R S S R L S
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5.3.3.7  L protein 
The L gene encodes for the longest NDV protein, the large polymerase protein, which is 
2204 amino acids in length.  As seen in Figure 5.8, there was generally good sequence 
conservation across the protein alignment, particularly between the Texas GB and 
Australian viruses.  
  
 
 
 
Herts 33/56 1 M A S S G P E R A E H Q I I L P E S H L S S P L V K H K L L Y Y W K L T G L P L P D E C D F D H L I L S R Q W K K I L E
Texas GB  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Meredith/02  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Herts 33/56 61 S A S P D T E R M I K L G R A V H Q T ? N H N S R I T G V L H P R C L E E L V S I E I P D S T N K F R K I E K K I Q I H
Texas GB  . . . . . . . . . . . . . . T . . . . L . . . . . . . . I . . . . . . . . . A . . . V . . . . . . . . . . . . . . . . .
Meredith/02  . . . . . . . . . . . . . . . . . . . L . . . . K . . . . . . . . . . . . . A . . . V . . . I . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . L . . . . K . . . . . . . . . . . . . A . . . V . . . . . . . . . . . . . . . . .
Herts 33/56 121 N T R Y G E L F T R L C T H V E K K L L G S S W S N N I S R S E E F N S I R T D P A F W F H S K W S T A K F A W L H I K
Texas GB  . . . . . . . . . . . . . . I . . . . . . . . . . . . V P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Meredith/02  . . . . . . . . . . . . . . . . . . . . . . . . . . . V P . . . . . . . . . . . . . . . . . . . . . . T . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . . . . . . . . V P . . . . . . . . . . . . . . . . . . . . . . T . . . . . . . .
Herts 33/56 181 Q I Q R H L I V A A R T R S A A N K L V T L A H K V G Q V F V T P E L V I V T H T D E N K F T C L T Q E L V L M Y A D M
Texas GB  . . . . . . . . . . . . . . . . . . . . M . T . . . . . . . . . . . . . . . . . . N . . . . . . . . . . . . . . . . . .
Meredith/02  . . . . . . . . . . . . . . . . . . . . K . T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . . . T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Herts 33/56 241 M E G R D M V N I I S S T A A H L K I L S E K I D D I L R L V D A L A R D L G N Q I Y D V V A L M E G F A Y G A V Q L L
Texas GB  . . . . . . . . . . . T . . V . . R S . . . . . N . . . Q . I . . . . K . . . . . V . . . . S . . . . . . . . . . . . .
Meredith/02  . . . . . . . . . . . . . . . . . R S . . . . . . . . . . . . . . . . K . . . . . V . . . . . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . R S . . . . . . . . . . . . . . . . K . . . . . V . . . . . . . . . . . . . . . . . .
Herts 33/56 301 E P S G T F A G D F F A F N L Q E L K D T L I G L L P N D I A R S V T H A I A M I F S G L D Q N Q A A E M L C L L R L W
Texas GB  . . . . . . . . . . . . . . . . . . . . I . . . . . . . . . . E . . . . . . . T V . . . . E . . . . . . . . . . . . . .
Meredith/02  . . . . . . . . . . . . . . . . . . . . . . . . . . . K . . . E . . . . . . . T V . . . . E . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . . . . . . . . K . . . E . . . . . . . T V . . . . E . . . . . . . . . . . . . .
Herts 33/56 361 G H P L L E S R T A A K A V R N Q M C A P K M V D F D M I L Q V L S F F K G T I I N G Y R K K N A G V W P R V K V D T I
Texas GB  . . . . . . . . I . . . . . . S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Meredith/02  . . . . . . . . I . . . . . . S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . I . . . . . . S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Herts 33/56 421 Y G K V I G Q L H A D S A E I S H D I M L R E Y K S L S A L E F E S C I E Y D P V T N L S M F L K D K A I A H P K D N W
Texas GB  . . . I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P . . . . . . . . . . . . . . . . . . . . . . N . . .
Meredith/02  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P . . . . . . I . . . . . . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P . . . . . . I . . . . . . . . . . . . . . . . . . .
Herts 33/56 481 L A S F R R N L L S E D Q K K N V K E A T S T N R L L I E F L E S N D F D P Y K E M E Y L T T L E Y L R D D N V A I S Y
Texas GB  . . . . . . . . . . . . . . . H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D . . V . .
Meredith/02  . . . . . . . . . . . . . . . H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V . .
Peats Ridge/98  . . . . . . . . . . . . . . . H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V . .
Herts 33/56 541 S L K E K E V K V N G R I F A K L T K K L R N C Q V M A E G I L A D Q I A P F F Q G N G V I Q D S I S L T K G M L A M S
Texas GB  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S . . . . .
Meredith/02  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S . . . . .
Herts 33/56 601 Q L S F N S N K K R I T D C K E R V S S N R N H D P K S K N R R R V A T F I T T D L Q K Y C L N W R Y Q T V K L F A H A
Texas GB  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I . . . . . .
Meredith/02  . . . . . . . . . . . . . . . . . . A . . . . . . Q . . . . . . . . . . . . . . . . . . . . . . . . . . . I . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . A . . . . . . Q . . . . . . . . . . . . . . . . . . . . . . . . . . . I . . . . . .
Herts 33/56 661 I N Q L M G L P H F F E W I H L R L M D T T M F V G D P F N P P S D P T D C D L S K V P N D D I Y I V S G R G G I E G L
Texas GB  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R . . . . . . . . . . A . . . . . . .
Meredith/02  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R . . . . . . . . . . A . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R . . . . . . . . . . A . . . . . . .
Herts 33/56 721 C Q K L W T M I S I A A I Q L A A A R S H C R V A C M V Q G D N Q V I A V T R E V R S D D P P E M V L T Q L H Q A S D N
Texas GB  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S . . . . . . . . . . . . . .
Meredith/02  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S . . . . . . . . . . . . . .
Herts 33/56 781 F F K E L I H V N H L I G H N L K D R E T I R S D T F F I Y S K R I F K D G A I L S Q V L K N S S K L V L I S G D L S E
Texas GB  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V . . . . . .
Meredith/02  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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Herts 33/56 841 N T V M S C A N I A S T V A R L C E N G L P K D F C Y Y L N Y L M S C V Q A Y F D S E F S I T N N S H S D F S Q S W I E
Texas GB  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I . . . . . T . . . . . . . . . . . . . P . L N . . . . .
Meredith/02  . . . . . . . . . . . . ? . . . . . . . . . . . . . . . . . . . . . . . . T . . . . . . . . . . S . Q P . S N . . . . .
Peats Ridge/98  . . . . . . . . . . . . I . . . . . . . . . . . . . . . . . . . . . . . . T . . . . . . . . . . S . Q P . S N . . . . .
Herts 33/56 901 D I S F V H S Y V L T P A Q L G G L S N L Q Y S R L Y T R N I G D P G T T A F A E I K R L E A V G L L N P S I M T N I L
Texas GB  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S . N . . . . . .
Meredith/02  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S . . . . . . . .
Herts 33/56 961 T R S P G N G D W A S L C N D P Y S F N F E T V A S P S I V L K K H T Q R V L F E T C S N P L L S G V H T E D N E A E E
Texas GB  . . P . . . . . . . . . . . . . . . . . . . . . . . . N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Meredith/02  . . P . . . . . . . . . . . . . . . . . . . . . . . . N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Peats Ridge/98  . . P . . . . . . . . . . . . . . . . . . . . . . . . N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Herts 33/56 1021 K A L A E F L L N Q E V I H P R V A H A I M E A S S V G R R K Q I Q G L V D T T N T V I K I A L T R R P L G I K R L M R
Texas GB  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Meredith/02  . . . . . . . . . . . . . . . . . . . . . . . . . . I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . . . . . . . I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Herts 33/56 1081 I V N Y S S M H A M L F R D D V F S P N R S N H P L V S S S M C S L T L A D Y A R N R S W S P L T G G R K I L G V S N P
Texas GB  . . . . . . . . . . . . . . . . . . S . . . . . . . . . . N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Meredith/02  . . S . . . . . . . . . . . . . . . S . . . . . . . . . . N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . S . . . . . . . . . . N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Herts 33/56 1141 D T I E L V E G E I L S V S G G C T R C D S G D E Q F T W F H L P S N I E L T D D T S K N P P M R V P Y L G S K T Q E R
Texas GB  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Meredith/02  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Herts 33/56 1201 R A A S L A K I A H M S P H V K A A L R A S S V L I W A Y G D N E I N W T A A L K I A R S R C N I N S E Y L R L L S P L
Texas GB  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V . . . . . . T . . K . . . . . . L . . . . . . . . .
Meredith/02  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M . . . . . . . . . . . . . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Herts 33/56 1261 P T A G N L Q H R L D D G I T Q M T F T P A S L Y R V S P Y I H I S N D S Q R L F T E E G V K E G N V V Y Q Q I M L L G
Texas GB  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Meredith/02  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Herts 33/56 1321 L S L I E S L F P M T T T R T Y D E I T L H L H S K F S C C I R E A P V A V P F E L L G V A P E L R T V T S N K F M Y D
Texas GB  . . . . . . I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F .
Meredith/02  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V . . . . . . . . . . . . . M . . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V . . . . . . . . . . . . . M . . . . . . . . . . . . . . .
Herts 33/56 1381 P S P V A E R D F A R L D L A I F K S Y E L N L E S Y P T I E L M N I L S I S S G K L I G Q S V V S Y D E D T S I K N D
Texas GB  . . . . S . G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Meredith/02  . . . . S . G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Peats Ridge/98  . . . . S . G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Herts 33/56 1441 A I I V Y D N T R N W I S E A Q N S D V I R L F E Y A A L E V L L D C S Y Q L Y Y L R V R G L D N I V L Y M S D L Y K N
Texas GB  . . . . . . . . . . . . . . . . . . . . V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G . . . . .
Meredith/02  . . . . . . . . . . . . . . . . . . . . V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Herts 33/56 1501 M P G I L L S N I A A T I S H P I I H S R L H A V G L V N H D G S H Q L A D T D F I E M S A K L L V S C T R R V V S G L
Texas GB  . . . . . . . . . . . . . . . . V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I . . .
Meredith/02  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Herts 33/56 1561 H A G N K Y D L L F P S V L D D N L S E K M L Q L I S R L C C L Y T V L F A T T R E I P K I R G L S A E E K C L V L T E
Texas GB  Y S . . . . . . . . . . . . . . . . N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S . . . .
Meredith/02  Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S . . . .
Peats Ridge/98  Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S . . . .
Herts 33/56 1621 Y L L S D A V K P L L S S D Q V S S I M S P N I V T F P A N L Y Y M S R K S L N L I R E R E D R D T I L A L L F P Q E P
Texas GB  . . . . . . . . . . . . P . . . . . . . . . . . I . . . . . . . . . . . . . . . . . . . . . . . . S . . . . . . . . . .
Meredith/02  . . . . . . . . . . . . . E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . K . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Herts 33/56 1681 I L E F P L V Q D I G A R V K D P L T R Q P A A F L Q E L D L S A P A R Y D A Y T L S Q V R S E C T L P N P E E D H L V
Texas GB  L . . . . S . . . . . . . . . . . F . . . . . . . . . . . . . . . . . . . . . F . . . . I H P . L . S . . L . . . Y . .
Meredith/02  L . . . . . . . . . . . . . . . . F . . . . . . . . . . . . . . . . . . . . . F . . . . . H . . H . S . I . . D . Y . .
Peats Ridge/98  L . . . . . . . . . . . . . . . . F . . . . . . . . . . . . . . . . . . . . . F . . . . . H . . H . S . . . . D . Y . .
Herts 33/56 1741 R Y L F R G I G T A S S S W Y K A S H L L S I P E V R Y A R H G N S L Y L A E G S G A I M S L L E L H V P H E T I Y Y N
Texas GB  . . . . . . . . . . . . . . . . . . . . . . V . . . . C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Meredith/02  . . . . . . . . . . . . . . . . . . . . . . V . . . . C . . . . . . . . . . . . . . . . . . . . . . . . . . . N . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . . . V . . . . C . . . . . . . . . . . . . . . . . . . . . . . . . . . N . . . .
Herts 33/56 1801 T L F S N E M N P P Q R H F G P T P T Q F L N S V V Y R N L Q A E V P C K D G F V Q E F R P L W R E N T E E S D L T S D
Texas GB  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T . . . . . . . . . . . . . . . . . . . . . . . . .
Meredith/02  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Herts 33/56 1861 K A V G Y I T S V V P Y R S V S L L H C D I E I P P G S N Q S I L D Q L A T N L S L I S M H S V R E G G V I I I K V L Y
Texas GB  . . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . L . . . . . I . . . . . A . . . . . . . . . V . . . . . .
Meredith/02  . . . C . . . . A . . . . . . . . . . . . . . . . . . . . . . L . . . . . . . . . . . A . . . T . . . . . V . . . . . .
Peats Ridge/98  . . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . L . . . . . . . . . . . A . . . I . . . . . V . . . . . .
Herts 33/56 1921 A M G Y Y F H L L M N L F T P C S T K G Y I L S N G Y A C R G D M E C Y L V F V M G Y L G G P T I V H E V V R M A K T L
Texas GB  . . . . . . . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F . . . . . . . . . . .
Meredith/02  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R . . . . F . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R . . . . F . . . . . . . . . . .
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Figure 5.8  L protein alignment 
  
Herts 33/56 1981 V Q R H G T L L S K S D E I T L T R L F T S Q Q R R V T D I L S S P L P R L V K F L R E N I D T A L I E A G G Q P V R P
Texas GB  . . . . . . . . . . . . . . . . . . . . . . . R Q . . . . . . . . . . . . . I . Y . . K . . . . . . . . . . . . . . . .
Meredith/02  . . . . . . . . . . . . . . . . . . . . N . . R Q . . . . . . . . . . . . . I . . . . K . . . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . . . . R Q . . . . . . . . . . . . . I . . . . K . . . . . . . . . . . . . . . .
Herts 33/56 2041 F C A E S L V S T L V D L T R R T Q I I A S H I D T A I R S V I Y M E A E G D L A D T V F L F T P Y N L S T D G K K R T
Texas GB  . . . . . . . . . . A . I . Q I . . . . . . . . . . I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Meredith/02  . . . . . . . R . . A . T . Q I . . . . . . . . . . V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . R . . A . T . Q M . . . . . . . . . . V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Herts 33/56 2101 S L K Q C T R Q I L E V T I L S L R S E N L N K V G D I I G L V L K G M I S L E D L I P L R T Y L K C S T C P K Y L K A
Texas GB  . . . . . . . . . . . . . . . G . . V . D . . . I . . V . S . . . . . . . . M . . . . . . . . . . . H . . . . . . . . .
Meredith/02  . . . . . . . . . . . . . . . G . . A . . . . . . . . V V S . . . . . . . . . . . . . . . . . . . . R . . . . . . . . S
Peats Ridge/98  . . . . . . . . . . . . . . . G . . A . . . . . . . . V V S . . . . . . . . . . . . . . . . . . . . R . . . . . . . . S
Herts 33/56 2161 V L G I T K L K E I F T D T S L L Y L T R A Q Q K F Y M K T I G N A V K ? Y Y G N C D S
Texas GB  . . . . . . . . . M . . . . . V . . . . . . . . . . . . . . . . . . . . G . . S . . . .
Meredith/02  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G . . S . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G . . S . . . .
 92 
5.3.3.8  Intergenic sequences 
The intergenic sequences and gene boundaries for each of the genes have been aligned 
in Figure 5.9.  The gene end and start sequences for each of the proteins were extremely 
well conserved, however there was significant diversity in the intergenic regions, 
particularly between the F-HN and HN-L proteins. 
 
 
Figure 5.9  Gene boundaries and intergenic sequences 
  
N-P
Herts 33/56 1792 A A U C U U U U U U U A U G C C C A U C U U 1813
Texas GB  . . . . . . . . . . C . . . . . . . . . . .
Meredith/02 . . . . . . . . . . C . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . C . . . . . . . . . . .
P-M
Herts 33/56 3244 A A U U C U U U U U U A U G C C C A U C U U 3265
Texas GB  . . . . . . . . . . . . . . . . . . . . . .
Meredith/02 . . . . . . . . . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . . .
M-F
Herts 33/56 4487 A A U C U U U U U U G U G C C C A U C U U 4507
Texas GB  . . . . . . . . . . . . . . . . . . . . .
Meredith/02 . . . . . . . . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . . . . . .
F-HN
Herts 33/56 6279 A A U U C U U U U U U G A U G G U C U A C G U C U A C U G A U C U C U C G U U A U A U G C C C A U C U U 6330
Texas GB . . A . . . . . . . . . . . . . C . A . . A . . . . . . . G . U . . C U . C . . . . . . . . . . . . . .
Meredith/02 . . . . . . . . . . . . . . . . C . . . . A . . . . . . . G . U . . C . . U . . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . . . . . C . . . . A . . . . . . . G . U . . C . . C . . . . . . . . . . . . . .
HN-L 
Herts 33/56 8312 A A U U C U U U U U U A U A C C U A C U A U C A C U C U A U G U U C C G U U U U G U U G A G U G C U A U C U G U C G U G C C C A U C C U 8379
Texas GB . . . . . . . . . . . . C . U U C . . C G . U . . . . . . . . . . . . . . . . . . . C . . . . A . C . . U . A . . A . . . . . . . . . .
Meredith/02 . . . . . . . . . . . . C . . . C . . C . C U G . C . . . . A . . . . . . . . . . . . . . . . . . C U C . . A . . . . . . . . . . . . .
Peats Ridge/98  . . . . . . . . . . . . C . . . C . . C . C U G . C . . . . A . . . . . . . . . . . . . . . . . . C U C . . A . . . . . . . . . . . . .
Gene end Gene startIntergenic sequence
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5.3.4 Phylogenetics 
The phylogenetic relationship of the F gene of viruses used in this study was examined in 
the form of a maximum likelihood tree (Figure 5.10).  As expected from previous studies, 
the Australian viruses cluster within Class II, genotype I.104  The Herts 33/56 virus in a 
separate genotype close to genotype I and Texas GB in genotype 2.82, 168 
 
 
 
Figure 5.10  Phylogenetic tree showing the relationship between Australian viruses (blue) and velogenic viruses (red) 
used in this study.    The maximum-likelihood phylogenetic tree based on the full length fusion gene has been estimated 
using a general time-reversible model with a gamma distribution and invariant sites.  Bootstrap values are shown as a 
percentage of 1000 replicates.  The virus genotype is indicated in roman numerals.  The scale bar represents nucleotide 
substitutions per site. 
 
 
5.3.5 Embryo histopathology 
The chorioallantoic membranes (CAM) and embryonic tissues were examined for NDV 
antigen staining.  The immunohistochemical staining characteristics are represented in 
Table 5.9.  All embryos showed strong staining throughout the CAM.  However the Peats 
Ridge/98 virus was only associated with staining on the endodermal surface as seen in 
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Figure 5.11A.  In addition, all viruses induced staining throughout the internal organs of the 
embryo, apart from the Peats Ridge/98 virus, in which no staining was detected. 
 
Tissue Meredith/02 Peats Ridge/98 Herts 33/56 Texas GB 
Chorioallantoic 
membrane 
+++ +++ +++ +++ 
Internal organsa +++ - +++ +++ 
Table 5.9  Immunohistochemical straining of embryos infected with each of the four ND viruses using the Q91-6 
monoclonal antibody aInternal organs include lung, liver and kidney; +++ widespread staining, - no staining. 
 
 
 
    
Figure 5.11  Immunohistochemistry of embryos and CAMs stained with NDV MAb Q91-6.  A - Peats Ridge/98, B. 
Meredith/02 CAM, C. Herts 33/56 embryo kidney, D. Meredith/02 embryo kidney. 
  
A 
D C 
B 
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5.4 Discussion 
This study has examined virological and molecular characteristics of four NDVs; two 
virulent viruses, Herts 33/56 and Texas GB and two Australian viruses, Meredith/02 and 
Peats Ridge/98.  The virus of interest in this study is Meredith/02 which appears to be less 
pathogenic for poultry than is indicated by its virulent fusion protein cleavage site.  In 
characterising this virus in comparison with some typical velogenic and lentogenic viruses, 
it was hoped to gain insight into why the Meredith/02 virus displays a less pathogenic 
phenotype.   
 
The exotic virulent viruses Herts 33/56 and Texas GB grew to titres per ml of 107.5 TCID50 
and 107.75 TCID50 respectively in DF-1 cells, whereas the Australia viruses, Meredith/02 
and Peats Ridge/98 grew to titres of 105.75 TCID50 and 105.5 TCID50, respectively.  
However, when inoculated into embryonated eggs (a more sensitive and natural culture 
system), there was minimal difference in titres, with all viruses reaching a titre of between 
109 EID50 and 1010.3 EID50 per ml.  The lower titres seen with the Australian viruses in cell 
culture may therefore be artefactual due to the sensitivity of the DF-1 cells.   
 
The mean death time in embryonated eggs is a well-established classification method for 
NDV.174  This study confirmed that the Herts 33/56 and Texas GB viruses both kill 
embryos rapidly, indicating a velogenic pathotype.  The Peat Ridge/98 virus took an 
extended period of time >90 hours to kill embyros, consistent with a lentogenic pathotype.  
However, the Meredith/02 virus killed all ten embryos of the highest dilution in 68 hours.  
This classifies it as a mesogenic virus.  The intracerebral pathogenicity index (ICPI) for the 
Meredith/02 virus has previously been calculated to be 1.61.71  ICPI values greater than or 
equal to 0.7 are classified as virulent (either velogenic or mesogenic).  Therefore, based 
on both the MDT and ICPI, it appears that the Meredith/02 virus is a mesogenic virus.   
 
Whole genome sequencing of each of the isolates was undertaken to compare each of the 
viral genes and determine if there were any significant nucleotide and/or amino acid 
changes which may influence the pathogenicity of the viruses.  Some of these viruses had 
previously been sequenced at the time that they were first isolated, however, all viruses 
were sequenced again to take advantage of recent developments in sequencing 
technologies.  Gene boundaries, including intergenic sequences were also aligned.  Gene 
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start and end sequences were well conserved and intergenic regions ranged from 1-47 
nucleotides in length, consistent with published NDV sequences.175 
 
When each of the viral proteins were aligned, the sequences contained a number of 
differences between the exotic and Australian strains, however none of these differences 
have previously been reported to be associated with pathogenicity.  For example, the M 
protein showed a non-basic amino acid substitution at R259G, the influence of which is 
unknown at this stage.  
 
Glycosylation sites were examined because they are important sites of post-translation 
modification that can significantly alter protein interactions.176  The only difference noted 
between the viruses was in the first HN glycosylation site, in which the Australian viruses 
contained the motif NSSG.  However, this amino acid sequence is also seen in other 
virulent viruses (e.g. Genbank AGL09175.1), so is unlikely to be associated with viral 
attenuation.134   
 
The phylogenetic analysis confirmed previous classifications of these four viruses.104, 168  
The Australian class II genotype I viruses also cluster with other viruses of low 
pathogenicity such as the V4 vaccine strain, other avirulent Australian viruses and viruses 
from wild birds.82  Whilst the original Herts 33 virus was designated a class II genotype IV 
virus, the related Herts 33/56 virus appears more closely related to the genotype I viruses, 
despite its high pathogenicity. The Texas GB virus clusters with class I genotype II viruses 
of which the majority are virulent, however this group also contains vaccine strains such as 
La Sota.  Whilst viruses in genotypes I and II continue to circulate worldwide, they are 
distinct from those in genotype VII which are currently causing severe disease outbreaks 
in Asia and the Middle East. 
 
The histopathological analysis of the embryonated eggs showed that the location of viral 
replication within the eggs varied with the virus strains.  As expected, the Peats Ridge/98 
virus, with an avirulent cleavage site was restricted to replication in the CAM on the 
endodermal surface of the allantoic membrane.  The virus was unable to invade into the 
mesenchymal tissue to reach the chorionic (ectodermal) layer.  This is consistent with 
previous descriptions of lentogenic Australian viruses.52  All 3 other viruses, including the 
Meredith/02 virus were able to replicate on both the endodermal and the ectodermal 
surface of the membrane, as well as throughout the internal organ parenchyma of the 
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developing embryo.   This indicates that the Meredith/02 fusion protein is able to be 
cleaved by furin-like proteases as with other virulent viruses.  As such, the cleavability of 
the fusion protein of the Meredith/02 virus is unlikely to be the cause of the decreased 
pathogenicity associated with the virus. 
 
Currently, there are no molecular methods available to differentiate between mesogenic 
and velogenic viruses and both are reportable to the OIE.  However, if specific molecular 
signatures were found to differentiate the two, this may not be the case.  Given that there a 
large number of amino acid variations that could account for the variation in pathogenicity 
between the mesogenic Meredith/02 virus and the velogenic viruses, a broad approach 
analysing of the roles of the individual proteins in pathogenicity may be useful.   Analyses 
could include in-vitro work investigating innate immune system antagonism, virus entry 
and budding from cells or in-vivo studies using full-length clones with interchanged genes.   
5.5 Conclusions 
The characteristics of these four NDVs, including viral titre, mean death time, amino acid 
sequence, phylogeny and embryo immunohistochemistry are consistent with their 
respective fusion protein cleavage sites and predicted pathogenicity.  The Meredith/02 
virus, despite its minimal pathogenicity in chickens, contains a virulent fusion protein 
cleavage site and is classified as mesogenic according to the mean death time in eggs.  In 
addition, it produces immunohistochemical staining in chicken embryos consistent with a 
virulent virus.   However, there were no obvious sequence motifs within the Meredith/02 
genome to account for the mild clinical signs observed experimentally and in the field in 
poultry. 
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CHAPTER 6  
THE INNATE IMMUNE RESPONSE TO THE AUSTRALIAN MEREDITH/02 
VIRUS   
6.1 Introduction 
Chapters 4 and 5 have examined various characteristics of an Australian Newcastle virus 
(NDV), Meredith/02, which has a polybasic fusion protein cleavage consistent with the OIE 
definition of a virulent NDV, but does not behave as a virulent virus when inoculated into 
chickens experimentally.  It is likely that there are other molecular determinants in this 
virus that somehow mitigate against the virulent cleavage site sequence.   
 
The Meredith/02 virus has been shown to have a decreased ability to replicate 
systemically within infected birds when compared with other velogenic viruses.  This could 
be associated with an increased host innate immune response to the virus.  For example, 
the virus may lead to greater production of antiviral cytokines in the early stages of 
infection, limiting its ability to replicate and spread.  To investigate this, this chapter will 
compare features of the chicken innate immune response to the Meredith/02 virus and the 
viscerotropic velogenic Herts 33/56 virus. 
 
The avian immune response to NDV comprises both adaptive and innate immunity.  
Adaptive immunity is derived from antibodies directed at the fusion and haemagglutinin 
proteins on the virus surface, along with cell-mediated immunity in the form of CD4+ and 
CD8+ T lymphocytes.177  The innate immune system on the other hand, comprises 
physical barriers, phagocytes, complement, natural killer cells and cytokines.  The 
production of certain cytokines in chickens has been shown to increase in response to 
infection with viruses such as avian influenza virus and NDV.178  After initial exposure to a 
virus, recognition of pathogen associated molecular patterns (PAMP) results in binding of 
pattern recognition receptors such as Toll-like receptors (TLR).179   Binding of TLRs 
induces the activation of genes encoding cytokine production including the type I interferon 
family comprising interferon- (IFN-) and interferon- β (IFN-β).177, 180  IFN- and IFN-β, 
once released, bind to class II cytokine receptors, IFNAR1 and IFNAR2 respectively 
(Figure 6.1).  This activates a signaling cascade via the Janus kinase (Jak) and signal 
transducer and activation of transcription (STAT) pathway, which results in the activation 
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of IFN-stimulated genes (ISG) which have a wide range of effects, including further 
cytokine production, cell degranulation and adenosine monophosphate production.181  One 
of these ISGs is the myxovirus resistance protein (Mx).  Mx is an IFN-induced GTPase, 
which has been shown to have antiviral activity in mice and humans using a number of 
mechanisms, including inhibiting early viral replication.182   The role of the Mx protein is 
more controversial in the chicken with some studies indicating an important role for Mx in 
the antiviral response to influenza and others showing that Mx has limited antiviral 
activity.180, 183, 184  However, whilst the definitive role that Mx plays in the defense against 
ND is not clear, it has been evaluated in this study to further compare the type I IFN 
pathways induced against NDV isolates of differing pathogenicity. 
 
 
Figure 6.1  The interferon signaling pathway.  ISRE, interferon-stimulated response element. Diagram adapted from.182 
 
In the case of NDV in vivo, it has been shown that the cytokine response to viral infection, 
in particular type I IFN induction (IFN-/β), varies with the virulence of the virus.  More 
virulent viruses such as CA02 have been shown to induce greater production of IFN-, 
IFN-, IL-1β and IL-6 compared with lentogenic viruses such as La Sota in vivo.185  
However, the role of cytokines in pathological damage to the host has not yet been 
elucidated.  Certainly some cytokines eg. interleukin-2 appear to be beneficial in clearing 
NDV by reducing viral titres.186  In the case of highly pathogenic avian influenza virus 
infection in humans, the increased production of cytokines, in the form of a ‘cytokine 
storm’, has been shown to be deleterious to the infected person.187  However, the ‘cytokine 
storm’ has not been demonstrated in the context of NDV in chickens as yet. 
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The NDV V protein, formed during RNA editing of the P gene, has been found to 
antagonize interferon production by targeting phosphorylated STAT1 and may also play a 
role in viral pathogenesis.11, 150  Studies using reverse genetics have also identified the 
viral replication complex (N, P and L proteins) as influencing the pathogenicity of the virus.  
Therefore, in order to further understand molecular basis for the decreased pathogenicity 
of the Australian Meredith/02 virus, the roles of the P and V proteins were examined in 
terms of their effect on innate immunity.   
 
Initially, this study compared the ability of each virus to induce expression of IFN-, IFN-β 
and Mx in cell culture.  Then, the ability of the P and V proteins of the Meredith/02 virus 
and Herts 33/56 virus to antagonize IFN-, IFN-β and Mx was assessed.  It was 
hypothesized that the Meredith/02 virus, being of decreased pathogenicity would not be 
able to suppress the innate immune pathways to the same extent as the Herts 33/56 virus, 
leading to comparatively greater cytokine levels in cell culture at early time points post 
infection.   
6.2 Materials and Methods 
6.2.1 Infection of DF-1 cells 
DF-1 cells were grown as described in Chapter 3.2.1 and used to seed 24-well tissue 
culture plates.  Four separate plates were used to enable cells to be harvested at four 
different time points.  When cells were 80% confluent, they were infected with either the 
Herts 33/56 virus or Meredith/02 virus at an MOI of 1 or Poly I:C (10 µg) using DMEM 
growth media with 5% foetal calf serum.  Cells were infected in triplicate with three control 
wells per plate. 
 
Cells were harvested at four time points, 0, 6, 12 and 24 hours by removing the overlying 
media and adding 140 µl MagMAXTM Lysis/Binding solution directly to each well as per 
Chapter 3.8.  Lysed cells were then stored at -80oC until RNA isolation, which was 
performed according to Chapter 3.8 using the Kingfisher Flex extraction machine.   
6.2.2 Gene expression SYBR Green Reverse Transcriptase PCR 
The RNA isolated in Chapter 6.2.1 was used to quantify the expression of IFN-α, IFN-β 
and Mx using previously published primers.188-190  The sequences of these primers can be 
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found in Appendix 1, Table A4.  The SYBR Green RNA to CT kit (Applied Biosystems) was 
used for PCR as per Chapter 3.9.2.  The RNA for each gene was quantified using 28S 
rRNA as an endogenous control for normalisation.  All data were then analysed using the 
comparative CT method with the control cells at time 0 hr as the reference sample. 
 
6.2.3 Phosphoprotein gene cloning 
The P genes from both the Herts 33/56 and Meredith/02 viruses were cloned by ligation 
into the pCAGGS expression vector.191  Primers were designed to incorporate restriction 
enzyme sites at either end and a haemagglutinin (HA) epitope tag at the 5’ end of the 
primer to allow for easy identification of the generated protein by Western blot if required.  
The structure of the primers (blue arrows) can be seen in Figure 6.2. 
 
 
Figure 6.2  Primer design for P gene cloning. 
 
Two overlapping forward primers were required to span the distance from the 5’ end of the 
F2 primer to the start of the P gene and one reverse primer was used to incorporate the 
XhoI restriction site.  The first forward primer (F1) contained the HA tag and the start of the 
P gene, whilst the second forward primer (F2) contained the EcoRI restriction site and the 
Kozak sequence, overlapping the F1 primer at the HA tag.  The exact primer sequences 
can be found in Appendix 1, Table A3. 
 
RNA for cloning was extracted from allantoic fluid that had been inoculated with the Herts 
33/56 and Meredith/02 viruses.  The QIAamp Viral RNA Mini kit (Qiagen) was used to 
isolate the RNA as per Chapter 3.8.   
 
PCR reactions were conducted using the SuperScript III One-Step RT-PCR System with 
Platinum Taq DNA Polymerase (Invitrogen).  Reactions were conducted in 50 µl volumes 
using 25 µl 2X reaction mix, 10 µl template RNA, 1 µl forward primer (10 µM), 1 µl reverse 
primer (10 µM), 2 µl SuperScript III RT/ Platinum Taq Mix and 11 µl nuclease-free water. 
The F1 forward primer was used in the first reaction with the following cycling conditions: 
P gene 
F1 (HA tag) 
F2 (EcoRI + Kozak + HA) 
Reverse (XhoI) 
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cDNA synthesis: 50oC for 30 minutes x 1 cycle 
Denaturation: 94oC for 2 minutes x 1 cycle 
PCR amplification: 94oC for 15 seconds (denaturation), 55oC for 30 seconds (annealing), 
68oC for 1 minute (extension) x 40 cycles 
Final extension:  68oC for 5 minutes x 1 cycle 
4oC ∞ 
 
The resulting PCR product was then used as the template in the next PCR reaction using 
the second forward primer (F2).  The Q5 high fidelity 2X master mix (New England 
Biosciences) was used for the second PCR with the following reagents in a 25 µl volume:  
12.5 µl 2X Q5 master mix, 1.25 µl F2 primer (10 µM), 1.25 µl reverse primer (10 µM), 1 µl 
of the template cDNA and 9 µl of nuclease-free water.  The following cycling conditions 
were used: 
Denaturation: 98oC for 30 seconds x 1 cycle 
PCR amplification: 98oC for 8 seconds (denaturation), 72oC for 68 seconds (annealing and 
extension) x 35 cycles 
Final extension:  72oC for 2 minutes x 1 cycle 
4oC ∞ 
 
A 1% agarose gel was used to load all 25 µl of the final PCR product with an expected 
band size of 1.1 kb.  When the correct band was obtained it was purified using the Wizard® 
SV Gel and PCR Clean-Up System (Promega) as described in Chapter 3.13.2.  The cDNA 
was then quantified using the NanoDrop. 
 
The pCAGGS vector and the P gene cDNA from both the Herts 33 and Meredith/02 
viruses were digested with the restriction enzymes EcoRI and XhoI to produce sticky ends 
and to ensure directional cloning.  The reactions were conducted in 50 µl volumes as 
follows:  5 µl 10X H buffer (Promega), 5 µl 10X Acetylated BSA, 1 µl EcoRI enzyme, 1 µl 
Xho1 enzyme, 31 µl nuclease free water and 7 µl cDNA.  The amount of cDNA used was 
between 1-3 µg.  The tubes were incubated for 3 hours at 37oC. 
Gel purification was used to ensure that only digested and linearised DNA was used in 
subsequent steps.  A 1% agarose gel was used to load approximately 40 µl of the digested 
cDNA.  If the correct sized bands were obtained, the gel was excised and cleaned using 
the Wizard® SV Gel and PCR Clean-Up System (Promega). 
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The P genes of both the Herts/33 and Meredith/02 viruses were ligated into pCAGGS 
vectors with a control vector for comparison.  The ligation reactions were conducted in 10 
µl volumes using 1 µl 10X T4 DNA ligase buffer (Promega), 1 µl pCAGGS vector DNA, 1 
µl insert DNA (P gene) and 1 µl T4 DNA ligase (Promega).  In the case of the control 
vector, 7 µl of nuclease free water was added in place of the insert DNA.  The reactions 
were incubated overnight at 4oC.   
 
Transformation of the ligated plasmids was achieved in Top 10 F Escherichia coli cells and 
LB agar plates with ampicillin added at 100 mg/ml, according to Chapter 3.13.5. 
 
A colony PCR was undertaken to ensure that the correct insert was present in the bacterial 
colony as per Chapter 3.13.6.  Colonies with the correct insert were purified (Chapter 
3.13.7) and sequenced using Sanger sequencing with the pCAGGS forward primer 
(Chapter 3.11).   
6.2.4 V protein 
The NDV V protein is formed after RNA editing of the P gene.  An additional G nucleotide 
is inserted at the P gene editing site, resulting in a +1 frameshift.  In order to insert the 
extra G nucleotide, two rounds of PCR were required using overlapping primers (Appendix 
1, Table A3).  Initially, the F1 and R1 primers were used to insert the additional C 
nucleotide on the complementary strand.  Then the F2 and R2 primers were used to insert 
the G nucleotide on the template strand.  The products of these two PCRs were mixed and 
then a PCR reaction using the F1 and R2 primers resulted in the final product.  The 
reactions can be seen in Figure 6.3.  Separate F2 and R1 primers were designed for the 
Herts 33/56 and Meredith/02 viruses due to sequence differences around the editing site. 
 
 
 
 
 
 
 
 
 
Figure 6.3  Primer design for V gene cloning 
P gene 
F1 (EcoRI + Kozak + HA tag) 
R2 (XhoI) 
Editing site 
389CT AAA AAG GGC CA401 
 
F2 
R1 
CT AAA AAG GGG CCA 
GA TTT TTC CCC GGT 
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The first rounds of PCR reactions (F1/R1 and F2/R2) were undertaken using the Q5 high 
fidelity 2X master mix as in Chapter 6.2.1, however the annealing temperature was 
increased from 55oC to 60oC.  The P gene cDNA with the attached HA tag and EcoRI 
restriction site was used as the template. 
 
The second round of PCR (F1 and R2) was also conducted with the Q5 high fidelity 2X 
master mix: 12.5 µl 2X Q5 master mix, 1.25 µl F2 primer (10 µM), 1.25 µl reverse primer 
(10 µM), 1 µl template (F1/R1 product), 1 µl template (F2/R2 product)  and 8 µl of 
nuclease-free water.  The reaction conditions are as above (Chapter 6.2.1). 
 
The final product was gel purified (Chapter 3.13.3) and digested with EcoRI and XhoI.  The 
digested products were then ligated into the pCAGGS vector as in Chapter 6.2.1.  
Following this, the vectors were transformed, purified and sequenced in the same manner 
as for the P gene clones (Chapter 6.2.3). 
6.2.3 Transfection 
DF-1 cells were grown as described in Chapter 3.2.1 and used to seed two, 24-well tissue 
culture plates.  When cells were 80% confluent, they were transfected with either the 
pCAGGS-Herts-P, pCAGGS-Herts-V, pCAGGS-Meredith-P, pCAGGS-Meredith-V or 
pCAGGS-GFP plasmids according to Chapter 3.14.1.  The pCAGGS-GFP plasmid had 
previously been constructed in the Marsh laboratory (Glenn Marsh, pers. comm).  Each of 
the plasmids were transfected into 6 individual wells with 6 control wells left untransfected.  
After 24 hours, half of the wells transfected with each of the plasmids were also 
transfected with Poly I:C to mimic viral infection.  At 48 hours, cells were examined and 
transfection efficiency in the pCAGGS-GFP transfected wells calculated by counting the 
number of fluorescent cells per four 10X fields.  This transfection efficiency was then used 
to estimate the ability of the other P and V gene plasmids to transfect cells.  Finally, media 
was removed and RNA isolated as per Chapter 3.8. 
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6.2.4 PCR amplification of interferon genes 
RNA from Chapter 6.2.3 was used in SYBR green RT-PCR reactions to quantify the levels 
of IFN-α, IFN-β and Mx mRNA.  The PCR method is outlined in Chapter 3.9.2 and primer 
sequences can be found in Appendix 1, Table A4.  The expression of each gene in DF-1 
cells when stimulated with Poly I:C was compared with the respective unstimulated cells 
and expressed as a fold change. 
6.3 Results 
6.3.1 Interferon expression 
The expression of type I interferon genes, IFN-, IFN-β and Mx in DF-1 cells after infection 
with NDV Herts 33/56, Meredith/02 or Poly I:C at 6, 12 and 24 hours post-infection is 
shown in Figure 6.4.  Results have been normalized to 28S rRNA are expressed as fold 
changes from control cells at 0 hours.  The columns reflect mean fold changes from three 
biological replicates and error bars reflect the 95% confidence intervals. 
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Figure 6.4  IFN- (A), IFN-β (B) and Mx (C) mRNA expression in DF-1 cells after infection with NDV Herts 33/56, 
Meredith/02 or Poly I:C.  Results are expressed as mean fold changes of three biological replicates with error bars 
representing 95% confidence intervals.  *Comparisons between Herts 33/56 and Meredith/02 p<0.05. 
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After stimulation with Poly I:C to mimic viral infection, as expected, the DF-1 cells exhibited 
a 5 fold increase in both IFN- and IFN-β mRNA.  This fold change decreased slightly at 
12 hours and there was a minimal increase again at 24 hours.  When infected with Herts 
33/56 virus, IFN- expression levels increased over time from 1.5-fold at 6 hours to 2.5-
fold at 24 hours.  Similarly, IFN-β levels increased from a fold change of 1.5 at 6 hours to 3 
at 24 hours.  Interferon expression levels also increased over time after infection with the 
Meredith/02 virus.  Fold changes were slightly higher with the Meredith/02 virus, from 1.8 
at 6 hours to 3.9 at 24 hours with IFN- and from 1.8 at 6 hours to 4.1 at 24 hours with 
IFN-β.  However, when comparing the fold changes for each virus at each time point, the 
differences were not significant (Student’s T-test, p<0.05).   
 
The Mx protein mRNA was also found to increase in response to both viral infection and 
Poly I:C stimulation.  Fold changes were much greater than those seen with the interferons 
and results have been expressed using a log scale.  Overall, the expression of Mx mRNA 
in response to Meredith/02 virus infection was much greater than that seen with Herts 
33/56 virus infection at each time point.  For example, at 6 hours, the Herts 33/56 virus 
induced an 6-fold change, whereas the Meredith/02 virus induced a 3,415-fold change.  
The fold changes for Mx mRNA expression were compared between the Herts 33/56 and 
Meredith/02 viruses and the differences at all three time pointswere all found to be 
significant (Student’s T-test, p<0.05). 
6.3.2 Interferon antagonism 
As seen in Chapter 6.3.1, the stimulation of cells with Poly I:C is able to induce expression 
of both IFN- and IFN-β mRNA, although the fold-changes were not large.  The V protein 
of NDV is known to antagonize interferon production and so the effect of both the P and V 
proteins of the Herts 33/56 and Meredith/02 ND viruses on interferon mRNA expression 
was investigated.  The P and V proteins from both viruses were transfected into DF-1 
cells, followed by Poly I:C stimulation and quantification of IFN- and IFN-β mRNA 
expression.   
 
Cells transfected were also transfected with the pCAGGS-GFP construct and were 
examined for fluorescence at 48 hours to assess transfection efficiency (Figure 6.5).  
Transfection efficiency at this time was approximately 90% and the cells were 
approximately 95% confluent.  
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Figure 6.5  DF-1 cells transfected with pCAGGS-GFP and examined by light microscopy (A) and fluorescent microscopy 
(B) 
 
SYBR green RT-PCR was used to quantify IFN- and IFN-β and the results of these 
experiments can be seen in Figure 6.6.  The error bars reflect the 95% confidence 
intervals around the mean from three biological replicates.  
 
  
A B 
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Figure 6.6  Expression of IFN- (A), IFN-β (B) and Mx (C) mRNA after transfection with pCAGGS-Herts-P/V or 
pCAGGS-Meredith-P/V and stimulation with Poly I:C.  Results are normalized to 28S rRNA and expressed as the mean 
fold change from the transfected but unstimulated control cells.  Error bars represent 95% confidence intervals.  * 
statistically significant results, p<0.05. 
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Stimulation with Poly I:C resulted in a positive fold change of both IFN- and IFN-β mRNA 
as seen in the last column in Figure 6.8 A and B respectively, where the cells were only 
transfected with the pCAGGS-GFP plasmid prior to stimulation.  When the cells were 
transfected with the pCAGGS-P plasmid, the fold change for IFN- was slightly less than 
that seen with the pCAGGS-GFP plasmid for both the Herts 33/56 and Meredith/02 
viruses.  For IFN-β, the fold change for the Herts 33/56 P gene was only slightly decreased 
from the pCAGGS-GFP level, whereas for the Meredith/02 virus the fold change was 
increased.  For both viruses, when the cells were transfected with the pCAGGS-V genes, 
the fold change of both IFN- and IFN-β was less than that of the pCAGGS-GFP gene and 
less than the respective pCAGGS-P gene, although none of these differences were 
statistically significant. 
 
When the effect of transfection of each gene on Mx mRNA expression was investigated, 
Poly I:C stimulation was seen to increase Mx expression in all cases.  Compared with 
pCAGGS-GFP transfection, the Herts 33/56 P gene, Meredith/02 P gene and Meredith/02 
V gene all slightly decreased Mx expression.  However, when the Herts 33/56 V gene was 
transfected, the fold change in Mx mRNA expression was seen to increase significantly 
compared with all other plasmids. 
6.4 Discussion 
This study has investigated components of the chicken innate immune system, specifically 
the interferon pathway, to attempt to understand why there are differences in pathogenicity 
between the Australian Meredith/02 NDV and a typical velogenic viscerotropic ND virus, 
Herts 33/56.  The innate immune system provides the initial response to viral infection 
before the adaptive immune system has time to develop.  If a virus is able to antagonize 
the innate immune system early in the course of infection, it may be able to replicate 
sufficiently so that the adaptive immune system is also rendered less effective.   
 
Given that the Meredith/02 virus behaves less pathogenically than the Herts 33/56 virus, it 
was hypothesized that the Meredith/02 virus may not antagonize interferon to the same 
extent.   This means that the innate immune response to Meredith/02 would be 
comparatively greater, resulting in decreased virus replication and limited systemic spread.  
This would then lead to a greater period of time to allow the adaptive immune response to 
develop and enhance the antiviral effect.  It therefore follows that the innate immune 
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response to velogenic viruses such as Herts 33/56 might be decreased, inducing less 
interferon production and allowing the virus to replicate to a greater degree early in the 
course of infection.   
 
Initially, the type I interferon response was investigated by infecting DF-1 cells with the two 
viruses and Poly I:C and comparing IFN-, IFN-β and Mx mRNA expression levels by real-
time PCR over 24 hours.  The Poly I:C is a synthetic construct which mimics double-
stranded RNA and stimulates the immune system in a similar way to a viral infection and in 
this work can be thought of as a control. The 24 hour time period, using an MOI of 1 was 
chosen as it would allow for enough virus replication to occur to induce a cytokine 
response without inducing a cytopathic effect.  As expected, the levels of both IFN- and 
IFN-β increased over the 24 hours with both viruses and Poly I:C.  The magnitude of the 
type I interferon expression (as indicated by size of the fold change relative to control 
cells), was fairly modest with a greatest fold change of 5 seen for IFN- β at 6 hrs after Poly 
I:C stimulation.  However, this minimal change is consistent with other work using Poly I:C 
in DF-1 cells 192 and with NDV 193.  The expression pattern of the two interferons was 
similar at each time point which was also expected, given that the interferons are of the 
same cytokine class (IFN type I).  This pattern of expression gives further validation to the 
results.   
 
When comparing the two viruses, the expression of type I interferons over 24 hours 
showed that whilst the Australian Meredith/02 virus induced a slightly greater mean 
cytokine response than that produced by the Herts 33/56 virus, there was no statistically 
significant difference between the two viruses.  However, this slightly higher mean 
interferon response induced by Meredith/02 was consistent with our hypothesis that the 
less pathogenic virus should induce a greater interferon response.   
 
One of the more interesting findings from the work, involved the expression of the Mx 
protein mRNA.  The Meredith/02 virus induced a strong production of Mx mRNA, which 
was consistent at all time points.  On the other hand, Herts 33/56 was only able to induce 
a slight increase in Mx mRNA production, which was less than that seen with Poly I:C.  
The Mx protein is induced by type I interferons and therefore, the gene expression pattern 
would be expected to follow that seen with IFN- and IFN-β.  However, it is possible that 
the small increase in type I interferon produced by Meredith/02, whilst not being 
statistically significant, was able to greatly up-regulate the transcription of the Mx gene.  
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Again, the results are consistent with the hypothesis that the less pathogenic virus 
(Meredith/02) would induce the production of more antiviral proteins early in the course of 
infection. 
 
There are limited studies that have examined the innate immune system response to NDV.  
Previous studies have used different virus strains, cell types, time frames and cytokines to 
analyse cytokine expression compared with the current study, which makes it difficult to 
appraise these results.  There are however, a few studies in which parallels can be drawn 
with this study.  In an experiment conducted by by Ecco et al., the cytokine response was 
analysed when birds were infected in-vivo.  It was shown that cytokines IFN-, IFN- β and 
IL-6 were increased in splenic sections from birds infected with typical viscerotropic 
velogenic viruses (particularly at 3 dpi), when compared with an Australian virulent ND 
virus and a mesogenic virus.193   There was only a minimal increase in fold change for IL-2 
and IFN-β with fold-changes typically less than 5, as seen with IFN- β in our work.  
Another study using chicken splenocytes showed that induction of type I and II interferons 
was greater with virulent NDV compared with a lentogenic strain at 6 hr.185  Both of these 
studies contrast with the in-vitro results of the current study.   
 
Other studies comparing the cytokine responses to avian influenza viruses of differing 
pathogenicity have produced variable results  One study showed that highly pathogenic 
viruses (H5N1) produce a weaker type I IFN response than the less pathogenic H3N2 
virus, which is consistent with our hypothesis.194  However, in another study comparing the 
cytokine response in the lung tissue of chickens infected with LPAI or HPAI, at 24 hrs the 
IFN- levels in the lung were higher in the cranial lung with LPAI infection, although IFN- 
levels were higher with HPAI in the caudal lung.195  This reasons for this difference were 
not elucidated by the authors.  Yet another study showed that HPAI but not LPAI induced 
increased cytokine expression in chicken dendritic cells.196 
 
The effect of P and V gene transfection on cytokine expression did not show a significant 
difference between the Meredith/02 and Herts 33/56 viruses, apart from when Mx was 
examined.  As expected, the V protein of both viruses reduced the expression of IFN- 
and IFN- when compared with the P protein, although these differences were not 
statistically significant.  The only statistically significant result was seen with Mx after Herts 
33/56 V gene transfection, whereby Mx mRNA expression was greatly increased.  This 
result is difficult to interpret, however it is unlikely that the Herts 33/56 V gene itself has 
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directly influenced the increased expression, rather that transcription of the Mx gene is so 
sensitive to interferon induction that it has ‘escaped’ suppression and a meaningful result 
has not been obtained.   
 
There are a number of limitations to this study that include the fact that the work was 
carried out in vitro and that only a limited range of cytokines were examined.  This work 
was conducted in cell culture using DF-1 cells.  DF-1 cells are an immortalized chicken 
embryo fibroblast cell line and were chosen because they facilitate NDV replication and 
are relatively easy to propagate.  However, fibroblasts are not a preferential cell type for 
NDV replication in vivo.  As seen in Chapter 4, the Meredith/02 virus appears to replicate 
initially in the epithelial cells associated with sites of inoculation, along with mononuclear 
cells (lymphocytes and macrophages).  Herts 33/56 also has a strong tropism for lymphoid 
tissue.  Therefore, whilst these viruses are able to replicate in fibroblasts, they may not 
exhibit the same cytokine response as would be found in the live bird.  In addition, whilst 
GFP was used as an indicator of protein expression in the DF-1 cells, individual Western 
blots were not performed for each of the proteins to definitively prove that the proteins had 
been expressed. 
It would also be interesting to examine other cytokines that play a key role in antiviral 
immunity such as IFN-.  IFN- is a class II interferon which is predominantly expressed in 
lymphocytes and has been found to decrease the pathogenicity of NDV in vivo.197  It was 
not included in this study as it was unlikely to be expressed highly in DF-1 cells.  
 
The aim of this work was to investigate whether the P and/or V genes of the Meredith/02 
and Herts 33/56 viruses may account for their difference in pathogenicity.  The study was 
conducted as an in vitro pilot trial to investigate whether further in vivo work with a greater 
range of cytokines was warranted.  Our transfection studies did not suggest that the 
proteins significantly differ in their effect on innate immunity.  However, the increased 
induction of Mx mRNA expression by the Meredith/02 virus is an interesting result that 
requires further investigation.   
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6.5 Conclusions 
This study has shown that the two NDVs Herts 33/56 and Meredith/02 are able to induce 
the production of type I interferons (IFN- and IFN-β) and the Mx protein in DF-1 cell 
culture.  There was no significant difference in the level of interferon induction between the 
virus isolates, however the induced expression of the Mx protein did vary.  More Mx 
protein was expressed when cells were infected with the Meredith/02 virus compared with 
the Herts 33/56 virus.  This increased expression of Mx may lead to a greater inhibition of 
replication for this virus, thereby decreasing its pathogenicity in infected birds as seen 
experimentally and in the field. 
 
The ability of the V genes of each of the viruses to antagonize interferon was confirmed 
but again, there was no significant difference in the degree to which the Herts 33/56 and 
Meredith/02 viruses could achieve this. 
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CHAPTER 7  
A VIRULENT AUSTRALIAN NEWCASTLE DISEASE VIRUS WITH AN 
ATTENUATED PHENOTYPE HAS A STEEPENED TRANSCRIPTION 
GRADIENT 
7.1 Introduction 
Previous chapters have examined an Australian Newcastle disease virus (NDV) isolate, 
Meredith/02, which displays minimal pathogenicity in chickens, despite containing a 
virulent fusion protein cleavage site according to the OIE definition.6  It is therefore 
assumed that there may be other molecular determinants that influence the virulence of 
this virus, other than the cleavage site.   
 
As seen in Chapter 5, there are numerous amino acid variations throughout the genomes 
of the Herts 33/56 and Meredith/02 viruses, of which none are in regions of known 
importance to pathogenicity.  This makes it difficult to identify any particular genes that 
may have a significant role in pathogenicity.  The previous work in Chapter 6 focused on 
the V protein’s effect on innate immunity but did not show any clearly pertinent differences 
between the Herts 33/56 and Meredith/02 viruses that may influence pathogenicity.  
Therefore, an analysis of the transcription gradient of both viruses may provide a broader 
insight into which genes could be targeted for further investigation into their role in 
pathogenicity. 
 
NDV, like all paramyxoviruses replicates after transcription of viral mRNA from genomic 
RNA.  Transcription of the negative sense RNA strand occurs within the cytoplasm and 
primarily involves the nucleocapsid protein (N), phosphoprotein (P) and large polymerase 
protein (L).  Each nucleocapsid protein binds to six nucleotides of the viral RNA, following 
the rule of six.  The subsequent attachment of the P and L proteins forms the 
ribonucleoprotein (RNP) complex.174  The viral RNA-dependent RNA polymerase (RNAP) 
then transcribes the genome in the direction from the 3’ leader (promoter) sequence to the 
5’ end, using a start-stop mechanism which terminates at the end of each gene and begins 
again at the start of the next gene.75  However, this process is not entirely efficient and 
occasionally the RNAP does not bind to subsequent genes.  As a result, the downstream 
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mRNAs are not transcribed and so the mRNAs are not produced in equimolar amounts.  
This leads to the formation of a gradient of transcribed mRNAs such that more 
nucleoprotein mRNAs are produced as compared with large polymerase mRNAs, as seen 
in Figure 7.1.  After transcription, the viral mRNAs are translated into the individual viral 
proteins. 
 
 
 
 
 
Figure 7.1  Gradient of transcription.  Transcription of the NDV RNA genome occurs in a 3’ to 5’ direction with more 
mRNA transcripts produced from genes closer to the 3’ end.   
 
It is possible to quantify the mRNAs produced by each gene of a virus by quantitative 
reverse transcriptase PCR (qRT-PCR) or agarose gel electrophoresis to create a 
transcription gradient for the virus isolate.  The profile of the gradient may then be 
compared between different isolates of NDV to investigate whether there is any correlation 
between the production of mRNAs and the virus phenotype.  Previously, quantification of 
the viral mRNAs of NDV has been studied using gel electrophoresis via Northern 
blotting.198  However, electrophoresis is a relatively less sensitive method of mRNA 
quantification and so this study will investigate the transcription gradient of NDV using 
qRT-PCR. 
 
The transcription gradients of a number of other paramxyoviruses, including measles, 
Sendai virus and Hendra virus have previously been described.199-201  In brains infected 
with measles virus, the transcription gradient of the viral mRNAs varied with the type of 
infection, with persistent infections showing a more shallow transcription gradient 
compared with the steeper curve of active infections.199 
 
The transcription gradient has also been found to vary between different strains of the 
same virus in the case of vesicular stomatitis virus, another negative-sense RNA virus.202  
In this case, a small plaque phenotype, attenuated strain was found to have a steepened 
transcription gradient and less viral mRNA transcription overall, when compared with the 
wild type virus.   
 
N P M F HN L 3’ 5’ 
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Therefore it is hypothesized that there may be differences in the transcription gradients of 
the Meredith/02 and Herts 33/56 viruses which could help to explain the difference 
between these viruses in their pathogenicity for poultry.  
7.2 Materials and Methods 
7.2.1. Infection of DF-1 cells 
DF-1 cells were grown to confluency as described in Chapter 3.2.1.  24-well plates were 
seeded with 5 x 104 cells per well in 1 ml growth media.  The cells were grown to 
approximately 95% confluency over 48 hours and then infected with either Herts 33/56 or 
Meredith/02 virus at an MOI of 0.1.  Cells were infected in triplicate or left uninfected as 
controls.  The cells were harvested at 0, 6, 12 and 24 hours by removal of media and the 
addition of 140 µl of MagMAX lysis buffer.  Lysed cells were then stored frozen at -80oC 
immediately.  A 24 hour infection period was chosen as it has been shown with measles 
virus that RNA and mRNA accumulates rapidly over the first 24 hours of replication and is 
relatively stable thereafter.203  Therefore any differences in transcription between virus 
isolates should be detectable within this timeframe. 
7.2.2 RNA isolation 
RNA was isolated as per Chapter 3.8 using the MagMAX express viral RNA isolation 
protocol (Ambion) on the Kingfisher Flex.  RNA was eluted in 60 µl of elution buffer and 
stored frozen at -80oC. 
7.2.3 cDNA Synthesis 
Two-step RT-PCR was used to quantify each of the mRNA viral gene transcripts.  cDNA 
was synthesized using the SuperScript® III First-Strand Synthesis SuperMix.  Oligo(dT)20 
primers were used to amplify the mRNA transcripts.  Oligo(dT)20 primers were chosen as 
they bind to the poly(A) 3’ tail of mRNA and will not transcribe the genomic RNA.  
Reactions were carried out in 24 µl volumes in 0.2 mL thin-walled PCR tubes using 
oligo(dT)20 primer (1 µl, 50 µM), annealing buffer (1 µl), nuclease-free water (8 µl) and 
template RNA (2 µl).  Tubes were heated to 65oC for 5 minutes using a GeneAmp PCR 
System 2400 (Perkin Elmer), then placed on ice for at least 1 minute.  Next, the 2X First-
Stand Reaction Mix (10 µl) was added to each tube, along with the SuperScript 
III®/RNaseOUTTM Enzyme Mix (2 µl).  The tubes were then heated to 50oC for 50 minutes 
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and reactions terminated at 85oC for 5 minutes.  Finally, samples were held on ice before 
use or stored at -20oC.  cDNA was diluted in RNAase free water using a 1 in 10 ratio 
before use in the PCR. 
7.2.4 mRNA gene transcript primer design 
Primers were designed for each gene (N, P, M, F, HN and L) using Geneious software as 
per Chapter 3.15 and a list of the primers used can be found in Appendix 1, Table A5.  The 
primers were aligned to both the Herts 33/56 and Meredith/02 viruses to confirm that there 
were no mismatches with either virus.  The primers were located within 1,200 bp of the 5’ 
end of each gene, to ensure that any mRNA that was not fully transcribed during the 
reverse transcription step was still detected by the primers.   β-actin was used as an 
endogenous control rather than the previously used ribosomal RNA because the oligo(dT) 
primer requires a polyadenylated sequence to bind which is not present on 18S rRNA or 
28S rRNA.  β-actin has also been shown to be one of the most stable genes for use as an 
endogenous control.204, 205  Previously published β-actin primers were used.185   
 
The location of the primers in relation to the NDV genome can be seen in Figure 7.2. 
 
 
 
Figure 7.2  Primer pair locations for NDV mRNA amplification.  Forward primers are represented by black arrows and 
reverse primers by grey arrows. 
 
7.2.5 SYBR green PCR 
Quantitative PCR was performed using the SYBR® Green PCR Master Mix (Applied 
Biosystems).  Reactions were undertaken in 10 µl, using 2X SYBR Green PCR Master Mix 
(5 µl), forward primer (0.2 µl, 200 µM), reverse primer (0.2 µl, 200 µM), nuclease-free 
water (3.6 µl) and template cDNA (1 µl).   
 
Cycling conditions were as follows: 
95oC for 10 min 
45 cycles of 95oC for 15 sec and 60oC for 1 min 
Melt curve:  95oC for 15 sec, 60oC for 15 sec, 95oC for 15 sec 
Melting curves were analysed to assess for non-specific amplification. 
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7.2.6 Standard curve generation 
Standard curves for each primer pair were generated by creating six, 10-fold dilutions of 
cDNA and PCR reactions performed as above in Chapter 7.2.5.  The efficiencies of the 
reactions were calculated by plotting the log of each template dilution series on the x-axis 
and the CT value on the y-axis.  A line of best was then used to determine the slope. 
The efficiency (E) of the reaction was then obtained using the equation: 
E = 10^(-1/slope). 
7.2.7 Data analysis 
The comparative CT method was used to express fold changes of each gene relative to the 
N gene as per Chapter 3.9.2 with all samples normalised to the endogenous β-actin 
control. 
 
Any outliers were identified from each of the triplicate technical replicates and removed 
from the analysis.  The average of each group of technical replicates was determined and 
used to find the mean and standard deviation of the three biological replicates for each 
target sample.  The comparative CT and subsequent fold change was then determined 
according to the Applied Biosystems calculations.206 
7.3 Results 
7.3.1 Optimisation and specificity of the polymerase chain reaction 
After infection with Herts 33/56 and Meredith/02 and harvesting of the DF-1 cells at 6, 12 
and 24 hours, the RNA was extracted and reverse transcribed into cDNA.  Standard 
curves were generated by SYBR green PCR for each of the primer pairs using ten-fold 
dilutions of the cDNA from a 12 hour Herts 33/56 sample.  The efficiencies of each 
reaction were then calculated and can be seen in Table 7.1. 
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Gene target Efficiency 
N 2.0 
P 1.9 
M 1.9 
F 1.9 
HN 2.0 
L 2.1 
β-actin 1.8 
Table 7.1  Efficiency of primer pairs for each gene target. 
 
The efficiencies were all within the range 1.8x to 2.2x, allowing the comparative CT method 
to be used for comparison.207 
 
Melting curves were analysed for the specificity of the PCR reactions and the associated 
plots can be seen in Figure 7.3.  All melting curves displayed single peaks indicating that 
only the target sequence had been amplified. 
 
Figure 7.3  Melting curve analysis for each of the 7 SYBR green PCR reactions 
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Any wells showing abnormal amplification curves or unusual melt curves were omitted 
from the analysis.  In all cases where samples were omitted, only one of the three 
technical replicates was affected.  For all PCR plates, there was no amplification detected 
in the negative control wells.   
 
7.3.2 Transcription gradients 
The fold changes for the individual genes of the viruses were then calculated and the 
transcription gradients were plotted as seen in Figure 7.4.  In addition, the ratio of mRNAs 
for each virus can be seen in Table 7.3.  The curves show a progressive decrease in the 
detection of the mRNA transcripts of each gene moving from the 3’ end of the genome to 
the 5’ end.  The cell cultures infected with either virus contained a much lower level of 
large polymerase gene transcription compared with the nucleocapsid gene. 
  
At 6 hours, the transcription gradients were relatively similar between the two viruses, 
however the gradient between the N and P transcripts was steeper for the Meredith virus, 
indicating that transcription of the Meredith/02 P gene is relatively less efficient.  At 6 
hours, the fold change for the Herts 33/56 P gene mRNA was 1.8 times that of the 
Meredith/02 mRNA.  At 12 hours a similar pattern is present, although the difference 
between the two gradients at the point of P gene transcription was even greater with the 
Herts 33/56 P gene transcript 3.2 times that of the Meredith P gene.  Once again, at 24 
hours the Meredith virus showed a steeper gradient, particularly between the N and P 
gene mRNA transcripts, with the Herts 33/56 P gene mRNA 14 times greater than the 
Meredith P gene mRNA.  In all cases, at the point of the M gene transcript, the gradients of 
the curves flattened significantly and there was little difference between the fold change of 
the M mRNA and L mRNA (relative to the N gene mRNA).  As seen in table 7.2, at 24 
hours, the proportions of transcribed mRNAs downstream from the nucleocapsid gene 
were minimal for the Meredith/02 virus with a ratio of mRNA of 100:3:2:1:3:1 
(N:P:M:F:HN:L).  In contrast, the equivalent ration for Herts 33/56 was 100:42:18:14:14:8. 
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Figure 7.4  Relative quantification of mRNA transcripts of NDV genes after infection of DF-1 cells with Herts 33/56 or 
Meredith/02 viruses at time points 6 hours (A), 12 hours (B) and 24 hours (C).  Each gene mRNA is expressed as the 
fold change relative to the N gene transcript.  Data were normalised to β-actin mRNA.   Error bars represent the standard 
deviation of the mean of 3 replicates. 
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Time (hrs) mRNA ratio 
(N:P:M:F:HN:L) 
 Herts 33/56 Meredith/02 
6 100:83:23:39:29:13 100:45:33:24:27:15 
12 100:103:33:29:41:14 100:32:26:25:30:20 
24 100:42:18:14:14:8 100:3:2:1:3:1 
Table 7.2  Ratio of transcribed mRNAs for each gene, expressed as a percentage relative to the N gene transcript. 
7.4 Discussion 
This study investigated the transcription gradients of two NDVs which share a common, 
virulent fusion protein cleavage site but which vary in pathogenicity.  The Herts 33/56 virus 
is a highly pathogenic viscerotropic, velogenic virus, whereas the Meredith/02 virus only 
produces mild clinical signs in infected chickens.  It has therefore been hypothesized that 
areas of the genome other than the fusion protein cleavage site must be responsible for 
the reduced pathogenicity of the Meredith/02 virus.  It was thought that significant 
differences in the transcription of the viral genes may help to explain the pathogenicity of 
the viruses.  Therefore, the transcription gradients of both viruses were constructed via 
qRT-PCR and compared.   
 
The overall slope of the transcription gradients presented in Figure 7.4 are consistent with 
what is known about the rate at which the genomes of RNA viruses are transcribed. It is 
well established that transcription is progressively attenuated as the polymerase moves 
from the 3’ to 5’ end of the viral RNA genome and this was confirmed for both the Herts 
33/56 and Meredith/02 viruses in this study.  Previous work by Collins, et al. using the 
virulent NDV-AV strain also showed that transcription of NDV genes occurs in non-
equimolar amounts with molar ratios of 100:65:41:33:3 corresponding to N:F:M:HN:L.198  
These ratios are relatively similar to those found in this study, apart from with Meredith/02 
at 24 hours.  At 24 hours, the Meredith/02 virus had a ratio of mRNA transcription of 
100:3:2:1:3:1.  This means that after transcription of the N gene had occurred, only 
minimal amounts of the remaining genome were transcribed.   
 
The substantially increased steepness in the transcription gradient between N and P for 
Meredith/02 at 24 hours is interesting.  An increased gradient can also be seen for Herts 
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33/56 at 24 hours, compared with the earlier time points, albeit not to the same extent as 
with Meredith/02. 
   
Presumably by 24 hours, the rate of viral replication and transcription have started to 
decrease due to availability of cellular components in the cell culture system.  However, 
this does not explain the difference between the proportion of P gene transcription by 
Herts/33 and Meredith/02.  Perhaps the RNAP of the Meredith/02 virus is more easily 
inhibited at an earlier time point than the RNAP of the Herts 33/56 virus.  Another 
paramyxovirus, Hendra virus has been shown to have a steepened transcription gradient 
at 24 hours at the matrix-fusion protein junction as opposed to the nucleocapsid-
phosphoprotein junction as in this case.208 
 
It is likely that the N, P and L proteins which comprise the viral replication complex have 
influenced the rate of transcription of the Meredith/02 virus.  The ratio of proteins within the 
viral replication complex is an important factor in the efficient replication for many 
viruses.209  The ratio of N, P and L mRNAs at 6 hrs is 100:83:13 for Herts 33/56 compared 
with 100:45:15 for Meredith/02.  There is therefore, a 2 fold difference in the proportion of 
P mRNA transcription between the viruses, perhaps limiting the efficiency of transcription 
of the Meredith/02 phosphoprotein and hence impairing replication complex formation. 
 
At the molecular level, there may be many reasons for these differences in transcription 
ratios.  The gene-start, gene-end and intergenic sequences between the individual genes 
help to modulate transcription but are not functional during virus replication.74, 210  
However, it was shown by Yan et al. that altering the length of the intergenic sequence of 
NDV can attenuate downstream transcription.153   
 
There are very few studies which examine the transcription gradients of virus strains which 
vary in pathogenicity.  However, the work investigating the steepened transcription 
gradient of an attenuated vesicular stomatitis virus (VSV) is consistent with our findings, in 
that the steepened gradient of Meredith/02 transcription is also associated with reduced 
pathogenicity.202  As hypothesized in the VSV study, it is also possible that there is a 
mutation in the Meredith/02 polymerase complex that prevents it from efficiently reinitiating 
transcription after the initial nucleocapsid protein mRNA has been transcribed. 
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When the sequences of the gene boundaries of the nucleocapsid and phosphoprotein 
were compared in Chapter 5.3.3.8, there were no differences between the Meredith/02 
and Herts 33/56 viruses.  Thus, it may be more likely that the differences in transcription 
reinitiation are due to variations in the large polymerase protein itself.    
 
It would also be interesting to extend this study to include additional ND viruses with 
varying pathogenicity for chickens, to investigate whether all less pathogenic viruses have 
an increased transcription gradient. 
 
These findings provide further evidence that regions of the NDV genome other than the 
fusion protein cleavage site may influence pathogenicity, particularly in the context of 
Australian ND viruses. 
7.5 Conclusions 
This study has shown that the mesogenic Australian Meredith/02 NDV has a steepened 
transcription gradient when compared with the virulent Herts 33/56 virus.  This steepened 
transcription gradient may indicate altered transcription of the Meredith/02 virus which 
could be related to components of the viral replication complex, in particular, the large 
polymerase protein.  However, further investigation is required to determine whether this is 
a consistent finding associated with the pathogenicity of other NDVs.  
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CHAPTER 8  
GENERAL DISCUSSION  
8.1  Introduction 
The overall aim of this thesis has been to investigate the molecular basis of pathogenicity 
of Newcastle disease virus (NDV) in chickens.    Newcastle disease (ND) can have 
significant impacts on poultry production, particularly in areas in which it is endemic, such 
as throughout Asia, Africa, the Middle East and parts of Central and Southern America.  
However viruses such as NDV can be difficult to control because of their wide variability in 
pathogenicity and broad host range.  This variability in pathogenicity has led to certain 
criteria being developed to assess whether a virus is likely to cause significant disease.  
These criteria are primarily based on the molecular sequence at the fusion protein 
cleavage site, with a multiple basic amino acid motif indicating a virulent (velogenic or 
mesogenic), OIE notifiable virus.6   
 
This work focused on an Australian NDV which caused an outbreak of ND in Meredith, 
Victoria in 2002. In this case and in other Australian outbreaks from 1998-2002, some of 
the veterinarians and poultry experts involved with investigating and controlling the 
disease at the time, found it difficult to believe that the clinical disease seen in the field was 
associated with a virulent NDV.9, 56  These Australian NDVs, whilst fitting the OIE definition 
of ND, did not appear as pathogenic in the field as expected.  However, as per Australian 
guidelines for the control of ND, the flocks were culled in an attempt to eradicate the virus.   
 
This work has attempted to further characterize the Meredith/02 NDV and to identify 
whether there are areas of the viral genome, other than the fusion protein cleavage site 
that may contribute to the decreased level of pathogenicity.  It was thought that if there 
were other markers of pathogenicity, in conjunction with the fusion protein cleavage site, 
they could be used to predict whether a virus may be somewhat less pathogenic, which 
may then lead to the use of alternative control methods, as opposed to culling.  
 
This work comprises four main components to investigate the pathogenicity of the 
Meredith/02 virus; comparative pathogenicity in an experimental setting, virological 
characterization, the ability of the Meredith/02 virus to both induce expression of and 
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antagonize components of the innate immune system and comparative transcription 
gradients.   
 
The key findings from each of these pieces of research will be discussed, along with 
overall conclusions and suggestions for future directions that research in this area could 
take. 
8.2  Comparative pathogenicity 
The purpose of the research conducted in Chapter 4 was to compare the pathogenicity of 
four NDVs for poultry in an experimental setting, using two virulent viruses that are exotic 
to Australia and two Australian viruses, including the Meredith/02 virus.  It was 
hypothesized that the Meredith/02 virus would not induce severe clinical signs in the 
challenged birds despite being classified as a virulent virus.  It was important to be able to 
observe the effect of the virus in a laboratory setting, using SPF birds that had not been 
exposed to other pathogens that could alter the expression of the disease.  The aim 
therefore, was to replicate what was seen in the field situation, however with controls and 
standard inocula to enable comparisons of pathogenicity and pathogenesis, including 
tissue tropism and degree of virus replication.   
 
The Peats Ridge/98 virus was included in the work because it was an avirulent virus that 
was determined to be the precursor to the Australian virulent viruses with only two 
nucleotides difference at the fusion protein cleavage site.71  The Herts 33/56 virus and 
Texas GB viruses were included because these viruses were known to represent the two 
velogenic pathotypes; viscerotropic and neurotropic respectively. 
 
It was found that the Meredith/02 virus had exactly the same fusion protein cleavage site 
as the velogenic viscerotropic Herts 33/56 virus.  However, as per the field situation, it 
displayed minimal clinical signs in chickens.  Only 2 out of 6 birds showed mild depression 
and increased respiratory effort on day 3 post inoculation and these signs resolved within 
hours.  This is unusual although not without precedent, as pigeon paramyxoviruses with 
virulent cleavage sites have also showed similarly minimal clinical signs in chickens as 
described in a review by Dortmans et al.3  In addition, other mesogenic viruses, can also 
be less pathogenic in an experimental setting than their fusion protein cleavage site motif 
would suggest.  In a similar experiment using the mesogenic Roakin and Anhinga viruses, 
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there were no clinical signs in the infected birds, although splenic pathology was noted 
grossly and histologically.98  Those two mesogenic viruses also had multibasic cleavage 
sites of 112RRQKRF117, as per the Texas GB virus, with the Roakin virus able to induce 
moderate mortality in poultry.211  The Anhinga virus was originally isolated from a dead 
Anhinga (darter) from a Florida zoo, however whether the mortality event was attributable 
to infection with NDV is unclear.212   
 
Given the importance of the presence of a polybasic fusion protein cleavage site to the 
definition of ND, the ability to correlate the sequence motif with clinical signs, particularly in 
the field situation is significant.  Whilst the laboratory setting is useful in providing baseline 
data for comparison, it does not entirely replicate a commercial poultry enterprise with the 
additional stressors of increased housing density and bacterial, viral and parasitic 
pathogens, amongst others.  Therefore, it should not be assumed that because a virus 
was virtually apathogenic experimentally, that it will behave similarly in a poultry flock. 
 
Whilst the key focus of this piece of research was to evaluate pathogenicity, pathogenesis 
of these four viruses was also investigated.  Explaining where and how the virus replicates 
within the host, can help to understand why one virus is more pathogenic than another and 
may provide future direction for molecular based pathotyping.  In this study, two birds were 
euthanased on both days 2 and 4 post inoculation to assess any early viral replication.  
The Peats Ridge/02 virus was restricted to replicating on epithelial surfaces at sites of 
inoculation, limiting the clinical signs seen.  However, whilst the Meredith/02 virus was able 
to spread systemically to lymphoid tissues such as the spleen early in the infectious 
process, the amount of virus present in these tissue was significantly less than with 
standard velogenic viruses.  This capacity to infect lymphoid tissue indicates that the 
fusion protein of the Meredith/02 virus is able to be cleaved by furin-like proteases as the 
cleavage site suggests.  This replication in lymphoid tissue predominantly associated with 
macrophages, which is well recognized for virulent NDV.98  The Meredith/02 virus 
however, did not replicate within neural tissue experimentally, thereby limiting its 
pathogenicity.  By comparison, the Herts 33/56 and Texas GB viruses did show antigen 
staining in the CNS.  At the time of its isolation, a small number of birds infected with the 
Meredith/02 virus were observed with mild nervous signs, so presumably, the virus is 
capable of replicating in nervous tissues given the appropriate circumstances.   
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Overall, the Meredith/02 virus was not able to replicate to the same degree as the Herts 
33/56 and Texas GB viruses and this was associated with a lesser degree of both quantity 
and distribution of antigen staining by immunohistochemistry.  These observations could 
be explained by host factors, such as the immune response to the Meredith/02 virus 
suppressing replication, or could be an intrinsic element of the virus itself, limiting key 
elements of virus entry, replication and budding. 
 
It would have been useful to be able to examine tissues from birds from the original 
outbreak, to compare lesion and antigenic distribution with the experimental birds.  
However, only a minimal number of poorly preserved specimens were available and so 
were not included in the analysis. 
Future work in this area would be useful to expand the range of Australian viruses used to 
investigate pathogenicity, particularly with additional viruses from the Mangrove Mountain 
outbreaks in 1998-1999.  During these outbreaks a range of clinical signs were noted, 
however the affected birds were also concurrently infected with agents such as Pasteurella 
multocida and Mareks disease virus.56 Therefore, assessing the pathogenicity of these 
viruses in SPF birds may lead to a clearer picture of how these viruses compare with each 
other.  Subsequent to this, whole genome sequence examination could be undertaken to 
identify sequence changes associated with the pathogenicity.  Similar work examining 
sequence variations in the NDVs from the 1998-2002 outbreaks has already been 
undertaken, however much of the work was purely based on molecular data without the 
incorporation of clinical signs and pathological lesions.53, 71 
8.3  Virus characterization 
Following on from the pathogenicity research in Chapter 4, it was necessary to 
characterize the Meredith/02 in more detail using standard virological techniques.  In this 
way the growth characteristics of the virus could be evaluated and used as baseline 
measures for further experimental work.  Again, the same four viruses were used to 
examine virus growth in cells and eggs, to calculate the mean death time in eggs, to 
sequence the whole genome of each of the viruses and to investigate virus replication 
within the chicken embryo.  After completing the comparative pathogenicity work, it was 
thought that the Meredith/02 virus could be classified as either a mesogenic or lentogenic 
pathotype.  Further clarification of the pathotype would then allow for a better comparison 
with other known viruses with similar characteristics.   
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The mean death time in eggs is one of the most well recognized methods for determining 
the pathotype of ND viruses.  The MDT for the Meredith/02 virus was calculated at 68 
hours which classifies it as a mesogen.  The Herts 33/56 and Texas GB viruses were both 
velogenic with MDTs of 44 and 60 hrs respectively and the Peats Ridge/98 virus was 
found to be lentogenic with an MDT of 116 hrs.  The MDT can also be compared with the 
ICPI, another measure of pathogenicity.  However, given that the ICPI represents an 
unnatural route of infection and that strong justifications are required for its use from an 
ethical perspective, it was not undertaken in this work.  Whilst the ICPI often correlates 
with the fusion protein cleavage site and the pathogenicity of a virus, it does not predict 
pathogenicity in cases.  Previous work completed at AAHL, showed that the ICPI of the 
Meredith/02 virus was 1.61, indicative of virulence.  Mesogenic viruses such as Roakin 
also have similar ICPIs of >0.7.213  Therefore whilst pathotypes do not have strict 
boundaries and there is often some overlap in characteristics of various ND viruses, it 
appears that the Meredith/02 virus should be considered a mesogen.  Given that other 
viruses from the 1998-2002 outbreaks have previously been reported as velogenic it would 
be useful to clarify the pathotype of these viruses as well, using the MDT along with 
experimental infection in poultry.104  It is interesting to note that in some countries where 
ND is endemic, mesogenic viruses are used as vaccines (R2B, Roakin, Mukteswar and 
Komarov viruses), however they are not acceptable in the Australian situation.6, 83, 214   
 
The whole genome sequences of all four viruses were constructed and analysed with 
reference to previous sequencing work.  Important structural features of the viruses were 
identified and compared when aligned.  Whilst there were no obvious sequence 
differences detected to account for the variations in pathogenicity between the viruses 
(apart from the F cleavage site of Peats Ridge/98), knowledge of the whole genome 
sequences could be used to inform further work, such as cloning of individual genes and 
construction of reverse genetics systems.  The P gene was shown to be the most variable 
across all four viruses at both the nt and aa level and as such was identified as a potential 
gene for further analysis.  The HN gene was the second most variable gene and the 
unique 9 aa extension of the Australian viruses could be a target for future investigations, 
although previous studies have given conflicting results on the importance of the HN gene 
in pathogenicity (as reviewed Chapter 2.8.3). 
 
During the initial outbreaks of ND in Australia in 1998, egg inoculation was used to assess 
the virulence of the virus (Deborah Middleton, pers. comm.).  Embryos at 9-11 days old 
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were inoculated with virus via the allantoic route and the chorioallantoic membrane and 
embryos examined by immunostaining for virus antigen.  Virulent viruses were able to 
replicate on both sides of the chorioallantoic membrane and throughout the developing 
embryo itself.  Avirulent or lentogenic viruses were restricted to replicating on the allantoic 
surface of the CAM.  This procedure was repeated with our four viruses and it was shown 
that the Meredith/02 virus was able to replicate throughout all surfaces of the CAM and 
that antigen was widely distributed throughout the internal organs of the developing 
chicken embryo.  This indicates that furin-like proteases are able to cleave the fusion 
protein at the multibasic amino acid cleavage site as per other virulent NDV strains.  
Therefore the cleavability of the fusion protein of the Meredith/02 virus does not appear to 
be the limiting factor for pathogenicity.  This finding is supported by the previous 
pathogenicity work in Chapter 4 that showed virus replication in the spleens and caecal 
tonsils of birds infected with Meredith/02 virus. 
 
Whilst this section of work was not able to identify any particular genes or molecular 
sequences that could explain the pathogenicity characteristics of the Meredith/02 virus, it 
provided a useful dataset for further molecular analysis.  It has also classified the 
Meredith/02 virus as a mesogen which allows comparisons to be drawn with other 
mesogenic ND viruses. 
8.4 Innate immune system 
Following on from the virus characterization work, it was important to narrow the focus of 
study to particular genes which may influence pathogenicity.  The V protein was chosen to 
investigate because of its role in antagonism of components of the innate immune system 
during NDV infection.11  The P gene encodes both the P protein and V protein as a result 
of RNA editing, therefore both proteins were included in the study.  It was hypothesized 
that the Meredith/02 virus may not be able to antagonize the innate immune system of the 
host effectively, leading to a decreased ability to replicate within avian cells. 
 
This study comprised two parts; initially the mRNA expression of interferon-, interferon- 
and the Mx protein was assessed by qRT-PCR after infection of DF-1 cells with either the 
Meredith/02 or Herts 33/56 virus.  Secondly, P and V proteins from each virus were 
expressed in DF-1 cells and their ability to antagonize interferon and Mx mRNA expression 
was evaluated.  Both of these viruses could induce transcription of IFN-, IFN-β and the 
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Mx genes, indicating that the DF-1 cell line could be used effectively to assess the 
antagonistic effects of the P and V proteins.  The levels of interferon gene expression were 
similar between both viruses, however more Mx mRNA was expressed with Meredith/02 
infection compared with infection with Herts 33/56.   
 
The results from the P and V protein antagonism experiment didn’t appear to show any 
significant differences between the two viruses in the degree to which interferon could be 
antagonized.  However, the V proteins of both viruses were able to antagonize interferon 
to a greater level than the respective P proteins, which helped to validate the experimental 
methodology.  There was one anomaly in this work however, in that the Mx mRNA was 
seen to be significantly more expressed when the Herts 33/56 V protein was transfected 
into the cells compared with transfection with the Herts 33/56 P protein.  This was unable 
to be explained from a virological perspective.  However, it appears that the Mx protein is 
particularly quick to respond to stimulation and can be transcribed at very high levels 
(Daniel Layton, pers. comm.).  Therefore, it is possible that in this experimental work, 
including the initial expression work with the Meredith/02 virus, that Mx mRNA expression 
was too responsive to stimulation to meaningfully evaluate.   
 
Overall, it was not possible to show that the V protein of the Meredith/02 virus was able to 
antagonize the innate immune system to a greater degree than the Herts 33/56 virus using 
the cytokines that were included in this work.  However, it would be beneficial to evaluate a 
broader set of innate immune system cytokines to fully validate this conclusion.  Given that 
that the innate immune system involves a complex network of interacting cytokines, it 
would be particularly useful to use techniques such as RNA-Seq to profile cytokine gene 
expression on a larger scale.  However, the cost of such analysis was prohibitive for this 
project.   
8.5 Transcription gradient 
Given that previous work had not readily identified a specific protein or molecular 
sequence of interest to evaluate for its effects on the pathogenicity of the Meredith/02 
virus, a broad approach to investigating the individual viral genes was taken.  This involved 
analyzing the transcriptional gradient of two of the viruses in this study; Herts 33/56 and 
Meredith/02.  It was hypothesized that significant differences in the transcription gradients 
of these two viruses could be associated with differences in the ability of the viruses to 
 133 
transcribe their genomes and thereby replicate.  A steeper gradient would imply less 
efficient transcription.  
 
After construction of the transcription curves, it was shown that the Meredith/02 virus did 
have a steeper gradient than the Herts 33/56 virus, particularly between the N and P gene 
mRNA transcripts.   Whilst the V protein was not specifically examined as part of the 
transcription gradient, it was assumed that transcripts encoding the V protein would be 
expressed in similar amounts to the P gene mRNA.  However, further work would be 
required to investigate this in more detail.   
 
Other work investigating the transcription gradients of Sendai, Hendra and measles 
viruses have also shown transcriptional attenuation at certain gene boundaries.  The 
Sendai virus shows attenuation at the M-F and HN-L boundaries, Hendra virus at the M-F 
and G-L boundaries and measles virus at the N-P and H-L boundaries.200,199,201  The 
attenuation seen with the Meredith/02 virus was therefore most similar to the measles 
virus.  It was suggested in the case of measles that the decreased numbers of gene 
transcripts at the 5’ end of the genome in persistently infected brain tissue could be 
associated with impaired budding of virus from the cell.  However, the effect of the 
decreased number of P transcripts could not be explained.  Work undertaken by Hodges, 
et al. draws parallels with this thesis as it also investigated an attenuated vesicular 
stomatitis virus strain, which was found to have a steepened transcription gradient.  It was 
hypothesized that mutation in the polymerase complex of the vesiculovirus may have 
resulted in decreased downstream transcription.215 
 
This transcription gradient investigation has been limited by the cell types and number of 
viruses used.  It would be helpful to repeat this work in different cell lines to ensure that the 
transcriptional profiles that were seen were not associated with the DF-1 cell line.  In 
addition, it would be worthwhile to produce transcription profiles of multiple ND viruses, 
representing all pathotypes, to determine whether the transcription gradient can always be 
correlated with pathogenicity.  This type of correlation has not been reported in the 
literature as yet. 
 
The genes that play the greatest role in virus transcription and may therefore have 
influenced the gradient are the N, P and L genes, otherwise known as the viral replication 
complex.  Given that transcription and translation are governed by similar mechanisms it 
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was therefore hypothesized that these genes may also have a role in pathogenicity of the 
Meredith/02 virus.  All three of these genes have previously been found to be determinants 
of pathogenicity of the pigeon paramyxovirus.12  Given that the gradient between the N 
and P genes of the Meredith/02 virus was the steepest, it could be hypothesized that either 
the P or L proteins are implicated in the attenuation of transcription.  When the sequences 
at the P gene boundaries were compared, there was no difference between the 
Meredith/02 and Herts 33/56 viruses.  Therefore, the most likely explanation for the 
reduced reinitiation of transcription at the P gene would be due to differences in the large 
polymerase protein. 
8.6 Further work 
After attempting to narrow the focus of the molecular basis of pathogenicity into particular 
regions of the NDV genome, it was hoped that by using reverse genetics techniques and 
interchanging specific genes, it would be possible to pinpoint sequences that explain the 
mesogenic pathotype of the Australian Meredith/02 virus.  However, over the time that this 
work was undertaken, it became apparent that it would be unlikely that identification of 
such specific regions would be within the scope of this study.  Therefore, a broader 
investigative approach was undertaken. 
 
In other studies such as that conducted by Dortmans et al. using the pigeon 
paramyxovirus, it has been found that multiple genes contribute to virulence, in their case, 
the viral replication complex (N, P and L genes).12  In the context of a virus that contains 
only six genes, this is still a significant portion of the genome and so pinpointing specific 
molecular pathogenicity determinants would involve even greater analysis.  That is not to 
say that it is an impossible task however. 
 
Overall, it seems that other than the fusion protein cleavage, which is the primary 
determinant of pathogenicity, pathogenicity of NDV is most likely a multigenic trait.  This 
makes determining the combination of molecular sequences that lead to overall 
pathogenicity very difficult.  In terms of diagnostic testing and influencing the guidelines 
that govern the declaration of an ND outbreak, it is important that pathogenicity 
determinants can be identified quickly and consistently across viruses.  It would be 
necessary to have particular regions of the genome to target diagnostically by qPCR.  
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Although, as next generation sequencing becomes more routinely incorporated into 
diagnostic testing, the need for specific qPCR may be reduced somewhat. 
 
It is possible that into the future, reverse genetics approaches may become more 
streamlined and less cost-prohibitive and such work may be more readily achievable than 
at present.  Certainly, the use of minigenome assays to investigate replication would be a 
useful initial step.  In addition, more sophisticated bioinformatics approaches may be able 
to identify pathogenic sequences more easily in silico.  In this context it would be useful to 
continue to investigate pathogenicity determinants for the Meredith/02 virus and other 
viruses, especially mesogens with unexplained phenotypes.  In particular, following up on 
the transcription gradient study and with reference to work by Dortmans et al. and Rout et 
al., it would be very interesting to further examine the large polymerase protein as a 
pathogenicity determinant.12, 13   
 
Whilst this research can’t be directly applied to the current status of ND diagnosis in 
Australia, there have been a number of questions posed during the course of this work that 
are worthy of discussion.  Firstly, if we were to detect ND viruses similar to the Meredith/02 
virus in Australia again, would a ND outbreak be declared?  Given that the current OIE 
definition of an ND outbreak is still based on the sequence motif at fusion protein cleavage 
site, then such a virus would still be notifiable to the OIE and control and eradication 
measures would be based on the current AUSVETPLAN guidelines.83  This would involve 
stamping out, disinfection, quarantine and movement controls.   
 
Secondly, is the OIE definition of a ND outbreak appropriate for mesogenic viruses such 
as the Meredith/02 virus?  Whilst the Meredith/02 virus did not produce the high mortality 
and morbidity rates of typical velogenic ND viruses, it still caused an egg drop on the 
affected property.  This would cause significant production losses in the context of a layer 
farm.  The potential impact of the virus on broiler production is however, unknown.  In 
addition, it is unclear whether the virus has the capacity to shed extensively, spread easily 
and potentially mutate to a more pathogenic form.  Therefore, in the absence of this data, 
it would be prudent to continue to include isolates with mesogenic pathotypes as notifiable 
ND viruses.  
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8.7  Conclusions 
This thesis has furthered our knowledge surrounding the molecular basis of pathogenicity 
of NDV in the context of an Australian virus isolated in Meredith, Victoria in 2002.  This 
virus has been classified as mesogenic based on its fusion protein cleavage site, MDT and 
ICPI and is therefore notifiable to the OIE despite causing minimal clinical signs in infected 
birds both in the field and experimentally.  The virus has a decreased ability to replicate 
systemically within infected poultry when compared with typical velogenic viruses, 
although it is able to replicate extensively throughout embryonated chicken eggs.  At the 
molecular level, there are a number of sequence differences between this virus and 
velogenic viruses, however none of these differences occur in regions with known 
functional importance.  Investigations into the induction of innate immunity and antagonism 
of interferon via the V protein have showed no meaningful differences between the 
Meredith/02 virus and the velogenic Herts 33/56 virus.  However, the Meredith/02 virus 
has an increased transcription gradient when compared with the velogenic Herts 33/56 
virus, with greatest transcriptional attenuation at the N-P junction, implicating the viral 
replication complex in pathogenicity. 
 
Therefore, this study has further characterized and provided important baseline data on 
the Meredith/02 virus, and whilst it has not been possible to determine specific molecular 
sequences are associated with its attenuated phenotype, it has provided options for further 
research in this area. 
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APPENDICES 
Appendix 1 Primer and probe sequences 
 
Primer/Probe Sequence (5’ – 3’) Reference 
NDV M 
forward 
AGTGATGTGCTCGGACCTTC 161 
NDV M 
reverse 
CCTGAGGAGAGGCATTTGCTA 
NDV probe [FAM] - TTCTCTAGCAGTGGGACAGCCTGC - 
[BHQ] 
18S forward CGGCTACCACATCCAAGGAA 216 
18S reverse GCTGGAATTACCGCGGCT 
18S probe [VIC] -TGCTGGCACCAGACTTGCCCTC - 
[TAMRA] 
Table A 1  Real-time TaqMan NDV PCR primers and probes 
Primer Sequence (5’ – 3’) Reference 
M13 forward CAGGAAACAGCTATGAC Applied Biosystems 
M13 reverse GTAAAACGACGGCCAG Applied Biosystems 
454 cDNA 
random primer 
GTTTCCCAGTAGGTCTCNNNNNNNN 217 
454 
amplification 
primer 
cgccGTTTCCCAGTAGGTCTC 217 
Table A 2  Cloning and Sequence Primers 
 
Primer Sequence (5’ – 3’) Reference* 
P gene F 1 GATGTTCCAGATTATGCTATGGCCACCTTT
ACAGATGCGG 
JB 
P gene F 2 gcatgaattcgccaccATGTATCCATATGATGTTC
CAGATTATGC 
JB 
P gene R gcatCTCGAGTTAGCCATTCAGCGCAAGGC
GC 
JB 
Herts 33/56 V 
F1 
gcatgaattc 
gccaccATGTATCCATATGATGTTCCAGATTA
TGC 
JB 
Herts 33/56 V 
F2 
GTCGTCCAATGCTAAAAAAGGGCCCATGG
TCGAGCCCTC 
JB 
Herts 33/56 V 
R1 
GAGGGCTCGACCATGGGCCCTTTTTTAGC
ATTGGACGAC 
JB 
Meredith V F1 gcat 
gaattcgccaccATGTATCCATATGATGTTCCAG
ATTATGC 
JB 
Meredith V F2 GTCATCTAATGCTAAAAAGGGGCCCAGTGT
CGAGCCCTC 
JB 
Meredith V R1 GAGGGCTCGACACTGGGCCCCTTTTTAGC
ATTAGATGAC 
JB 
Meredith V R2 gcat CTCGAG 
TTAGCCATTCAGCGCAAGGCGC 
JB 
pCAGGS 
forward 
GTGCTGGTTGTTGTGCTGTCTC JB 
Table A 3  Cloning primers for P and V protein expression  (*JB:  Jemma Bergfeld unpublished) 
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Primer/Probe Sequence (5’ to 3’) Reference 
IFN-alpha fwd GACAGCCAACGCCAAAGC 188 
IFN-alpha rev GTCGCTGCTGTCCAAGCATT 188 
IFN-beta fwd ACAACTTCCTACAGCACAACAACTA 189 
IFN-beta rev GCCTGGAGGCGGACATG 189 
Mx fwd GTCCAAGAGGCTGAATAACAGAGAA 190 
Mx rev GGTCGGATCTTTCTGTCATATTGGT 190 
28S fwd GGCGAAGCCAGAGGAAACT 188 
28 rev GACGACCGATTTGCACGTC 188 
Table A 4  SYBR Green PCR Primers for immune genes 
 
Primer/Probe Sequence (5’ to 3’) Reference* 
NDV N 
forward 
TATGCAGGAGCGCAATCCAA JB 
NDV N 
reverse 
TTGCGGCCTCTCTTAAGCTC JB 
NDV P forward CTCTCCGATCAGAGCAGAGC JB 
NDV P reverse AGACATCATCGCCTGCACAA JB 
NDV M 
forward 
AGTGATGTGCTCGGACCTTC 161 
NDV M 
reverse 
CCTGAGGAGAGGCATTTGCTA 161 
NDV F forward GTAGTGGCCTGATCACCGG JB 
NDV F reverse CAGGTAGGTGGCACGCATAT JB 
NDV HN 
forward 
GGTTGCACTCGGATACCCTC JB 
NDV HN 
reverse 
ATGTCCGAAGCACACCAAGT JB 
NDV L forward TCCAGTCCTTTACCGAGACT JB 
NDV L reverse AAGCTCTCTGCACAGAACGG JB 
β-actin forward AGAGGCTCCCCTGAACCCCAAAGC 185 
β-actin reverse CTGGATGGCTACATACATGGCTGG 185 
Table A 5  Transcription gradient SYBR green primers (*JB: Jemma Bergfeld unpublished) 
 
 
 
